Paul Wayne Armstrong | Scholars@Duke

Paul Wayne Armstrong
Adjunct Professor in the Department of Medicine

Current Appointments & Affiliations

Adjunct Professor in the Department of Medicine, Medicine, Cardiology, Medicine 2015

Contact Information

Background
Education, Training, & Certifications
- Cardiology Fellowship, Massachusetts General Hospital 1969 - 1971
- Assistant Residency, Medicine, Queen's University (Canada) 1967 - 1969
- Internship, University of Toronto (Canada) 1966 - 1967
- M.D., Queens University 1966
Previous Appointments & Affiliations
- Visiting Professor of Medicine, Medicine, Cardiology, Medicine 2001
Publications & Artistic Works
Selected Publications
- Academic Articles
  - Butler, Javed, Yinggan Zheng, Muhammad Shahzeb Khan, Diana Bonderman, Lars H. Lund, Christopher R. deFilippi, Robert O. Blaustein, et al. “Ejection Fraction, Biomarkers, and Outcomes and Impact of Vericiguat on Outcomes Across EF in VICTORIA.” Jacc Heart Fail 11, no. 5 (May 2023): 583–92. https://doi.org/10.1016/j.jchf.2022.12.014.
    Full Text Link to Item
  - Kaul, Padma, Sarah Rathwell, Carolyn S. P. Lam, Cynthia M. Westerhout, John A. Spertus, Kevin J. Anstrom, Robert O. Blaustein, et al. “Patient-Reported Frailty and Functional Status in Heart Failure With Preserved Ejection Fraction: Insights From VITALITY-HFpEF.” Jacc Heart Fail 11, no. 4 (April 2023): 392–403. https://doi.org/10.1016/j.jchf.2022.11.015.
    Full Text Link to Item
  - Pieske, Burkert, Elisabeth Pieske-Kraigher, Carolyn S. P. Lam, Vojtěch Melenovský, Karen Sliwa, Yuri Lopatin, Juan Luis Arango, et al. “Effect of vericiguat on left ventricular structure and function in patients with heart failure with reduced ejection fraction: the VICTORIA echocardiographic substudy.” Eur J Heart Fail, March 30, 2023. https://doi.org/10.1002/ejhf.2836.
    Full Text Link to Item
  - Felker, G Michael, Rebecca North, Hillary Mulder, W Schuyler Jones, Kevin J. Anstrom, Mahesh J. Patel, Javed Butler, et al. “Clinical Implications of Negatively Adjudicated Heart Failure Events: Data From the VICTORIA Study.” Circulation 147, no. 8 (February 21, 2023): 694–96. https://doi.org/10.1161/CIRCULATIONAHA.122.062055.
    Full Text Link to Item
  - Armstrong, Paul W., Eric R. Bates, and Mario Gaudino. “Left main coronary disease: evolving management concepts.” Eur Heart J 43, no. 44 (November 21, 2022): 4635–43. https://doi.org/10.1093/eurheartj/ehac542.
    Full Text Link to Item
  - Trujillo, Maria E., Leticia Arrington, Yogesh Patel, Julie Passarell, Larissa Wenning, Robert O. Blaustein, Paul W. Armstrong, Michaela Meyer, Corina Becker, and Ferdous Gheyas. “Population Pharmacokinetics of Vericiguat in Patients With Heart Failure With Reduced Ejection Fraction: An Integrated Analysis.” Clin Pharmacol Ther 112, no. 5 (November 2022): 1061–69. https://doi.org/10.1002/cpt.2712.
    Full Text Link to Item
  - Armstrong, Paul W., Yinggan Zheng, Richard W. Troughton, Lars H. Lund, Jian Zhang, Carolyn S. P. Lam, Cynthia M. Westerhout, et al. “Sequential Evaluation of NT-proBNP in Heart Failure: Insights Into Clinical Outcomes and Efficacy of Vericiguat.” Jacc Heart Fail 10, no. 9 (September 2022): 677–88. https://doi.org/10.1016/j.jchf.2022.04.015.
    Full Text Link to Item
  - Senni, Michele, Wendimagegn G. Alemayehu, David Sim, Frank Edelmann, Javed Butler, Justin Ezekowitz, Adrian F. Hernandez, et al. “Efficacy and safety of vericiguat in patients with heart failure with reduced ejection fraction treated with sacubitril/valsartan: insights from the VICTORIA trial.” Eur J Heart Fail 24, no. 9 (September 2022): 1614–22. https://doi.org/10.1002/ejhf.2608.
    Full Text Link to Item
  - Greene, Stephen J., Justin A. Ezekowitz, Kevin J. Anstrom, Vladimir Demyanenko, Michael M. Givertz, Ileana L. Piña, Christopher M. O’Connor, et al. “Medical Therapy During Hospitalization for Heart Failure With Reduced Ejection Fraction: The VICTORIA Registry.” J Card Fail 28, no. 7 (July 2022): 1063–77. https://doi.org/10.1016/j.cardfail.2022.02.011.
    Full Text Link to Item
  - Butler, Javed, Amanda Stebbins, Vojtěch Melenovský, Nancy K. Sweitzer, Martin R. Cowie, Josef Stehlik, Muhammad Shahzeb Khan, et al. “Vericiguat and Health-Related Quality of Life in Patients With Heart Failure With Reduced Ejection Fraction: Insights From the VICTORIA Trial.” Circ Heart Fail 15, no. 6 (June 2022): e009337. https://doi.org/10.1161/CIRCHEARTFAILURE.121.009337.
    Full Text Link to Item
  - Saldarriaga, Clara, Dan Atar, Amanda Stebbins, Basil S. Lewis, Imran Zainal Abidin, Robert O. Blaustein, Javed Butler, et al. “Vericiguat in patients with coronary artery disease and heart failure with reduced ejection fraction.” Eur J Heart Fail 24, no. 5 (May 2022): 782–90. https://doi.org/10.1002/ejhf.2468.
    Full Text Link to Item
  - Shavadia, Jay S., Wendimagegn Alemayehu, Christopher deFilippi, Cynthia M. Westerhout, Jasper Tromp, Christopher B. Granger, Paul W. Armstrong, and Sean van Diepen. “Novel multi-marker proteomics in phenotypically matched patients with ST-segment myocardial infarction: association with clinical outcomes.” J Thromb Thrombolysis 53, no. 4 (May 2022): 841–50. https://doi.org/10.1007/s11239-021-02582-5.
    Full Text Link to Item
  - Lam, Carolyn S. P., Hillary Mulder, Yuri Lopatin, Jose B. Vazquez-Tanus, David Siu, Justin Ezekowitz, Burkert Pieske, et al. “Blood Pressure and Safety Events With Vericiguat in the VICTORIA Trial.” J Am Heart Assoc 10, no. 22 (November 16, 2021): e021094. https://doi.org/10.1161/JAHA.121.021094.
    Full Text Link to Item
  - Ezekowitz, Justin A., Yinggan Zheng, Alain Cohen-Solal, Vojtěch Melenovský, Jorge Escobedo, Javed Butler, Adrian F. Hernandez, et al. “Hemoglobin and Clinical Outcomes in the Vericiguat Global Study in Patients With Heart Failure and Reduced Ejection Fraction (VICTORIA).” Circulation 144, no. 18 (November 2, 2021): 1489–99. https://doi.org/10.1161/CIRCULATIONAHA.121.056797.
    Full Text Link to Item
  - Ezekowitz, Justin, Robert J. Mentz, Cynthia M. Westerhout, Nancy K. Sweitzer, Michael M. Givertz, Ileana L. Piña, Christopher M. O’Connor, et al. “Participation in a Heart Failure Clinical Trial: Perspectives and Opportunities From the VICTORIA Trial and VICTORIA Simultaneous Registry.” Circ Heart Fail 14, no. 9 (September 2021): e008242. https://doi.org/10.1161/CIRCHEARTFAILURE.120.008242.
    Full Text Link to Item
  - Armstrong, Paul W. “Extending the Product Label for Ticagrelor: Looking Under the FDA Hood.” Circulation 144, no. 8 (August 24, 2021): 583–85. https://doi.org/10.1161/CIRCULATIONAHA.121.055907.
    Full Text Link to Item
  - Ponikowski, Piotr, Wendimagegn Alemayehu, Ali Oto, M Cecilia Bahit, Ebrahim Noori, Mahesh J. Patel, Javed Butler, et al. “Vericiguat in patients with atrial fibrillation and heart failure with reduced ejection fraction: insights from the VICTORIA trial.” Eur J Heart Fail 23, no. 8 (August 2021): 1300–1312. https://doi.org/10.1002/ejhf.2285.
    Full Text Link to Item
  - Voors, Adriaan A., Hillary Mulder, Eugene Reyes, Martin R. Cowie, Johan Lassus, Adrian F. Hernandez, Justin A. Ezekowitz, et al. “Renal function and the effects of vericiguat in patients with worsening heart failure with reduced ejection fraction: insights from the VICTORIA (Vericiguat Global Study in Subjects with HFrEF) trial.” Eur J Heart Fail 23, no. 8 (August 2021): 1313–21. https://doi.org/10.1002/ejhf.2221.
    Full Text Link to Item
  - Mentz, Robert J., Hillary Mulder, Arend Mosterd, Nancy K. Sweitzer, Michele Senni, Javed Butler, Justin A. Ezekowitz, et al. “Clinical Outcome Predictions for the VerICiguaT Global Study in Subjects With Heart Failure With Reduced Ejection Fraction (VICTORIA) Trial.” J Card Fail, June 24, 2021. https://doi.org/10.1016/j.cardfail.2021.05.016.
    Full Text Link to Item
  - Lam, Carolyn S. P., Anna Giczewska, Karen Sliwa, Frank Edelmann, Jens Refsgaard, Edimar Bocchi, Justin A. Ezekowitz, et al. “Clinical Outcomes and Response to Vericiguat According to Index Heart Failure Event: Insights From the VICTORIA Trial.” Jama Cardiol 6, no. 6 (June 1, 2021): 706–12. https://doi.org/10.1001/jamacardio.2020.6455.
    Full Text Link to Item
  - Armstrong, Paul W., and Justin A. Ezekowitz. “Reply: Optimal Positioning of Novel Heart Failure Pharmacotherapies: The Case of Vericiguat.” Jacc Heart Fail 9, no. 5 (May 2021): 403. https://doi.org/10.1016/j.jchf.2021.03.001.
    Full Text Link to Item
  - Diepen, Sean van, and Paul W. Armstrong. “Learning whether to subtract beta-blockers: it's about time.” Eur Heart J 42, no. 9 (March 1, 2021): 915–18. https://doi.org/10.1093/eurheartj/ehaa1033.
    Full Text Link to Item
  - Armstrong, P. W., and V. Fuster. “In Memoriam: James T. Willerson, 1939 to 2020.” Journal of the American College of Cardiology 76, no. 18 (November 3, 2020): 2173–74. https://doi.org/10.1016/j.jacc.2020.09.587.
    Full Text
  - Ezekowitz, Justin A., Christopher M. O’Connor, Richard W. Troughton, Wendimagegn G. Alemayehu, Cynthia M. Westerhout, Adriaan A. Voors, Javed Butler, et al. “N-Terminal Pro-B-Type Natriuretic Peptide and Clinical Outcomes: Vericiguat Heart Failure With Reduced Ejection Fraction Study.” Jacc Heart Fail 8, no. 11 (November 2020): 931–39. https://doi.org/10.1016/j.jchf.2020.08.008.
    Full Text Link to Item
  - Luoma, Leiah M., Cynthia M. Westerhout, Christopher B. Granger, and Paul W. Armstrong. “Influence of Clinical Trials of Acute Coronary Syndrome Beyond the Primary Hypothesis: A Systematic Review.” Jama Cardiol 5, no. 11 (November 1, 2020): 1286–97. https://doi.org/10.1001/jamacardio.2020.2855.
    Full Text Link to Item
  - McAlister, Finlay A., Yinggan Zheng, Cynthia M. Westerhout, John B. Buse, Eberhard Standl, Darren K. McGuire, Frans Van de Werf, et al. “Association between glycated haemoglobin levels and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease: a secondary analysis of the TECOS randomized clinical trial.” Eur J Heart Fail 22, no. 11 (November 2020): 2026–34. https://doi.org/10.1002/ejhf.1958.
    Full Text Link to Item
  - Armstrong, Paul W., Carolyn S. P. Lam, Kevin J. Anstrom, Justin Ezekowitz, Adrian F. Hernandez, Christopher M. O’Connor, Burkert Pieske, et al. “Effect of Vericiguat vs Placebo on Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The VITALITY-HFpEF Randomized Clinical Trial.” Jama 324, no. 15 (October 20, 2020): 1512–21. https://doi.org/10.1001/jama.2020.15922.
    Full Text Link to Item
  - Armstrong, Paul W., Kevin J. Anstrom, Christopher M. O’Connor, and Christopher M. VICTORIA Study Group. “Vericiguat in Heart Failure with Reduced Ejection Fraction. Reply.” N Engl J Med 383, no. 15 (October 8, 2020): 1497–98. https://doi.org/10.1056/NEJMc2027731.
    Full Text Link to Item
  - Armstrong, Paul W., Burkert Pieske, and Christopher M. O’Connor. “Effects of vericiguat in heart failure with reduced ejection fraction: do not forget sST2. Reply.” Eur J Heart Fail 22, no. 10 (October 2020): 1935. https://doi.org/10.1002/ejhf.1765.
    Full Text Link to Item
  - Marquis-Gravel, Guillaume, Megan L. Neely, Marco Valgimigli, Francesco Costa, David Van Klaveren, Rituparna Altner, Deepak L. Bhatt, et al. “Long-Term Bleeding Risk Prediction with Dual Antiplatelet Therapy After Acute Coronary Syndromes Treated Without Revascularization.” Circ Cardiovasc Qual Outcomes 13, no. 9 (September 2020): e006582. https://doi.org/10.1161/CIRCOUTCOMES.120.006582.
    Full Text Link to Item
  - Butler, Javed, Kevin J. Anstrom, and Paul W. Armstrong. “Comparing the Benefit of Novel Therapies Across Clinical Trials: Insights From the VICTORIA Trial.” Circulation 142, no. 8 (August 25, 2020): 717–19. https://doi.org/10.1161/CIRCULATIONAHA.120.047086.
    Full Text Link to Item
  - Armstrong, Paul W., Kris Bogaerts, Robert Welsh, Peter R. Sinnaeve, Patrick Goldstein, Alain Pages, Thierry Danays, Frans Van de Werf, and Frans STREAM 2 Study Groups (appendix). “The Second Strategic Reperfusion Early After Myocardial Infarction (STREAM-2) study optimizing pharmacoinvasive reperfusion strategy in older ST-elevation myocardial infarction patients.” Am Heart J 226 (August 2020): 140–46. https://doi.org/10.1016/j.ahj.2020.04.029.
    Full Text Link to Item
  - Marquis-Gravel, Guillaume, Frederik Dalgaard, Aaron D. Jones, Yuliya Lokhnygina, Stefan K. James, Robert A. Harrington, Lars Wallentin, et al. “Post-Discharge Bleeding and Mortality Following Acute Coronary Syndromes With or Without PCI.” J Am Coll Cardiol 76, no. 2 (July 14, 2020): 162–71. https://doi.org/10.1016/j.jacc.2020.05.031.
    Full Text Link to Item
  - Bainey, Kevin R., Wendimagegn Alemayehu, Paul W. Armstrong, Cynthia M. Westerhout, Padma Kaul, and Robert C. Welsh. “Long-Term Outcomes of Complete Revascularization With Percutaneous Coronary Intervention in Acute Coronary Syndromes.” Jacc Cardiovasc Interv 13, no. 13 (July 13, 2020): 1557–67. https://doi.org/10.1016/j.jcin.2020.04.034.
    Full Text Link to Item
  - Shavadia, Jay S., Christopher B. Granger, Wendimagegn Alemayehu, Cynthia M. Westerhout, Thomas J. Povsic, Sean Van Diepen, Christopher Defilippi, and Paul W. Armstrong. “Novel Biomarkers, ST-Elevation Resolution, and Clinical Outcomes Following Primary Percutaneous Coronary Intervention.” J Am Heart Assoc 9, no. 13 (July 7, 2020): e016033. https://doi.org/10.1161/JAHA.120.016033.
    Full Text Link to Item
  - Bainey, Kevin R., Eric R. Bates, and Paul W. Armstrong. “ST-Segment-Elevation Myocardial Infarction Care and COVID-19: The Value Proposition of Fibrinolytic Therapy and the Pharmacoinvasive Strategy.” Circ Cardiovasc Qual Outcomes 13, no. 6 (June 2020): e006834. https://doi.org/10.1161/CIRCOUTCOMES.120.006834.
    Full Text Link to Item
  - Bhatt, Ankeet S., Andrew P. Ambrosy, Allison Dunning, Adam D. DeVore, Javed Butler, Shelby Reed, Adriaan Voors, et al. “The burden of non-cardiac comorbidities and association with clinical outcomes in an acute heart failure trial - insights from ASCEND-HF.” Eur J Heart Fail 22, no. 6 (June 2020): 1022–31. https://doi.org/10.1002/ejhf.1795.
    Full Text Link to Item
  - Armstrong, Paul W., Burkert Pieske, Kevin J. Anstrom, Justin Ezekowitz, Adrian F. Hernandez, Javed Butler, Carolyn S. P. Lam, et al. “Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction.” N Engl J Med 382, no. 20 (May 14, 2020): 1883–93. https://doi.org/10.1056/NEJMoa1915928.
    Full Text Link to Item
  - Armstrong, Paul W. “Enhancing Cardiovascular Care: Global Collaboration Is How It Happens.” Circulation 141, no. 17 (April 28, 2020): 1357–59. https://doi.org/10.1161/CIRCULATIONAHA.120.046394.
    Full Text Link to Item
  - McAlister, F. A., A. Savu, J. A. Ezekowitz, P. W. Armstrong, and P. Kaul. “The hospital frailty risk score in patients with heart failure is strongly associated with outcomes but less so with pharmacotherapy.” J Intern Med 287, no. 3 (March 2020): 322–32. https://doi.org/10.1111/joim.13002.
    Full Text Link to Item
  - De Ferrari, Gaetano M., Susanna R. Stevens, Giuseppe Ambrosio, Sergio Leonardi, Paul W. Armstrong, Jennifer B. Green, Malgorzata Wamil, Rury R. Holman, Eric D. Peterson, and Eric D. TECOS Study Group. “Low-density lipoprotein cholesterol treatment and outcomes in patients with type 2 diabetes and established cardiovascular disease: Insights from TECOS.” Am Heart J 220 (February 2020): 82–88. https://doi.org/10.1016/j.ahj.2019.11.005.
    Full Text Link to Item
  - Shavadia, Jay S., Christopher B. Granger, Wendimagegn Alemayehu, Cynthia M. Westerhout, Thomas J. Povsic, Sorin J. Brener, Sean van Diepen, Christopher Defilippi, and Paul W. Armstrong. “High-throughput targeted proteomics discovery approach and spontaneous reperfusion in ST-segment elevation myocardial infarction.” Am Heart J 220 (February 2020): 137–44. https://doi.org/10.1016/j.ahj.2019.09.015.
    Full Text Link to Item
  - McAlister, Finlay A., Justin A. Ezekowitz, and Paul W. Armstrong. “Heart failure treatment and the art of medical decision making.” Eur J Heart Fail 21, no. 12 (December 2019): 1510–14. https://doi.org/10.1002/ejhf.1655.
    Full Text Link to Item
  - Pieske, Burkert, Mahesh J. Patel, Cynthia M. Westerhout, Kevin J. Anstrom, Javed Butler, Justin Ezekowitz, Adrian F. Hernandez, et al. “Baseline features of the VICTORIA (Vericiguat Global Study in Subjects with Heart Failure with Reduced Ejection Fraction) trial.” Eur J Heart Fail 21, no. 12 (December 2019): 1596–1604. https://doi.org/10.1002/ejhf.1664.
    Full Text Link to Item
  - Shavadia, Jay S., Yinggan Zheng, Jennifer B. Green, Paul W. Armstrong, Cynthia M. Westerhout, Darren K. McGuire, Jan H. Cornel, Rury R. Holman, and Eric D. Peterson. “Associations between β-blocker therapy and cardiovascular outcomes in patients with diabetes and established cardiovascular disease.” Am Heart J 218 (December 2019): 92–99. https://doi.org/10.1016/j.ahj.2019.09.013.
    Full Text Link to Item
  - Bainey, Kevin R., Paul W. Armstrong, Yinggan Zheng, Neil Brass, Benjamin D. Tyrrell, Raymond Leung, Cynthia M. Westerhout, and Robert C. Welsh. “Pharmacoinvasive Strategy Versus Primary Percutaneous Coronary Intervention in ST-Elevation Myocardial Infarction in Clinical Practice: Insights From the Vital Heart Response Registry.” Circ Cardiovasc Interv 12, no. 10 (October 2019): e008059. https://doi.org/10.1161/CIRCINTERVENTIONS.119.008059.
    Full Text Link to Item
  - Kwee, Lydia Coulter, Megan L. Neely, Elizabeth Grass, Simon G. Gregory, Matthew T. Roe, E Magnus Ohman, Keith A. A. Fox, et al. “Associations of osteopontin and NT-proBNP with circulating miRNA levels in acute coronary syndrome.” Physiol Genomics 51, no. 10 (October 1, 2019): 506–15. https://doi.org/10.1152/physiolgenomics.00033.2019.
    Full Text Link to Item
  - Grodin, Justin L., Max J. Liebo, Javed Butler, Marco Metra, G Michael Felker, Adrian F. Hernandez, Adriaan A. Voors, et al. “Prognostic Implications of Changes in Amino-Terminal Pro-B-Type Natriuretic Peptide in Acute Decompensated Heart Failure: Insights From ASCEND-HF.” J Card Fail 25, no. 9 (September 2019): 703–11. https://doi.org/10.1016/j.cardfail.2019.04.002.
    Full Text Link to Item
  - Triposkiadis, Filippos, Javed Butler, Francois M. Abboud, Paul W. Armstrong, Stamatis Adamopoulos, John J. Atherton, Johannes Backs, et al. “The continuous heart failure spectrum: moving beyond an ejection fraction classification.” Eur Heart J 40, no. 26 (July 1, 2019): 2155–63. https://doi.org/10.1093/eurheartj/ehz158.
    Full Text Link to Item
  - Armstrong, Paul W., and C David Naylor. “Counteracting Health Misinformation: A Role for Medical Journals?” Jama 321, no. 19 (May 21, 2019): 1863–64. https://doi.org/10.1001/jama.2019.5168.
    Full Text Link to Item
  - Butler, Javed, Carolyn S. P. Lam, Kevin J. Anstrom, Justin Ezekowitz, Adrian F. Hernandez, Christopher M. O’Connor, Burkert Pieske, et al. “Rationale and Design of the VITALITY-HFpEF Trial.” Circ Heart Fail 12, no. 5 (May 2019): e005998. https://doi.org/10.1161/CIRCHEARTFAILURE.119.005998.
    Full Text Link to Item
  - Stewart, Ralph A. H., Claes Held, Sue Krug-Gourley, Dawn Waterworth, Amanda Stebbins, Karen Chiswell, Emil Hagstrom, Paul W. Armstrong, Lars Wallentin, and Harvey White. “Cardiovascular and Lifestyle Risk Factors and Cognitive Function in Patients With Stable Coronary Heart Disease.” J Am Heart Assoc 8, no. 7 (April 2, 2019): e010641. https://doi.org/10.1161/JAHA.118.010641.
    Full Text Link to Item
  - Kaul, Padma, Karen P. Alexander, E Magnus Ohman, Anamaria Savu, Matthew T. Roe, Shaun G. Goodman, Keith A. Fox, et al. “Sex And Prognostic Significance of Self-Reported Frailty in Non-ST-Segment Elevation Acute Coronary Syndromes: Insights From the TRILOGY ACS Trial.” Can J Cardiol 35, no. 4 (April 2019): 430–37. https://doi.org/10.1016/j.cjca.2018.12.035.
    Full Text Link to Item
  - Wong, Graham C., Michelle Welsford, Craig Ainsworth, Wael Abuzeid, Christopher B. Fordyce, Jennifer Greene, Thao Huynh, et al. “2019 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology Guidelines on the Acute Management of ST-Elevation Myocardial Infarction: Focused Update on Regionalization and Reperfusion.” Can J Cardiol 35, no. 2 (February 2019): 107–32. https://doi.org/10.1016/j.cjca.2018.11.031.
    Full Text Link to Item
  - Vanhaverbeke, Maarten, Kris Bogaerts, Peter R. Sinnaeve, Luc Janssens, Paul W. Armstrong, and Frans Van de Werf. “Prevention of Cardiogenic Shock After Acute Myocardial Infarction.” Circulation 139, no. 1 (January 2, 2019): 137–39. https://doi.org/10.1161/CIRCULATIONAHA.118.036536.
    Full Text Link to Item
  - Ungar, Leo, Robert M. Clare, Fatima Rodriguez, Bradley J. Kolls, Paul W. Armstrong, Philip Aylward, Claes Held, et al. “Stroke Outcomes With Vorapaxar Versus Placebo in Patients With Acute Coronary Syndromes: Insights From the TRACER Trial.” J Am Heart Assoc 7, no. 24 (December 18, 2018): e009609. https://doi.org/10.1161/JAHA.118.009609.
    Full Text Link to Item
  - Fanaroff, Alexander C., Derek Cyr, Megan L. Neely, Jeffery Bakal, Harvey D. White, Keith A. A. Fox, Paul W. Armstrong, Renato D. Lopes, E Magnus Ohman, and Matthew T. Roe. “Days Alive and Out of Hospital: Exploring a Patient-Centered, Pragmatic Outcome in a Clinical Trial of Patients With Acute Coronary Syndromes.” Circ Cardiovasc Qual Outcomes 11, no. 12 (December 2018): e004755. https://doi.org/10.1161/CIRCOUTCOMES.118.004755.
    Full Text Link to Item
  - Fudim, Marat, Kishan S. Parikh, Allison Dunning, Adam D. DeVore, Robert J. Mentz, Phillip J. Schulte, Paul W. Armstrong, et al. “Relation of Volume Overload to Clinical Outcomes in Acute Heart Failure (From ASCEND-HF).” Am J Cardiol 122, no. 9 (November 1, 2018): 1506–12. https://doi.org/10.1016/j.amjcard.2018.07.023.
    Full Text Link to Item
  - Alfredsson, Joakim, Jennifer B. Green, Susanna R. Stevens, Shelby D. Reed, Paul W. Armstrong, M. Angelyn Bethel, Samuel S. Engel, et al. “Sex differences in management and outcomes of patients with type 2 diabetes and cardiovascular disease: A report from TECOS.” Diabetes Obes Metab 20, no. 10 (October 2018): 2379–88. https://doi.org/10.1111/dom.13377.
    Full Text Link to Item
  - Greene, Stephen J., Adrian F. Hernandez, Jie-Lena Sun, Javed Butler, Paul W. Armstrong, Justin A. Ezekowitz, Faiez Zannad, et al. “Relationship Between Enrolling Country Income Level and Patient Profile, Protocol Completion, and Trial End Points.” Circ Cardiovasc Qual Outcomes 11, no. 10 (October 2018): e004783. https://doi.org/10.1161/CIRCOUTCOMES.118.004783.
    Full Text Link to Item
  - Welsh, Robert C., Patrick Goldstein, Peter Sinnaeve, Miodrag C. Ostojic, Yinggan Zheng, Thierry Danays, Cynthia M. Westerhout, Frans Van de Werf, and Paul W. Armstrong. “Relationship between community hospital versus pre-hospital location of randomisation and clinical outcomes in ST-elevation myocardial infarction patients: insights from the Stream study.” Eur Heart J Acute Cardiovasc Care 7, no. 6 (September 2018): 504–13. https://doi.org/10.1177/2048872617700872.
    Full Text Link to Item
  - Tricoci, Pierluigi, Megan Neely, Michael J. Whitley, Leonard C. Edelstein, Lukas M. Simon, Chad Shaw, Paolo Fortina, et al. “Effects of genetic variation in protease activated receptor 4 after an acute coronary syndrome: Analysis from the TRACER trial.” Blood Cells Mol Dis 72 (September 2018): 37–43. https://doi.org/10.1016/j.bcmd.2018.07.004.
    Full Text Link to Item
  - Yan, Andrew T., Matthew T. Roe, Megan Neely, Derek D. Cyr, Harvey White, Keith A. A. Fox, Dorairaj Prabhakaran, Paul W. Armstrong, Erik M. Ohman, and Shaun G. Goodman. “Early discontinuation of prasugrel or clopidogrel in acute coronary syndromes: insights from the TRILOGY ACS trial.” Coron Artery Dis 29, no. 6 (September 2018): 469–76. https://doi.org/10.1097/MCA.0000000000000623.
    Full Text Link to Item
  - Bainey, Kevin R., Robert C. Welsh, Wendimagegn Alemayehu, Cynthia M. Westerhout, Dean Traboulsi, Todd Anderson, Neil Brass, Paul W. Armstrong, and Padma Kaul. “Population-level incidence and outcomes of myocardial infarction with non-obstructive coronary arteries (MINOCA): Insights from the Alberta contemporary acute coronary syndrome patients invasive treatment strategies (COAPT) study.” Int J Cardiol 264 (August 1, 2018): 12–17. https://doi.org/10.1016/j.ijcard.2018.04.004.
    Full Text Link to Item
  - Grodin, Justin L., Javed Butler, Marco Metra, G Michael Felker, Adriaan A. Voors, John J. McMurray, Paul W. Armstrong, et al. “Circulating Cardiac Troponin I Levels Measured by a Novel Highly Sensitive Assay in Acute Decompensated Heart Failure: Insights From the ASCEND-HF Trial.” J Card Fail 24, no. 8 (August 2018): 512–19. https://doi.org/10.1016/j.cardfail.2018.06.008.
    Full Text Link to Item
  - Scirica, Benjamin M., Sameer Bansilal, Farideh Davoudi, Paul W. Armstrong, Robert M. Clare, Phillip J. Schulte, Karen S. Pieper, et al. “Safety of ticagrelor in patients with baseline conduction abnormalities: A PLATO (Study of Platelet Inhibition and Patient Outcomes) analysis.” Am Heart J 202 (August 2018): 54–60. https://doi.org/10.1016/j.ahj.2018.04.020.
    Full Text Link to Item
  - Armstrong, Paul W., and Joseph A. Hill. “Circulation Global Rounds.” Circulation 138, no. 1 (July 3, 2018): 10–11. https://doi.org/10.1161/CIRCULATIONAHA.118.035695.
    Full Text Link to Item
  - Rymer, Jennifer A., Michael W. Tempelhof, Robert M. Clare, Karen S. Pieper, Christopher B. Granger, Frans Van de Werf, David J. Moliterno, et al. “Discharge timing and outcomes after uncomplicated non-ST-segment elevation acute myocardial infarction.” Am Heart J 201 (July 2018): 103–10. https://doi.org/10.1016/j.ahj.2018.04.010.
    Full Text Link to Item
  - Verma, Amanda K., Jie-Lena Sun, Adrian Hernandez, John R. Teerlink, Phillip J. Schulte, Justin Ezekowitz, Adriaan Voors, et al. “Rate pressure product and the components of heart rate and systolic blood pressure in hospitalized heart failure patients with preserved ejection fraction: Insights from ASCEND-HF.” Clin Cardiol 41, no. 7 (July 2018): 945–52. https://doi.org/10.1002/clc.22981.
    Full Text Link to Item
  - Armstrong, Paul W., Robert J. Mentz, and Cynthia M. Westerhout. “Traveling the Interstices of Data Sharing.” Jacc Heart Fail 6, no. 6 (June 2018): 533–35. https://doi.org/10.1016/j.jchf.2018.02.003.
    Full Text Link to Item
  - Tricoci, Pierluigi, L Kristin Newby, Robert M. Clare, Sergio Leonardi, C Michael Gibson, Robert P. Giugliano, Paul W. Armstrong, et al. “Prognostic and Practical Validation of Current Definitions of Myocardial Infarction Associated With Percutaneous Coronary Intervention.” Jacc Cardiovasc Interv 11, no. 9 (May 14, 2018): 856–64. https://doi.org/10.1016/j.jcin.2018.02.006.
    Full Text Link to Item
  - Cerbin, Lukasz P., Andrew P. Ambrosy, Stephen J. Greene, Paul W. Armstrong, Javed Butler, Adrian Coles, Adam D. DeVore, et al. “Is Time of the Essence? The Impact of Time of Hospital Presentation in Acute Heart Failure: Insights From ASCEND-HF Trial.” Jacc Heart Fail 6, no. 4 (April 2018): 298–307. https://doi.org/10.1016/j.jchf.2018.01.018.
    Full Text Link to Item
  - Michalak, Marek, and Paul W. Armstrong. “Exploring New Cardiovascular Pathways: Are Soluble Guanylate Cyclase Stimulators the Right Direction?” Circ Heart Fail 11, no. 3 (March 2018): e004813. https://doi.org/10.1161/CIRCHEARTFAILURE.118.004813.
    Full Text Link to Item
  - Mehta, Shamir R., Kevin R. Bainey, Warren J. Cantor, Marie Lordkipanidzé, Guillaume Marquis-Gravel, Simon D. Robinson, Matthew Sibbald, et al. “2018 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology Focused Update of the Guidelines for the Use of Antiplatelet Therapy.” Can J Cardiol 34, no. 3 (March 2018): 214–33. https://doi.org/10.1016/j.cjca.2017.12.012.
    Full Text Link to Item
  - Standl, Eberhard, Susanna R. Stevens, Paul W. Armstrong, John B. Buse, Juliana C. N. Chan, Jennifer B. Green, John M. Lachin, et al. “Increased Risk of Severe Hypoglycemic Events Before and After Cardiovascular Outcomes in TECOS Suggests an At-Risk Type 2 Diabetes Frail Patient Phenotype.” Diabetes Care 41, no. 3 (March 2018): 596–603. https://doi.org/10.2337/dc17-1778.
    Full Text Link to Item
  - Bhatt, Ankeet S., Lauren B. Cooper, Andrew P. Ambrosy, Robert M. Clare, Adrian Coles, Emer Joyce, Arun Krishnamoorthy, et al. “Interaction of Body Mass Index on the Association Between N-Terminal-Pro-b-Type Natriuretic Peptide and Morbidity and Mortality in Patients With Acute Heart Failure: Findings From ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure).” J Am Heart Assoc 7, no. 3 (February 3, 2018). https://doi.org/10.1161/JAHA.117.006740.
    Full Text Link to Item
  - Guimarães, Patrícia O., Sergio Leonardi, Zhen Huang, Lars Wallentin, Frans Van de Werf, Philip E. Aylward, Claes Held, et al. “Clinical features and outcomes of patients with type 2 myocardial infarction: Insights from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) trial.” Am Heart J 196 (February 2018): 28–35. https://doi.org/10.1016/j.ahj.2017.10.007.
    Full Text Link to Item
  - Armstrong, Paul W., Lothar Roessig, Mahesh J. Patel, Kevin J. Anstrom, Javed Butler, Adriaan A. Voors, Carolyn S. P. Lam, et al. “A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of the Oral Soluble Guanylate Cyclase Stimulator: The VICTORIA Trial.” Jacc Heart Fail 6, no. 2 (February 2018): 96–104. https://doi.org/10.1016/j.jchf.2017.08.013.
    Full Text Link to Item
  - Fudim, Marat, Christopher M. O’Connor, Allison Dunning, Andrew P. Ambrosy, Paul W. Armstrong, Adrian Coles, Justin A. Ezekowitz, et al. “Aetiology, timing and clinical predictors of early vs. late readmission following index hospitalization for acute heart failure: insights from ASCEND-HF.” Eur J Heart Fail 20, no. 2 (February 2018): 304–14. https://doi.org/10.1002/ejhf.1020.
    Full Text Link to Item
  - Hagström, E., F. Norlund, A. Stebbins, P. W. Armstrong, K. Chiswell, C. B. Granger, J. López-Sendón, et al. “Psychosocial stress and major cardiovascular events in patients with stable coronary heart disease.” J Intern Med 283, no. 1 (January 2018): 83–92. https://doi.org/10.1111/joim.12692.
    Full Text Link to Item
  - Sharma, Abhinav, Jennifer B. Green, Allison Dunning, Yuliya Lokhnygina, Sana M. Al-Khatib, Renato D. Lopes, John B. Buse, et al. “Causes of Death in a Contemporary Cohort of Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: Insights From the TECOS Trial.” Diabetes Care 40, no. 12 (December 2017): 1763–70. https://doi.org/10.2337/dc17-1091.
    Full Text Link to Item
  - Navar, Ann Marie, Dianne S. Gallup, Yuliya Lokhnygina, Jennifer B. Green, Darren K. McGuire, Paul W. Armstrong, John B. Buse, et al. “Hypertension Control in Adults With Diabetes Mellitus and Recurrent Cardiovascular Events: Global Results From the Trial Evaluating Cardiovascular Outcomes With Sitagliptin.” Hypertension 70, no. 5 (November 2017): 907–14. https://doi.org/10.1161/HYPERTENSIONAHA.117.09482.
    Full Text Link to Item
  - Russo, Juan J., Shaun G. Goodman, Warren J. Cantor, Dennis T. Ko, Akshay Bagai, Mary K. Tan, Carlo Di Mario, et al. “Does renal function affect the efficacy or safety of a pharmacoinvasive strategy in patients with ST-elevation myocardial infarction? A meta-analysis.” Am Heart J 193 (November 2017): 46–54. https://doi.org/10.1016/j.ahj.2017.07.015.
    Full Text Link to Item
  - Zheng, Yinggan, Kevin R. Bainey, Benjamin D. Tyrrell, Neil Brass, Paul W. Armstrong, and Robert C. Welsh. “Relationships Between Baseline Q Waves, Time From Symptom Onset, and Clinical Outcomes in ST-Segment-Elevation Myocardial Infarction Patients: Insights From the Vital Heart Response Registry.” Circ Cardiovasc Interv 10, no. 11 (November 2017). https://doi.org/10.1161/CIRCINTERVENTIONS.117.005399.
    Full Text Link to Item
  - Armstrong, Paul W., and Robert C. Welsh. “Recalibrating Reperfusion Waypoints.” Circulation 136, no. 16 (October 17, 2017): 1474–76. https://doi.org/10.1161/CIRCULATIONAHA.117.030869.
    Full Text Link to Item
  - Stewart, Ralph A. H., Claes Held, Nermin Hadziosmanovic, Paul W. Armstrong, Christopher P. Cannon, Christopher B. Granger, Emil Hagström, et al. “Physical Activity and Mortality in Patients With Stable Coronary Heart Disease.” J Am Coll Cardiol 70, no. 14 (October 3, 2017): 1689–1700. https://doi.org/10.1016/j.jacc.2017.08.017.
    Full Text Link to Item
  - Pagidipati, Neha J., Ann Marie Navar, Karen S. Pieper, Jennifer B. Green, M Angelyn Bethel, Paul W. Armstrong, Robert G. Josse, et al. “Secondary Prevention of Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus: International Insights From the TECOS Trial (Trial Evaluating Cardiovascular Outcomes With Sitagliptin).” Circulation 136, no. 13 (September 26, 2017): 1193–1203. https://doi.org/10.1161/CIRCULATIONAHA.117.027252.
    Full Text Link to Item
  - Ewy, Gordon A., and Paul W. Armstrong. “A Natural Biomarker Deserving Attention: Gasping Following Primary Cardiac Arrest.” J Am Coll Cardiol 70, no. 12 (September 19, 2017): 1477–78. https://doi.org/10.1016/j.jacc.2017.07.780.
    Full Text Link to Item
  - Giannitsis, Evangelos, Lars Wallentin, Stefan K. James, Maria Bertilsson, Agneta Siegbahn, Robert F. Storey, Steen Husted, et al. “Outcomes after planned invasive or conservative treatment strategy in patients with non-ST-elevation acute coronary syndrome and a normal value of high sensitivity troponin at randomisation: A Platelet Inhibition and Patient Outcomes (PLATO) trial biomarker substudy.” Eur Heart J Acute Cardiovasc Care 6, no. 6 (September 2017): 500–510. https://doi.org/10.1177/2048872616641901.
    Full Text Link to Item
  - Stewart, Ralph A. H., Emil Hagström, Claes Held, Tom Kai Ming Wang, Paul W. Armstrong, Philip E. Aylward, Christopher P. Cannon, et al. “Self-Reported Health and Outcomes in Patients With Stable Coronary Heart Disease.” J Am Heart Assoc 6, no. 8 (August 22, 2017). https://doi.org/10.1161/JAHA.117.006096.
    Full Text Link to Item
  - McAlister, Finlay A., Andreas Laupacis, and Paul W. Armstrong. “Finding the right balance between precision medicine and personalized care.” Cmaj 189, no. 33 (August 21, 2017): E1065–68. https://doi.org/10.1503/cmaj.170107.
    Full Text Link to Item
  - Lindholm, Daniel, Johan Lindbäck, Paul W. Armstrong, Andrzej Budaj, Christopher P. Cannon, Christopher B. Granger, Emil Hagström, et al. “Biomarker-Based Risk Model to Predict Cardiovascular Mortality in Patients With Stable Coronary Disease.” J Am Coll Cardiol 70, no. 7 (August 15, 2017): 813–26. https://doi.org/10.1016/j.jacc.2017.06.030.
    Full Text Link to Item
  - Bainey, Kevin R., Padma Kaul, Paul W. Armstrong, Anamaria Savu, Cynthia M. Westerhout, Colleen M. Norris, Neil Brass, et al. “Hospital variation in treatment and outcomes in acute coronary syndromes: Insights from the Alberta Contemporary Acute Coronary Syndrome Patients Invasive Treatment Strategies (COAPT) study.” Int J Cardiol 241 (August 15, 2017): 70–75. https://doi.org/10.1016/j.ijcard.2017.04.109.
    Full Text Link to Item
  - Alfredsson, Joakim, Benjamin Neely, Megan L. Neely, Deepak L. Bhatt, Shaun G. Goodman, Pierluigi Tricoci, Kenneth W. Mahaffey, et al. “Predicting the risk of bleeding during dual antiplatelet therapy after acute coronary syndromes.” Heart 103, no. 15 (August 2017): 1168–76. https://doi.org/10.1136/heartjnl-2016-310090.
    Full Text Link to Item
  - Chan, Mark Y., Megan L. Neely, Matthew T. Roe, Shaun G. Goodman, David Erlinge, Jan H. Cornel, Kenneth J. Winters, et al. “Temporal Biomarker Profiling Reveals Longitudinal Changes in Risk of Death or Myocardial Infarction in Non-ST-Segment Elevation Acute Coronary Syndrome.” Clin Chem 63, no. 7 (July 2017): 1214–26. https://doi.org/10.1373/clinchem.2016.265272.
    Full Text Link to Item
  - Greene, Stephen J., Adrian F. Hernandez, Allison Dunning, Andrew P. Ambrosy, Paul W. Armstrong, Javed Butler, Lukasz P. Cerbin, et al. “Hospitalization for Recently Diagnosed Versus Worsening Chronic Heart Failure: From the ASCEND-HF Trial.” J Am Coll Cardiol 69, no. 25 (June 27, 2017): 3029–39. https://doi.org/10.1016/j.jacc.2017.04.043.
    Full Text Link to Item
  - Armstrong, Paul W., and Cynthia M. Westerhout. “Composite End Points in Clinical Research: A Time for Reappraisal.” Circulation 135, no. 23 (June 6, 2017): 2299–2307. https://doi.org/10.1161/CIRCULATIONAHA.117.026229.
    Full Text Link to Item
  - Dalby, Anthony J., Shmuel Gottlieb, Derek D. Cyr, Erik Magnus Ohman, Darren K. McGuire, Witold Ruzyllo, Deepak L. Bhatt, et al. “Dual antiplatelet therapy in patients with diabetes and acute coronary syndromes managed without revascularization.” Am Heart J 188 (June 2017): 156–66. https://doi.org/10.1016/j.ahj.2017.03.015.
    Full Text Link to Item
  - Raslan, Ismail R., Paul Brown, Cynthia M. Westerhout, Justin A. Ezekowitz, Adrian F. Hernandez, Randall C. Starling, Christopher O’Connor, et al. “Characterization of hemodynamically stable acute heart failure patients requiring a critical care unit admission: Derivation, validation, and refinement of a risk score.” Am Heart J 188 (June 2017): 127–35. https://doi.org/10.1016/j.ahj.2017.03.014.
    Full Text Link to Item
  - Sepehrvand, Nariman, Yinggan Zheng, Paul W. Armstrong, Robert C. Welsh, and Justin A. Ezekowitz. “Identifying Low-risk Patients for Early Discharge From Emergency Department Without Using Subjective Descriptions of Chest Pain: Insights From Providing Rapid Out of Hospital Acute Cardiovascular Treatment (PROACT) 3 and 4 Trials.” Acad Emerg Med 24, no. 6 (June 2017): 691–700. https://doi.org/10.1111/acem.13183.
    Full Text Link to Item
  - Wang, Alice, Lydia Coulter Kwee, Elizabeth Grass, Megan L. Neely, Simon G. Gregory, Keith A. A. Fox, Paul W. Armstrong, et al. “Whole blood sequencing reveals circulating microRNA associations with high-risk traits in non-ST-segment elevation acute coronary syndrome.” Atherosclerosis 261 (June 2017): 19–25. https://doi.org/10.1016/j.atherosclerosis.2017.03.041.
    Full Text Link to Item
  - Armstrong, Paul W., and Frans Van de Werf. “STREAM characterisation correction.” Lancet 389, no. 10084 (May 27, 2017): 2102. https://doi.org/10.1016/S0140-6736(17)31335-1.
    Full Text Link to Item
  - Armstrong, Paul W., and Justin A. Ezekowitz. “Navigating Choices Among a Sea of Comorbidities.” J Am Coll Cardiol 69, no. 19 (May 16, 2017): 2380–82. https://doi.org/10.1016/j.jacc.2017.03.022.
    Full Text Link to Item
  - Hess, Connie N., Robert M. Clare, Megan L. Neely, Pierluigi Tricoci, Kenneth W. Mahaffey, Stefan K. James, John H. Alexander, et al. “Differential occurrence, profile, and impact of first recurrent cardiovascular events after an acute coronary syndrome.” Am Heart J 187 (May 2017): 194–203. https://doi.org/10.1016/j.ahj.2017.01.016.
    Full Text Link to Item
  - Rydén, Lars, Frans Van de Werf, Paul W. Armstrong, Darren K. McGuire, Eberhard Standl, Eric D. Peterson, and Rury R. Holman. “Corrections needed to 2016 ESC and AHA guidelines on heart failure.” Lancet Diabetes Endocrinol 5, no. 5 (May 2017): 325–26. https://doi.org/10.1016/S2213-8587(17)30102-X.
    Full Text Link to Item
  - Valgimigli, Marco, Francesco Costa, Yuliya Lokhnygina, Robert M. Clare, Lars Wallentin, David J. Moliterno, Paul W. Armstrong, et al. “Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial.” Eur Heart J 38, no. 11 (March 14, 2017): 804–10. https://doi.org/10.1093/eurheartj/ehw525.
    Full Text Link to Item
  - Harskamp, Ralf E., Robert M. Clare, Giuseppe Ambrosio, Claes Held, Yuliya Lokhnygina, David J. Moliterno, Harvey D. White, et al. “Use of thienopyridine prior to presentation with non-ST-segment elevation acute coronary syndrome and association with safety and efficacy of vorapaxar: insights from the TRACER trial.” Eur Heart J Acute Cardiovasc Care 6, no. 2 (March 2017): 155–63. https://doi.org/10.1177/2048872616633880.
    Full Text Link to Item
  - Armstrong, Paul W., Yinggan Zheng, Cynthia M. Westerhout, Fernado Rosell-Ortiz, Peter Sinnaeve, Yves Lambert, Renato D. Lopes, et al. “Corrigendum to "Reduced dose tenecteplase and outcomes in elderly ST-segment elevation myocardial infarction patients: Insights from the Strategic Reperfusion Early After Myocardial infarction trial" [Am Heart J 169/6 (2015) 890-898].” Am Heart J 184 (February 2017): 157. https://doi.org/10.1016/j.ahj.2017.01.005.
    Full Text Link to Item
  - Kitai, Takeshi, Justin L. Grodin, Robert J. Mentz, Adrian F. Hernandez, Javed Butler, Marco Metra, John J. McMurray, et al. “Insufficient reduction in heart rate during hospitalization despite beta-blocker treatment in acute decompensated heart failure: insights from the ASCEND-HF trial.” Eur J Heart Fail 19, no. 2 (February 2017): 241–49. https://doi.org/10.1002/ejhf.629.
    Full Text Link to Item
  - Diepen, Sean van, Meng Lin, Justin A. Ezekowitz, Finlay A. McAlister, Douglas S. Lee, Shaun G. Goodman, Paul W. Armstrong, and Padma Kaul. “Interprovincial Differences in Canadian Coronary Care Unit Resource Use and Outcomes.” Can J Cardiol 33, no. 1 (January 2017): 166–69. https://doi.org/10.1016/j.cjca.2016.10.009.
    Full Text Link to Item
  - Ambrosy, Andrew P., Lukasz P. Cerbin, Paul W. Armstrong, Javed Butler, Adrian Coles, Adam D. DeVore, Mark E. Dunlap, et al. “Body Weight Change During and After Hospitalization for Acute Heart Failure: Patient Characteristics, Markers of Congestion, and Outcomes: Findings From the ASCEND-HF Trial.” Jacc Heart Fail 5, no. 1 (January 2017): 1–13. https://doi.org/10.1016/j.jchf.2016.09.012.
    Full Text Link to Item
  - Ezekowitz, Justin A., and Paul W. Armstrong. “Diabetes and heart failure in the crosshairs: where is the target?” Eur J Heart Fail 19, no. 1 (January 2017): 66–68. https://doi.org/10.1002/ejhf.703.
    Full Text Link to Item
  - Josse, Robert G., Sumit R. Majumdar, Yinggan Zheng, Amanda Adler, M Angelyn Bethel, John B. Buse, Jennifer B. Green, et al. “Sitagliptin and risk of fractures in type 2 diabetes: Results from the TECOS trial.” Diabetes Obes Metab 19, no. 1 (January 2017): 78–86. https://doi.org/10.1111/dom.12786.
    Full Text Link to Item
  - Povsic, Thomas J., Monica G. Lawrence, A Michael Lincoff, Roxana Mehran, Christopher P. Rusconi, Steven L. Zelenkofske, Zhen Huang, et al. “Pre-existing anti-PEG antibodies are associated with severe immediate allergic reactions to pegnivacogin, a PEGylated aptamer.” J Allergy Clin Immunol 138, no. 6 (December 2016): 1712–15. https://doi.org/10.1016/j.jaci.2016.04.058.
    Full Text Link to Item
  - Cornel, Jan H., E Magnus Ohman, Benjamin Neely, Joseph A. Jakubowski, Deepak L. Bhatt, Harvey D. White, Diego Ardissino, et al. “Relationship of Platelet Reactivity With Bleeding Outcomes During Long-Term Treatment With Dual Antiplatelet Therapy for Medically Managed Patients With Non-ST-Segment Elevation Acute Coronary Syndromes.” J Am Heart Assoc 5, no. 11 (November 4, 2016). https://doi.org/10.1161/JAHA.116.003977.
    Full Text Open Access Copy Link to Item
  - Shavadia, Jay, and Paul W. Armstrong. “Risk stratification in non-ST elevation acute coronary syndromes: searching for the right formula.” Eur Heart J 37, no. 40 (October 21, 2016): 3111–13. https://doi.org/10.1093/eurheartj/ehv586.
    Full Text Link to Item
  - Henry, Timothy D., and Paul W. Armstrong. “The Choice Is Reperfusion Therapy: But Which One?” Jacc Cardiovasc Interv 9, no. 19 (October 10, 2016): 2021–23. https://doi.org/10.1016/j.jcin.2016.08.004.
    Full Text Link to Item
  - Diepen, Sean van, Wendimagegn G. Alemayehu, Yinggan Zheng, Pierre Theroux, L Kristin Newby, Kenneth W. Mahaffey, Christopher B. Granger, and Paul W. Armstrong. “Temporal changes in biomarkers and their relationships to reperfusion and to clinical outcomes among patients with ST segment elevation myocardial infarction.” J Thromb Thrombolysis 42, no. 3 (October 2016): 376–85. https://doi.org/10.1007/s11239-016-1390-z.
    Full Text Link to Item
  - Jackson, Larry R., Jonathan P. Piccini, Derek D. Cyr, Matthew T. Roe, Megan L. Neely, Felipe Martinez, Thomas F. Lüscher, et al. “Dual Antiplatelet Therapy and Outcomes in Patients With Atrial Fibrillation and Acute Coronary Syndromes Managed Medically Without Revascularization: Insights From the TRILOGY ACS Trial.” Clin Cardiol 39, no. 9 (September 2016): 497–506. https://doi.org/10.1002/clc.22562.
    Full Text Link to Item
  - Greene, Stephen J., Adrian F. Hernandez, Jie-Lena Sun, Marco Metra, Javed Butler, Andrew P. Ambrosy, Justin A. Ezekowitz, et al. “Influence of Clinical Trial Site Enrollment on Patient Characteristics, Protocol Completion, and End Points: Insights From the ASCEND-HF Trial (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure).” Circ Heart Fail 9, no. 9 (September 2016). https://doi.org/10.1161/CIRCHEARTFAILURE.116.002986.
    Full Text Link to Item
  - Armstrong, Paul W., and Finlay A. McAlister. “Searching for Adherence: Can We Fulfill the Promise of Evidence-Based Medicines?” J Am Coll Cardiol 68, no. 8 (August 23, 2016): 802–4. https://doi.org/10.1016/j.jacc.2016.06.006.
    Full Text Link to Item
  - Academic Research Organization Consortium for Continuing Evaluation of Scientific Studies--Cardiovascular (ACCESS CV), Michael, Manesh R. Patel, Paul W. Armstrong, Deepak L. Bhatt, Eugene Braunwald, A John Camm, Keith A. A. Fox, et al. “Sharing Data from Cardiovascular Clinical Trials--A Proposal.” N Engl J Med 375, no. 5 (August 4, 2016): 407–9. https://doi.org/10.1056/NEJMp1605260.
    Full Text Link to Item
  - Armaganijan, Luciana V., Karen P. Alexander, Zhen Huang, Pierluigi Tricoci, Claes Held, Frans Van de Werf, Paul W. Armstrong, et al. “Effect of age on efficacy and safety of vorapaxar in patients with non-ST-segment elevation acute coronary syndrome: Insights from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) trial.” Am Heart J 178 (August 2016): 176–84. https://doi.org/10.1016/j.ahj.2016.05.012.
    Full Text Link to Item
  - Kaul, Padma, E Magnus Ohman, J David Knight, Kevin J. Anstrom, Matthew T. Roe, William E. Boden, Judith S. Hochman, et al. “Health-related quality of life outcomes with prasugrel among medically managed non-ST-segment elevation acute coronary syndrome patients: Insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes (TRILOGY ACS) trial.” Am Heart J 178 (August 2016): 55–64. https://doi.org/10.1016/j.ahj.2016.03.017.
    Full Text Link to Item
  - Chin, Chee Tang, William E. Boden, Matthew T. Roe, Benjamin Neely, Megan L. Neely, Jose L. Leiva-Pons, Ramón Corbalán, et al. “Effect of prior clopidogrel use on outcomes in medically managed acute coronary syndrome patients.” Heart 102, no. 15 (August 1, 2016): 1221–29. https://doi.org/10.1136/heartjnl-2015-308840.
    Full Text Link to Item
  - Déry, Jean-Pierre, Kenneth W. Mahaffey, Pierluigi Tricoci, Harvey D. White, Mohua Podder, Cynthia M. Westerhout, David J. Moliterno, et al. “Arterial access site and outcomes in patients undergoing percutaneous coronary intervention with and without vorapaxar.” Catheter Cardiovasc Interv 88, no. 2 (August 2016): 163–73. https://doi.org/10.1002/ccd.26335.
    Full Text Link to Item
  - Kaul, Padma, Robert C. Welsh, Wei Liu, Anamaria Savu, Dale R. Weiss, and Paul W. Armstrong. “Temporal and Provincial Variation in Ambulance Use Among Patients Who Present to Acute Care Hospitals With ST-Elevation Myocardial Infarction.” Can J Cardiol 32, no. 8 (August 2016): 949–55. https://doi.org/10.1016/j.cjca.2015.09.017.
    Full Text Link to Item
  - Åkerblom, Axel, Robert M. Clare, Yuliya Lokhnygina, Lars Wallentin, Claes Held, Frans Van de Werf, David J. Moliterno, et al. “Albuminuria and cardiovascular events in patients with acute coronary syndromes: Results from the TRACER trial.” Am Heart J 178 (August 2016): 1–8. https://doi.org/10.1016/j.ahj.2016.04.013.
    Full Text Link to Item
  - Wallentin, Lars, Claes Held, Paul W. Armstrong, Christopher P. Cannon, Richard Y. Davies, Christopher B. Granger, Emil Hagström, et al. “Lipoprotein-Associated Phospholipase A2 Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease.” J Am Heart Assoc 5, no. 6 (June 21, 2016). https://doi.org/10.1161/JAHA.116.003407.
    Full Text Link to Item
  - Shavadia, Jay, Robert Welsh, Anthony Gershlick, Yinggan Zheng, Kurt Huber, Sigrun Halvorsen, Phillipe G. Steg, Frans Van de Werf, and Paul W. Armstrong. “Relationship Between Arterial Access and Outcomes in ST-Elevation Myocardial Infarction With a Pharmacoinvasive Versus Primary Percutaneous Coronary Intervention Strategy: Insights From the STrategic Reperfusion Early After Myocardial Infarction (STREAM) Study.” J Am Heart Assoc 5, no. 6 (June 13, 2016). https://doi.org/10.1161/JAHA.116.003559.
    Full Text Link to Item
  - Berry, C., K. K. Poppe, G. D. Gamble, N. J. Earle, J. A. Ezekowitz, I. B. Squire, J. J. V. McMurray, et al. “Prognostic significance of anaemia in patients with heart failure with preserved and reduced ejection fraction: results from the MAGGIC individual patient data meta-analysis.” Qjm 109, no. 6 (June 2016): 377–82. https://doi.org/10.1093/qjmed/hcv087.
    Full Text Link to Item
  - Hagström, Emil, Matthew T. Roe, Gail Hafley, Megan L. Neely, Mandeep S. Sidhu, Kenneth J. Winters, Dorairaj Prabhakaran, et al. “Association Between Very Low Levels of High-Density Lipoprotein Cholesterol and Long-term Outcomes of Patients With Acute Coronary Syndrome Treated Without Revascularization: Insights From the TRILOGY ACS Trial.” Clin Cardiol 39, no. 6 (June 2016): 329–37. https://doi.org/10.1002/clc.22533.
    Full Text Link to Item
  - Metra, Marco, Robert J. Mentz, Adrian F. Hernandez, Gretchen M. Heizer, Paul W. Armstrong, Nadine Clausell, Ramon Corbalan, et al. “Geographic Differences in Patients in a Global Acute Heart Failure Clinical Trial (from the ASCEND-HF Trial).” Am J Cardiol 117, no. 11 (June 1, 2016): 1771–78. https://doi.org/10.1016/j.amjcard.2016.03.002.
    Full Text Link to Item
  - White, Harvey D., Cynthia M. Westerhout, Karen P. Alexander, Matthew T. Roe, Kenneth J. Winters, Derek D. Cyr, Keith Aa Fox, et al. “Frailty is associated with worse outcomes in non-ST-segment elevation acute coronary syndromes: Insights from the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trial.” Eur Heart J Acute Cardiovasc Care 5, no. 3 (June 2016): 231–42. https://doi.org/10.1177/2048872615581502.
    Full Text Link to Item
  - Wong, Yee Weng, Robert J. Mentz, G Michael Felker, Justin Ezekowitz, Karen Pieper, Gretchen Heizer, Vic Hasselblad, et al. “Nesiritide in patients hospitalized for acute heart failure: does timing matter? Implication for future acute heart failure trials.” Eur J Heart Fail 18, no. 6 (June 2016): 684–92. https://doi.org/10.1002/ejhf.487.
    Full Text Link to Item
  - Vranckx, Pascal, Harvey D. White, Zhen Huang, Kenneth W. Mahaffey, Paul W. Armstrong, Frans Van de Werf, David J. Moliterno, et al. “Validation of BARC Bleeding Criteria in Patients With Acute Coronary Syndromes: The TRACER Trial.” J Am Coll Cardiol 67, no. 18 (May 10, 2016): 2135–44. https://doi.org/10.1016/j.jacc.2016.02.056.
    Full Text Link to Item
  - McGuire, Darren K., Frans Van de Werf, Paul W. Armstrong, Eberhard Standl, Joerg Koglin, Jennifer B. Green, M Angelyn Bethel, et al. “Association Between Sitagliptin Use and Heart Failure Hospitalization and Related Outcomes in Type 2 Diabetes Mellitus: Secondary Analysis of a Randomized Clinical Trial.” Jama Cardiol 1, no. 2 (May 1, 2016): 126–35. https://doi.org/10.1001/jamacardio.2016.0103.
    Full Text Link to Item
  - Popma, Christopher J., Shi Sheng, Serge Korjian, Yazan Daaboul, Gerald Chi, Pierluigi Tricoci, Zhen Huang, et al. “Lack of Concordance Between Local Investigators, Angiographic Core Laboratory, and Clinical Event Committee in the Assessment of Stent Thrombosis: Results From the TRACER Angiographic Substudy.” Circ Cardiovasc Interv 9, no. 5 (May 2016): e003114. https://doi.org/10.1161/CIRCINTERVENTIONS.115.003114.
    Full Text Link to Item
  - Kragholm, Kristian, Sarah A. Goldstein, Qinghong Yang, Renato D. Lopes, Phillip J. Schulte, Gwen M. Bernacki, Harvey D. White, et al. “Trends in Enrollment, Clinical Characteristics, Treatment, and Outcomes According to Age in Non-ST-Segment-Elevation Acute Coronary Syndromes Clinical Trials.” Circulation 133, no. 16 (April 19, 2016): 1560–73. https://doi.org/10.1161/CIRCULATIONAHA.115.017299.
    Full Text Link to Item
  - Bainey, Kevin R., Claudio Fresco, Yinggan Zheng, Sigrun Halvorsen, Antonio Carvalho, Miodrag Ostojic, Patrick Goldstein, et al. “Implications of ischaemic area at risk and mode of reperfusion in ST-elevation myocardial infarction.” Heart 102, no. 7 (April 2016): 527–33. https://doi.org/10.1136/heartjnl-2015-308075.
    Full Text Link to Item
  - Hess, Paul L., Daniel M. Wojdyla, Sana M. Al-Khatib, Yuliya Lokhnygina, Lars Wallentin, Paul W. Armstrong, Matthew T. Roe, et al. “Sudden Cardiac Death After Non-ST-Segment Elevation Acute Coronary Syndrome.” Jama Cardiol 1, no. 1 (April 1, 2016): 73–79. https://doi.org/10.1001/jamacardio.2015.0359.
    Full Text Link to Item
  - Chin, Chee Tang, Benjamin Neely, E. Magnus Ohman, Paul W. Armstrong, Ramón Corbalán, Harvey D. White, Dorairaj Prabhakaran, et al. “Time-Varying Effects of Prasugrel Versus Clopidogrel on the Long-Term Risks of Stroke After Acute Coronary Syndromes: Results From the TRILOGY ACS Trial.” Stroke 47, no. 4 (April 2016): 1135–39. https://doi.org/10.1161/STROKEAHA.115.012454.
    Full Text Link to Item
  - Samsky, Marc D., Allison Dunning, Adam D. DeVore, Phillip J. Schulte, Randall C. Starling, WH Wilson Tang, Paul W. Armstrong, et al. “Liver function tests in patients with acute heart failure and associated outcomes: insights from ASCEND-HF.” Eur J Heart Fail 18, no. 4 (April 2016): 424–32. https://doi.org/10.1002/ejhf.440.
    Full Text Link to Item
  - Sepehrvand, Nariman, Yinggan Zheng, Paul W. Armstrong, Robert Welsh, Shaun G. Goodman, Wayne Tymchak, Fadi Khadour, Michael Chan, Dale Weiss, and Justin A. Ezekowitz. “Alignment of site versus adjudication committee-based diagnosis with patient outcomes: Insights from the Providing Rapid Out of Hospital Acute Cardiovascular Treatment 3 trial.” Clin Trials 13, no. 2 (April 2016): 140–48. https://doi.org/10.1177/1740774515601437.
    Full Text Link to Item
  - Lopes, Renato D., Sergio Leonardi, Benjamin Neely, Megan L. Neely, E Magnus Ohman, Diego Ardissino, Christian W. Hamm, et al. “Spontaneous MI After Non-ST-Segment Elevation Acute Coronary Syndrome Managed Without Revascularization: The TRILOGY ACS Trial.” J Am Coll Cardiol 67, no. 11 (March 22, 2016): 1289–97. https://doi.org/10.1016/j.jacc.2016.01.034.
    Full Text Link to Item
  - Ezekowitz, Justin A., Mohua Podder, Adrian F. Hernandez, Paul W. Armstrong, Randall C. Starling, Christopher M. O’Connor, and Robert M. Califf. “Arrival by ambulance in acute heart failure: insights into the mode of presentation from Acute Studies of Nesiritide in Decompensated Heart Failure (ASCEND-HF).” Bmj Open 6, no. 3 (March 17, 2016): e010201. https://doi.org/10.1136/bmjopen-2015-010201.
    Full Text Link to Item
  - Ambrosy, Andrew P., Adrian F. Hernandez, Paul W. Armstrong, Javed Butler, Allison Dunning, Justin A. Ezekowitz, G Michael Felker, et al. “The clinical course of health status and association with outcomes in patients hospitalized for heart failure: insights from ASCEND-HF.” Eur J Heart Fail 18, no. 3 (March 2016): 306–13. https://doi.org/10.1002/ejhf.420.
    Full Text Link to Item
  - Doll, Jacob A., Megan L. Neely, Matthew T. Roe, Paul W. Armstrong, Harvey D. White, Dorairaj Prabhakaran, Kenneth J. Winters, et al. “Impact of CYP2C19 Metabolizer Status on Patients With ACS Treated With Prasugrel Versus Clopidogrel.” J Am Coll Cardiol 67, no. 8 (March 1, 2016): 936–47. https://doi.org/10.1016/j.jacc.2015.12.036.
    Full Text Link to Item
  - Perez, Antonio L., Justin L. Grodin, Yuping Wu, Adrian F. Hernandez, Javed Butler, Marco Metra, G Michael Felker, et al. “Increased mortality with elevated plasma endothelin-1 in acute heart failure: an ASCEND-HF biomarker substudy.” Eur J Heart Fail 18, no. 3 (March 2016): 290–97. https://doi.org/10.1002/ejhf.456.
    Full Text Link to Item
  - Vavalle, John P., Sean van Diepen, Robert M. Clare, Judith S. Hochman, W Douglas Weaver, Rajendra H. Mehta, Karen S. Pieper, et al. “Renal failure in patients with ST-segment elevation acute myocardial infarction treated with primary percutaneous coronary intervention: Predictors, clinical and angiographic features, and outcomes.” Am Heart J 173 (March 2016): 57–66. https://doi.org/10.1016/j.ahj.2015.12.001.
    Full Text Link to Item
  - Sinnaeve, Peter R., Thierry Danays, Kris Bogaerts, Frans Van de Werf, and Paul W. Armstrong. “Drug Treatment of STEMI in the Elderly: Focus on Fibrinolytic Therapy and Insights from the STREAM Trial.” Drugs Aging 33, no. 2 (February 2016): 109–18. https://doi.org/10.1007/s40266-016-0345-6.
    Full Text Link to Item
  - Mentz, Robert J., Vic Hasselblad, Adam D. DeVore, Marco Metra, Adriaan A. Voors, Paul W. Armstrong, Justin A. Ezekowitz, et al. “Torsemide Versus Furosemide in Patients With Acute Heart Failure (from the ASCEND-HF Trial).” Am J Cardiol 117, no. 3 (February 1, 2016): 404–11. https://doi.org/10.1016/j.amjcard.2015.10.059.
    Full Text Link to Item
  - Lincoff, A Michael, Roxana Mehran, Thomas J. Povsic, Steven L. Zelenkofske, Zhen Huang, Paul W. Armstrong, P Gabriel Steg, et al. “Effect of the REG1 anticoagulation system versus bivalirudin on outcomes after percutaneous coronary intervention (REGULATE-PCI): a randomised clinical trial.” Lancet 387, no. 10016 (January 23, 2016): 349–56. https://doi.org/10.1016/S0140-6736(15)00515-2.
    Full Text Link to Item
  - Roe, Matthew T., Derek D. Cyr, Debra Eckart, Phillip J. Schulte, Michael A. Morse, Kimberly L. Blackwell, Neal E. Ready, et al. “Ascertainment, classification, and impact of neoplasm detection during prolonged treatment with dual antiplatelet therapy with prasugrel vs. clopidogrel following acute coronary syndrome.” Eur Heart J 37, no. 4 (January 21, 2016): 412–22. https://doi.org/10.1093/eurheartj/ehv611.
    Full Text Link to Item
  - Bainey, Kevin R., and Paul W. Armstrong. “Transatlantic Comparison of ST-Segment Elevation Myocardial Infarction Guidelines: Insights From the United States and Europe.” J Am Coll Cardiol 67, no. 2 (January 19, 2016): 216–29. https://doi.org/10.1016/j.jacc.2015.11.010.
    Full Text Link to Item
  - Pokorney, Sean D., Christina Radder, Phillip J. Schulte, Sana M. Al-Khatib, Pierluigi Tricocci, Frans Van de Werf, Stefan K. James, et al. “High-degree atrioventricular block, asystole, and electro-mechanical dissociation complicating non-ST-segment elevation myocardial infarction.” Am Heart J 171, no. 1 (January 2016): 25–32. https://doi.org/10.1016/j.ahj.2015.09.004.
    Full Text Link to Item
  - Tang, WH Wilson, Yuping Wu, Justin L. Grodin, Amy P. Hsu, Adrian F. Hernandez, Javed Butler, Marco Metra, et al. “Prognostic Value of Baseline and Changes in Circulating Soluble ST2 Levels and the Effects of Nesiritide in Acute Decompensated Heart Failure.” Jacc Heart Fail 4, no. 1 (January 2016): 68–77. https://doi.org/10.1016/j.jchf.2015.07.015.
    Full Text Link to Item
  - Diepen, Sean van, Pierluigi Tricoci, Mohua Podder, Cynthia M. Westerhout, Philip E. Aylward, Claes Held, Frans Van de Werf, et al. “Efficacy and Safety of Vorapaxar in Non-ST-Segment Elevation Acute Coronary Syndrome Patients Undergoing Noncardiac Surgery.” J Am Heart Assoc 4, no. 12 (December 15, 2015). https://doi.org/10.1161/JAHA.115.002546.
    Full Text Link to Item
  - Bakal, Jeffrey A., Cynthia M. Westerhout, and Paul W. Armstrong. “Impact of weighted composite compared to traditional composite endpoints for the design of randomized controlled trials.” Stat Methods Med Res 24, no. 6 (December 2015): 980–88. https://doi.org/10.1177/0962280211436004.
    Full Text Link to Item
  - Ezekowitz, Justin A., Robert C. Welsh, Dale Weiss, Michael Chan, William Keeble, Fadi Khadour, Sanjay Sharma, et al. “Providing Rapid Out of Hospital Acute Cardiovascular Treatment 4 (PROACT-4).” J Am Heart Assoc 4, no. 12 (December 1, 2015). https://doi.org/10.1161/JAHA.115.002859.
    Full Text Link to Item
  - Clemmensen, Peter, Matthew T. Roe, Judith S. Hochman, Derek D. Cyr, Megan L. Neely, Darren K. McGuire, Jan H. Cornel, et al. “Long-term outcomes for women versus men with unstable angina/non-ST-segment elevation myocardial infarction managed medically without revascularization: insights from the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes trial.” Am Heart J 170, no. 4 (October 2015): 695-705.e5. https://doi.org/10.1016/j.ahj.2015.06.011.
    Full Text Link to Item
  - Grodin, Justin L., Antonio L. Perez, Yuping Wu, Adrian F. Hernandez, Javed Butler, Marco Metra, G Michael Felker, et al. “Circulating Kidney Injury Molecule-1 Levels in Acute Heart Failure: Insights From the ASCEND-HF Trial (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure).” Jacc Heart Fail 3, no. 10 (October 2015): 777–85. https://doi.org/10.1016/j.jchf.2015.06.006.
    Full Text Link to Item
  - Nicolau, Jose Carlos, Deepak L. Bhatt, Matthew T. Roe, Yuliya Lokhnygina, Benjamin Neely, Ramón Corbalán, José L. Leiva-Pons, et al. “Concomitant proton-pump inhibitor use, platelet activity, and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel and managed without revascularization: insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes trial.” Am Heart J 170, no. 4 (October 2015): 683-694.e3. https://doi.org/10.1016/j.ahj.2015.05.017.
    Full Text Link to Item
  - Shavadia, Jay, Yinggan Zheng, Neda Dianati Maleki, Kurt Huber, Sigrun Halvorsen, Patrick Goldstein, Anthony H. Gershlick, Robert Wilcox, Frans Van de Werf, and Paul W. Armstrong. “Infarct Size, Shock, and Heart Failure: Does Reperfusion Strategy Matter in Early Presenting Patients With ST-Segment Elevation Myocardial Infarction?” J Am Heart Assoc 4, no. 8 (August 24, 2015): e002049. https://doi.org/10.1161/JAHA.115.002049.
    Full Text Link to Item
  - Abualnaja, Seraj, Mohua Podder, Adrian F. Hernandez, John J. V. McMurray, Randall C. Starling, Christopher M. O’Connor, Robert M. Califf, Paul W. Armstrong, and Justin A. Ezekowitz. “Acute Heart Failure and Atrial Fibrillation: Insights From the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure (ASCEND-HF) Trial.” J Am Heart Assoc 4, no. 8 (August 24, 2015): e002092. https://doi.org/10.1161/JAHA.115.002092.
    Full Text Link to Item
  - Kelly, Jacob P., Robert J. Mentz, Vic Hasselblad, Justin A. Ezekowitz, Paul W. Armstrong, Faiez Zannad, G Michael Felker, Robert M. Califf, Christopher M. O’Connor, and Adrian F. Hernandez. “Worsening heart failure during hospitalization for acute heart failure: Insights from the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure (ASCEND-HF).” Am Heart J 170, no. 2 (August 2015): 298–305. https://doi.org/10.1016/j.ahj.2015.04.007.
    Full Text Link to Item
  - Khazanie, Prateeti, Gretchen M. Heizer, Vic Hasselblad, Paul W. Armstrong, Robert M. Califf, Justin Ezekowitz, Kenneth Dickstein, et al. “Predictors of clinical outcomes in acute decompensated heart failure: Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure outcome models.” Am Heart J 170, no. 2 (August 2015): 290–97. https://doi.org/10.1016/j.ahj.2015.04.006.
    Full Text Link to Item
  - Kholaif, Naji, Yinggan Zheng, Pushpa Jagasia, Anders Himmelmann, Stefan K. James, Philippe Gabriel Steg, Robert F. Storey, Cynthia M. Westerhout, and Paul W. Armstrong. “Baseline Q waves and time from symptom onset to ST-segment elevation myocardial infarction: insights from PLATO on the influence of sex.” Am J Med 128, no. 8 (August 2015): 914.e11-914.e19. https://doi.org/10.1016/j.amjmed.2015.03.005.
    Full Text Link to Item
  - Green, Jennifer B., M Angelyn Bethel, Paul W. Armstrong, John B. Buse, Samuel S. Engel, Jyotsna Garg, Robert Josse, et al. “Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes.” N Engl J Med 373, no. 3 (July 16, 2015): 232–42. https://doi.org/10.1056/NEJMoa1501352.
    Full Text Link to Item
  - Kragholm, Kristian, Sharif A. Halim, Qinghong Yang, Phillip J. Schulte, Judith S. Hochman, Chiara Melloni, Kenneth W. Mahaffey, et al. “Sex-Stratified Trends in Enrollment, Patient Characteristics, Treatment, and Outcomes Among Non-ST-Segment Elevation Acute Coronary Syndrome Patients: Insights From Clinical Trials Over 17 Years.” Circ Cardiovasc Qual Outcomes 8, no. 4 (July 2015): 357–67. https://doi.org/10.1161/CIRCOUTCOMES.114.001615.
    Full Text Link to Item
  - Cannon, Christopher P., Michael A. Blazing, Robert P. Giugliano, Amy McCagg, Jennifer A. White, Pierre Theroux, Harald Darius, et al. “Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.” N Engl J Med 372, no. 25 (June 18, 2015): 2387–97. https://doi.org/10.1056/NEJMoa1410489.
    Full Text Link to Item
  - Mahaffey, Kenneth W., Rebecca Hager, Daniel Wojdyla, Harvey D. White, Paul W. Armstrong, John H. Alexander, Pierluigi Tricoci, et al. “Meta-analysis of intracranial hemorrhage in acute coronary syndromes: incidence, predictors, and clinical outcomes.” J Am Heart Assoc 4, no. 6 (June 18, 2015): e001512. https://doi.org/10.1161/JAHA.114.001512.
    Full Text Link to Item
  - Armstrong, Paul W., Yinggan Zheng, Cynthia M. Westerhout, Fernado Rosell-Ortiz, Peter Sinnaeve, Yves Lambert, Renato D. Lopes, et al. “Reduced dose tenecteplase and outcomes in elderly ST-segment elevation myocardial infarction patients: Insights from the STrategic Reperfusion Early After Myocardial infarction trial.” Am Heart J 169, no. 6 (June 2015): 890-898.e1. https://doi.org/10.1016/j.ahj.2015.03.011.
    Full Text Link to Item
  - Bagai, Akshay, Zhen Huang, Yuliya Lokhnygina, Robert A. Harrington, Paul W. Armstrong, John Strony, Harvey D. White, et al. “Magnitude of troponin elevation and long-term clinical outcomes in acute coronary syndrome patients treated with and without revascularization.” Circ Cardiovasc Interv 8, no. 6 (June 2015): e002314. https://doi.org/10.1161/CIRCINTERVENTIONS.115.002314.
    Full Text Link to Item
  - Bainey, Kevin R., Manesh R. Patel, and Paul W. Armstrong. “Evaluation of Cardiac Magnetic Resonance as a Surrogate in ST-Segment Elevation Myocardial Infarction.” Am J Cardiol 115, no. 11 (June 1, 2015): 1607–14. https://doi.org/10.1016/j.amjcard.2015.02.065.
    Full Text Link to Item
  - Roe, Matthew T., Kenneth W. Mahaffey, Justin A. Ezekowitz, John H. Alexander, Shaun G. Goodman, Adrian Hernandez, Tracy Temple, et al. “The future of cardiovascular clinical research in North America and beyond-addressing challenges and leveraging opportunities through unique academic and grassroots collaborations.” Am Heart J 169, no. 6 (June 2015): 743–50. https://doi.org/10.1016/j.ahj.2015.03.002.
    Full Text Link to Item
  - Cornel, Jan H., Pierluigi Tricoci, Yuliya Lokhnygina, David J. Moliterno, Lars Wallentin, Paul W. Armstrong, Philip E. Aylward, et al. “Glycoprotein IIb/IIIa Receptor Inhibitors in Combination With Vorapaxar, a Platelet Thrombin Receptor Antagonist, Among Patients With Non-ST-Segment Elevation Acute Coronary Syndromes (from the TRACER Trial).” Am J Cardiol 115, no. 10 (May 15, 2015): 1325–32. https://doi.org/10.1016/j.amjcard.2015.02.043.
    Full Text Link to Item
  - Gershlick, Anthony H., Cynthia M. Westerhout, Paul W. Armstrong, Kurt Huber, Sigrun Halvorsen, Philippe Gabriel Steg, Miodrag Ostojic, et al. “Impact of a pharmacoinvasive strategy when delays to primary PCI are prolonged.” Heart 101, no. 9 (May 2015): 692–98. https://doi.org/10.1136/heartjnl-2014-306686.
    Full Text Link to Item
  - McAlister, Finlay A., Julie Wang, Linda Donovan, Douglas S. Lee, Paul W. Armstrong, and Jack V. Tu. “Influence of Patient Goals of Care on Performance Measures in Patients Hospitalized for Heart Failure: An Analysis of the Enhanced Feedback For Effective Cardiac Treatment (EFFECT) Registry.” Circ Heart Fail 8, no. 3 (May 2015): 481–88. https://doi.org/10.1161/CIRCHEARTFAILURE.114.001712.
    Full Text Link to Item
  - Fordyce, Christopher B., Matthew T. Roe, Tariq Ahmad, Peter Libby, Jeffrey S. Borer, William R. Hiatt, Michael R. Bristow, et al. “Cardiovascular drug development: is it dead or just hibernating?” J Am Coll Cardiol 65, no. 15 (April 21, 2015): 1567–82. https://doi.org/10.1016/j.jacc.2015.03.016.
    Full Text Link to Item
  - Armstrong, P. W. “The making of an author.” American Heart Journal 169, no. 4 (April 1, 2015): 446–47. https://doi.org/10.1016/j.ahj.2015.01.005.
    Full Text
  - Bethel, M. A., J. B. Green, J. Milton, A. Tajar, S. S. Engel, R. M. Califf, R. R. Holman, and R. R. TECOS Executive Committee. “Regional, age and sex differences in baseline characteristics of patients enrolled in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS).” Diabetes Obes Metab 17, no. 4 (April 2015): 395–402. https://doi.org/10.1111/dom.12441.
    Full Text Link to Item
  - Al-Majed, Nawaf S., Paul W. Armstrong, Jeffrey A. Bakal, Adrian F. Hernandez, and Justin A. Ezekowitz. “Correlation between peak expiratory flow rate and NT-proBNP in patients with acute heart failure. An analysis from ASCEND-HF trial.” Int J Cardiol 182 (March 1, 2015): 184–86. https://doi.org/10.1016/j.ijcard.2014.12.138.
    Full Text Link to Item
  - Bakal, Jeffrey A., Matthew T. Roe, E Magnus Ohman, Shaun G. Goodman, Keith A. A. Fox, Yinggan Zheng, Cynthia M. Westerhout, et al. “Applying novel methods to assess clinical outcomes: insights from the TRILOGY ACS trial.” Eur Heart J 36, no. 6 (February 7, 2015): 385-92a. https://doi.org/10.1093/eurheartj/ehu262.
    Full Text Link to Item
  - Roy, Ambuj, Matthew T. Roe, Megan L. Neely, Derek D. Cyr, Dmitry Zamoryakhin, Keith A. A. Fox, Harvey D. White, Paul W. Armstrong, E Magnus Ohman, and Dorairaj Prabhakaran. “Impact of Human Development Index on the profile and outcomes of patients with acute coronary syndrome.” Heart 101, no. 4 (February 2015): 279–86. https://doi.org/10.1136/heartjnl-2014-306389.
    Full Text Link to Item
  - Colin-Ramirez, Eloisa, Finlay A. McAlister, Yinggan Zheng, Sangita Sharma, Paul W. Armstrong, and Justin A. Ezekowitz. “The long-term effects of dietary sodium restriction on clinical outcomes in patients with heart failure. The SODIUM-HF (Study of Dietary Intervention Under 100 mmol in Heart Failure): a pilot study.” Am Heart J 169, no. 2 (February 2015): 274-281.e1. https://doi.org/10.1016/j.ahj.2014.11.013.
    Full Text Link to Item
  - Madan, Mina, Sigrun Halvorsen, Carlo Di Mario, Mary Tan, Cynthia M. Westerhout, Warren J. Cantor, Michel R. Le May, et al. “Relationship between time to invasive assessment and clinical outcomes of patients undergoing an early invasive strategy after fibrinolysis for ST-segment elevation myocardial infarction: a patient-level analysis of the randomized early routine invasive clinical trials.” Jacc Cardiovasc Interv 8, no. 1 Pt B (January 2015): 166–74. https://doi.org/10.1016/j.jcin.2014.09.005.
    Full Text Link to Item
  - De Blois, Jonathan, Tord Kjellstrom, Stefan Agewall, Justin A. Ezekowitz, Paul W. Armstrong, and Dan Atar. “The Effects of Climate Change on Cardiac Health.” Cardiology 131, no. 4 (2015): 209–17. https://doi.org/10.1159/000398787.
    Full Text Link to Item
  - Stafinski, Tania, Devidas Menon, Alex Nardelli, Jeff Bakal, Justin Ezekowitz, Wayne Tymchak, Robert Welsh, Gabor Gyenes, and Paul W. Armstrong. “Incorporating patient preferences into clinical trial design: results of the opinions of patients on treatment implications of new studies (OPTIONS) project.” Am Heart J 169, no. 1 (January 2015): 122-31.e22. https://doi.org/10.1016/j.ahj.2014.10.002.
    Full Text Link to Item
  - Tang, WH Wilson, Matthias Dupont, Adrian F. Hernandez, Adriaan A. Voors, Amy P. Hsu, G Michael Felker, Javed Butler, et al. “Comparative assessment of short-term adverse events in acute heart failure with cystatin C and other estimates of renal function: results from the ASCEND-HF trial.” Jacc Heart Fail 3, no. 1 (January 2015): 40–49. https://doi.org/10.1016/j.jchf.2014.06.014.
    Full Text Link to Item
  - Das, Debraj, Jeffery A. Bakal, Cynthia M. Westerhout, Adrian F. Hernandez, Christopher M. O’Connor, Dan Atar, John J. V. McMurray, Paul W. Armstrong, and Justin A. Ezekowitz. “The association between meteorological events and acute heart failure: new insights from ASCEND-HF.” Int J Cardiol 177, no. 3 (December 20, 2014): 819–24. https://doi.org/10.1016/j.ijcard.2014.11.066.
    Full Text Link to Item
  - Tricoci, Pierluigi, Yuliya Lokhnygina, Zhen Huang, Frans Van de Werf, Jan H. Cornel, Edmond Chen, Lars Wallentin, et al. “Vorapaxar with or without clopidogrel after non-ST-segment elevation acute coronary syndromes: results from the thrombin receptor antagonist for clinical event reduction in acute coronary syndrome trial.” Am Heart J 168, no. 6 (December 2014): 869-77.e1. https://doi.org/10.1016/j.ahj.2014.09.002.
    Full Text Link to Item
  - Park, Duk-Woo, Robert M. Clare, Phillip J. Schulte, Karen S. Pieper, Linda K. Shaw, Robert M. Califf, E Magnus Ohman, et al. “Extent, location, and clinical significance of non-infarct-related coronary artery disease among patients with ST-elevation myocardial infarction.” Jama 312, no. 19 (November 19, 2014): 2019–27. https://doi.org/10.1001/jama.2014.15095.
    Full Text Link to Item
  - Toleva, Olga, Cynthia M. Westerhout, Manohara P. J. Senaratne, Christoph Bode, Magnus Lindroos, Vitaly A. Sulimov, Gilles Montalescot, et al. “Practice patterns and clinical outcomes among non-ST-segment elevation acute coronary syndrome (NSTE-ACS) patients presenting to primary and tertiary hospitals: insights from the EARLY glycoprotein IIb/IIIa inhibition in NSTE-ACS (EARLY-ACS) trial.” Catheter Cardiovasc Interv 84, no. 6 (November 15, 2014): 934–42. https://doi.org/10.1002/ccd.25590.
    Full Text Link to Item
  - Bagai, Akshay, Mary Tan, Carlo Di Mario, Sigrun Halvorsen, Warren J. Cantor, Michel R. Le May, Francisco Fernandez-Aviles, et al. “Routine invasive management early after fibrinolysis: relationship between baseline risk and treatment effects in a pooled patient-level analysis of 7 randomized controlled trials.” Am Heart J 168, no. 5 (November 2014): 757–65. https://doi.org/10.1016/j.ahj.2014.07.027.
    Full Text Link to Item
  - Patel, Priyesh A., Gretchen Heizer, Christopher M. O’Connor, Phillip J. Schulte, Kenneth Dickstein, Justin A. Ezekowitz, Paul W. Armstrong, et al. “Hypotension during hospitalization for acute heart failure is independently associated with 30-day mortality: findings from ASCEND-HF.” Circ Heart Fail 7, no. 6 (November 2014): 918–25. https://doi.org/10.1161/CIRCHEARTFAILURE.113.000872.
    Full Text Link to Item
  - Bagai, Akshay, Phillip J. Schulte, Christopher B. Granger, Kenneth W. Mahaffey, Robert H. Christenson, Gregory Bell, Renato D. Lopes, et al. “Prognostic implications of creatine kinase-MB measurements in ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention.” Am Heart J 168, no. 4 (October 2014): 503-511.e2. https://doi.org/10.1016/j.ahj.2014.06.008.
    Full Text Link to Item
  - Bainey, Kevin R., and Paul W. Armstrong. “Ameliorating reperfusion injury in STEMI: dead or alive?” Eur Heart J 35, no. 37 (October 1, 2014): 2504–6. https://doi.org/10.1093/eurheartj/ehu200.
    Full Text Link to Item
  - Dianati Maleki, Neda, Frans Van de Werf, Patrick Goldstein, Jennifer A. Adgey, Yves Lambert, Vitaly Sulimov, Fernando Rosell-Ortiz, et al. “Aborted myocardial infarction in ST-elevation myocardial infarction: insights from the STrategic Reperfusion Early After Myocardial infarction trial.” Heart 100, no. 19 (October 2014): 1543–49. https://doi.org/10.1136/heartjnl-2014-306023.
    Full Text Link to Item
  - Ezekowitz, Justin A., Robert C. Welsh, Courtney Gubbels, Neil Brass, Michael Chan, William Keeble, Fadi Khadour, et al. “Providing Rapid Out of Hospital Acute Cardiovascular Treatment 3 (PROACT-3).” Can J Cardiol 30, no. 10 (October 2014): 1208–15. https://doi.org/10.1016/j.cjca.2014.04.012.
    Full Text Link to Item
  - Jones, William Schuyler, Pierluigi Tricoci, Zhen Huang, David J. Moliterno, Robert A. Harrington, Peter R. Sinnaeve, John Strony, et al. “Vorapaxar in patients with peripheral artery disease and acute coronary syndrome: insights from Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER).” Am Heart J 168, no. 4 (October 2014): 588–96. https://doi.org/10.1016/j.ahj.2014.06.017.
    Full Text Link to Item
  - Sinnaeve, Peter R., Paul W. Armstrong, Anthony H. Gershlick, Patrick Goldstein, Robert Wilcox, Yves Lambert, Thierry Danays, et al. “ST-segment-elevation myocardial infarction patients randomized to a pharmaco-invasive strategy or primary percutaneous coronary intervention: Strategic Reperfusion Early After Myocardial Infarction (STREAM) 1-year mortality follow-up.” Circulation 130, no. 14 (September 30, 2014): 1139–45. https://doi.org/10.1161/CIRCULATIONAHA.114.009570.
    Full Text Link to Item
  - Welsh, Robert C., Frans Van de Werf, Cynthia M. Westerhout, Patrick Goldstein, Anthony H. Gershlick, Robert G. Wilcox, Thierry Danays, et al. “Outcomes of a pharmacoinvasive strategy for successful versus failed fibrinolysis and primary percutaneous intervention in acute myocardial infarction (from the STrategic Reperfusion Early After Myocardial Infarction [STREAM] study).” Am J Cardiol 114, no. 6 (September 15, 2014): 811–19. https://doi.org/10.1016/j.amjcard.2014.06.011.
    Full Text Link to Item
  - Held, Claes, Pierluigi Tricoci, Zhen Huang, Frans Van de Werf, Harvey D. White, Paul W. Armstrong, Giuseppe Ambrosio, et al. “Vorapaxar, a platelet thrombin-receptor antagonist, in medically managed patients with non-ST-segment elevation acute coronary syndrome: results from the TRACER trial.” Eur Heart J Acute Cardiovasc Care 3, no. 3 (September 2014): 246–56. https://doi.org/10.1177/2048872614527838.
    Full Text Link to Item
  - Valgimigli, Marco, Pierluigi Tricoci, Zhen Huang, Philip E. Aylward, Paul W. Armstrong, Frans Van de Werf, Sergio Leonardi, et al. “Usefulness and safety of vorapaxar in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention (from the TRACER Trial).” Am J Cardiol 114, no. 5 (September 1, 2014): 665–73. https://doi.org/10.1016/j.amjcard.2014.05.054.
    Full Text Link to Item
  - Mehta, Rajendra H., Cynthia M. Westerhout, Yinggan Zheng, Robert P. Giugliano, Kurt Huber, Dorairaj Prabhakaran, Robert A. Harrington, Kristin L. Newby, Paul W. Armstrong, and Paul W. EARLY ACS Investigators. “Association of metabolic syndrome and its individual components with outcomes among patients with high-risk non-ST-segment elevation acute coronary syndromes.” Am Heart J 168, no. 2 (August 2014): 182-8.e1. https://doi.org/10.1016/j.ahj.2014.04.009.
    Full Text Link to Item
  - Hess, Connie N., Matthew T. Roe, C Michael Gibson, Robert J. Temple, Michael J. Pencina, Deborah A. Zarin, Kevin J. Anstrom, et al. “Independent data monitoring committees: preparing a path for the future.” Am Heart J 168, no. 2 (August 2014): 135-41.e1. https://doi.org/10.1016/j.ahj.2014.05.003.
    Full Text Link to Item
  - White, Harvey D., Zhen Huang, Pierluigi Tricoci, Frans Van de Werf, Lars Wallentin, Yuliya Lokhnygina, David J. Moliterno, Philip E. Aylward, Kenneth W. Mahaffey, and Paul W. Armstrong. “Reduction in overall occurrences of ischemic events with vorapaxar: results from TRACER.” J Am Heart Assoc 3, no. 4 (July 10, 2014). https://doi.org/10.1161/JAHA.114.001032.
    Full Text Link to Item
  - Huber, Kurt, Bernard J. Gersh, Patrick Goldstein, Christopher B. Granger, and Paul W. Armstrong. “The organization, function, and outcomes of ST-elevation myocardial infarction networks worldwide: current state, unmet needs and future directions.” Eur Heart J 35, no. 23 (June 14, 2014): 1526–32. https://doi.org/10.1093/eurheartj/ehu125.
    Full Text Link to Item
  - Armstrong, Paul W., and Frans Van de Werf. “No STEMI left behind.” J Assoc Physicians India 62, no. 6 (June 2014): 469–70.
    Link to Item
  - Armstrong, Paul W. “Acute coronary syndromes: Right direction--moving proximally in timing of STEMI care.” Nat Rev Cardiol 11, no. 6 (June 2014): 320–21. https://doi.org/10.1038/nrcardio.2014.61.
    Full Text Link to Item
  - STABILITY Investigators, Lars, Harvey D. White, Claes Held, Ralph Stewart, Elizabeth Tarka, Rebekkah Brown, Richard Y. Davies, et al. “Darapladib for preventing ischemic events in stable coronary heart disease.” N Engl J Med 370, no. 18 (May 1, 2014): 1702–11. https://doi.org/10.1056/NEJMoa1315878.
    Full Text Link to Item
  - Bainey, Kevin R., and Paul W. Armstrong. “Clinical perspectives on reperfusion injury in acute myocardial infarction.” Am Heart J 167, no. 5 (May 2014): 637–45. https://doi.org/10.1016/j.ahj.2014.01.015.
    Full Text Link to Item
  - Kunadian, Vijay, Robert P. Giugliano, L Kristin Newby, Cafer Zorkun, Jianping Guo, Akshay Bagai, Gilles Montalescot, et al. “Angiographic outcomes with early eptifibatide therapy in non-ST-segment elevation acute coronary syndrome (from the EARLY ACS Trial).” Am J Cardiol 113, no. 8 (April 15, 2014): 1297–1305. https://doi.org/10.1016/j.amjcard.2014.01.404.
    Full Text Link to Item
  - Whellan, David J., Pierluigi Tricoci, Edmond Chen, Zhen Huang, David Leibowitz, Pascal Vranckx, Gregary D. Marhefka, et al. “Vorapaxar in acute coronary syndrome patients undergoing coronary artery bypass graft surgery: subgroup analysis from the TRACER trial (Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome).” J Am Coll Cardiol 63, no. 11 (March 25, 2014): 1048–57. https://doi.org/10.1016/j.jacc.2013.10.048.
    Full Text Link to Item
  - Mahaffey, Kenneth W., Zhen Huang, Lars Wallentin, Robert F. Storey, Lisa K. Jennings, Pierluigi Tricoci, Harvey D. White, et al. “Association of aspirin dose and vorapaxar safety and efficacy in patients with non-ST-segment elevation acute coronary syndrome (from the TRACER Trial).” Am J Cardiol 113, no. 6 (March 15, 2014): 936–44. https://doi.org/10.1016/j.amjcard.2013.11.052.
    Full Text Link to Item
  - Bainey, Kevin R., Paul W. Armstrong, Gregg C. Fonarow, Christopher P. Cannon, Adrian F. Hernandez, Eric D. Peterson, W Frank Peacock, et al. “Use of renin-angiotensin system blockers in acute coronary syndromes: findings from Get With the Guidelines-Coronary Artery Disease Program.” Circ Cardiovasc Qual Outcomes 7, no. 2 (March 2014): 227–35. https://doi.org/10.1161/CIRCOUTCOMES.113.000422.
    Full Text Link to Item
  - Calvo, Gonzalo, John J. V. McMurray, Christopher B. Granger, Ángeles Alonso-García, Paul Armstrong, Marcus Flather, Antonio Gómez-Outes, et al. “Large streamlined trials in cardiovascular disease.” Eur Heart J 35, no. 9 (March 2014): 544–48. https://doi.org/10.1093/eurheartj/eht535.
    Full Text Link to Item
  - Toma, Mustafa, Justin A. Ezekowitz, Jeffrey A. Bakal, Christopher M. O’Connor, Adrian F. Hernandez, Muhammad Rizwan Sardar, Ronald Zolty, et al. “The relationship between left ventricular ejection fraction and mortality in patients with acute heart failure: insights from the ASCEND-HF Trial.” Eur J Heart Fail 16, no. 3 (March 2014): 334–41. https://doi.org/10.1002/ejhf.19.
    Full Text Link to Item
  - Bao, M. H., P. W. Armstrong, Y. Zheng, C. M. Westerhout, H. Siha, and R. C. Welsh. “The prognostic relationship of qt interval and dispersion in patients with acute st elevation myocardial infarction.” Experimental and Clinical Cardiology 20, no. 1 (January 1, 2014): 1464–89.
  - Welsh, R. C., F. Van de Werf, C. M. Westerhout, P. Goldstein, A. H. Gershlick, R. G. Wilcox, T. Danays, et al. “Outcomes of a pharmacoinvasive strategy for successful versus failed fibrinolysis and primary percutaneous intervention in acute myocardial infarction (from the STrategic Reperfusion Early After Myocardial Infarction [STREAM] study).” The American Journal of Cardiology 114, no. 6 (January 1, 2014): 811–19.
  - Bao, Mike H., Yinggan Zheng, Cynthia M. Westerhout, Yuling Fu, Galen S. Wagner, Bernard Chaitman, Christopher B. Granger, and Paul W. Armstrong. “Prognostic implications of quantitative evaluation of baseline Q-wave width in ST-segment elevation myocardial infarction.” J Electrocardiol 47, no. 4 (2014): 465–71. https://doi.org/10.1016/j.jelectrocard.2014.04.013.
    Full Text Link to Item
  - Dianati Maleki, Neda, Karen Stocke, Yinggan Zheng, Cynthia M. Westerhout, Yuling Fu, Bernard R. Chaitman, Ahmed Awad, Pushpa Jagasia, and Paul W. Armstrong. “An assessment of ST-segment measurement variability between two core electrocardiogram laboratories.” J Electrocardiol 47, no. 1 (2014): 38–44. https://doi.org/10.1016/j.jelectrocard.2013.10.005.
    Full Text Link to Item
  - Kaul, Padma, Shelby D. Reed, Adrian F. Hernandez, Jonathan G. Howlett, Justin A. Ezekowitz, Yanhong Li, Yinggan Zheng, et al. “Differences in treatment, outcomes, and quality of life among patients with heart failure in Canada and the United States.” Jacc Heart Fail 1, no. 6 (December 2013): 523–30. https://doi.org/10.1016/j.jchf.2013.07.004.
    Full Text Link to Item
  - Bagai, Akshay, Paul W. Armstrong, Amanda Stebbins, Kenneth W. Mahaffey, Judith S. Hochman, W Douglas Weaver, Manesh R. Patel, Christopher B. Granger, and Renato D. Lopes. “Prognostic implications of left ventricular end-diastolic pressure during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: Findings from the Assessment of Pexelizumab in Acute Myocardial Infarction study.” Am Heart J 166, no. 5 (November 2013): 913–19. https://doi.org/10.1016/j.ahj.2013.08.006.
    Full Text Link to Item
  - Eggers, Kai M., Paul W. Armstrong, Robert M. Califf, Nina Johnston, Maarten L. Simoons, Per Venge, and Stefan K. James. “Clinical and prognostic implications of circulating pentraxin 3 levels in non ST-elevation acute coronary syndrome.” Clin Biochem 46, no. 16–17 (November 2013): 1655–59. https://doi.org/10.1016/j.clinbiochem.2013.08.014.
    Full Text Link to Item
  - Stewart, Ralph, Claes Held, Rebekkah Brown, Ola Vedin, Emil Hagstrom, Eva Lonn, Paul Armstrong, et al. “Physical activity in patients with stable coronary heart disease: an international perspective.” Eur Heart J 34, no. 42 (November 2013): 3286–93. https://doi.org/10.1093/eurheartj/eht258.
    Full Text Link to Item
  - Armstrong, Paul W., and Robert M. Califf. “Data and safety monitoring boards: academic credit where credit is due?” Jama 310, no. 15 (October 16, 2013): 1563–64. https://doi.org/10.1001/jama.2013.280383.
    Full Text Link to Item
  - Diepen, Sean van, L Kristin Newby, Amanda Stebbins, Paul W. Armstrong, and Christopher B. Granger. “Response to letter "associations of inflammatory biomarkers to body mass index among patients with acute coronary syndrome".” Int J Cardiol 168, no. 4 (October 9, 2013): 4543. https://doi.org/10.1016/j.ijcard.2013.06.094.
    Full Text Link to Item
  - Diepen, Sean van, L Kristin Newby, Renato D. Lopes, Amanda Stebbins, Vic Hasselblad, Stefan James, Matthew T. Roe, et al. “Prognostic relevance of baseline pro- and anti-inflammatory markers in STEMI: an APEX AMI substudy.” Int J Cardiol 168, no. 3 (October 3, 2013): 2127–33. https://doi.org/10.1016/j.ijcard.2013.01.004.
    Full Text Link to Item
  - Lopes, Renato D., Jennifer A. White, Dan Atar, Matyas Keltai, Neal S. Kleiman, Harvey D. White, Petr Widimsky, et al. “Incidence, treatment, and outcomes of atrial fibrillation complicating non-ST-segment elevation acute coronary syndromes.” Int J Cardiol 168, no. 3 (October 3, 2013): 2510–17. https://doi.org/10.1016/j.ijcard.2013.03.037.
    Full Text Link to Item
  - Ezekowitz, Justin A., Jeffrey A. Bakal, Cynthia M. Westerhout, Robert P. Giugliano, Harvey White, Matyas Keltai, Dorairaj Prabhakaran, et al. “The relationship between meteorological conditions and index acute coronary events in a global clinical trial.” Int J Cardiol 168, no. 3 (October 3, 2013): 2315–21. https://doi.org/10.1016/j.ijcard.2013.01.061.
    Full Text Link to Item
  - Zannad, Faiez, Angeles Alonso Garcia, Stefan D. Anker, Paul W. Armstrong, Gonzalo Calvo, John G. F. Cleland, Jay N. Cohn, et al. “Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus document.” Eur J Heart Fail 15, no. 10 (October 2013): 1082–94. https://doi.org/10.1093/eurjhf/hft095.
    Full Text Link to Item
  - Kaul, Padma, Jean-François Tanguay, L Kristin Newby, Judith S. Hochman, Cynthia M. Westerhout, Robert M. Califf, Pierluigi Tricoci, et al. “Association between bleeding and mortality among women and men with high-risk acute coronary syndromes: insights from the Early versus Delayed, Provisional Eptifibatide in Acute Coronary Syndromes (EARLY ACS) trial.” Am Heart J 166, no. 4 (October 2013): 723–28. https://doi.org/10.1016/j.ahj.2013.07.014.
    Full Text Link to Item
  - Lopes, Renato D., Jennifer A. White, Pierluigi Tricoci, Harvey D. White, Paul W. Armstrong, Eugene Braunwald, Robert P. Giugliano, et al. “Age, treatment, and outcomes in high-risk non-ST-segment elevation acute coronary syndrome patients: insights from the EARLY ACS trial.” Int J Cardiol 167, no. 6 (September 10, 2013): 2580–87. https://doi.org/10.1016/j.ijcard.2012.06.053.
    Full Text Link to Item
  - Diepen, Sean van, John P. Vavalle, L Kristin Newby, Robert Clare, Karen S. Pieper, Justin A. Ezekowitz, Judith S. Hochman, Kenneth W. Mahaffey, Paul W. Armstrong, and Christopher B. Granger. “The systemic inflammatory response syndrome in patients with ST-segment elevation myocardial infarction.” Crit Care Med 41, no. 9 (September 2013): 2080–87. https://doi.org/10.1097/CCM.0b013e31828a67b2.
    Full Text Link to Item
  - Bagai, Akshay, Jennifer A. White, Yuliya Lokhnygina, Robert P. Giugliano, Frans Van de Werf, Gilles Montalescot, Paul W. Armstrong, et al. “Routine early eptifibatide versus delayed provisional use at percutaneous coronary intervention in high-risk non-ST-segment elevation acute coronary syndromes patients: an analysis from the Early Glycoprotein IIb/IIIa Inhibition in Non-ST-Segment Elevation Acute Coronary Syndrome trial.” Am Heart J 166, no. 3 (September 2013): 466–73. https://doi.org/10.1016/j.ahj.2013.05.019.
    Full Text Link to Item
  - Hess, Connie N., Phillip J. Schulte, L Kristin Newby, Philippe Gabriel Steg, Anthony J. Dalby, Marc J. Schweiger, Basil S. Lewis, et al. “Duration of eptifibatide infusion after percutaneous coronary intervention and outcomes among high-risk patients with non-ST-segment elevation acute coronary syndrome: insights from EARLY ACS.” Eur Heart J Acute Cardiovasc Care 2, no. 3 (September 2013): 246–55. https://doi.org/10.1177/2048872612474922.
    Full Text Link to Item
  - Howlett, Jonathan G., Justin A. Ezekowitz, Mohua Podder, Adrian F. Hernandez, Rafael Diaz, Kenneth Dickstein, Mark E. Dunlap, et al. “Global variation in quality of care among patients hospitalized with acute heart failure in an international trial: findings from the acute study clinical effectiveness of nesiritide in decompensated heart failure trial (ASCEND-HF).” Circ Cardiovasc Qual Outcomes 6, no. 5 (September 1, 2013): 534–42. https://doi.org/10.1161/CIRCOUTCOMES.113.000119.
    Full Text Link to Item
  - Reed, Shelby D., Padma Kaul, Yanhong Li, Zubin J. Eapen, Linda Davidson-Ray, Kevin A. Schulman, Barry M. Massie, et al. “Medical resource use, costs, and quality of life in patients with acute decompensated heart failure: findings from ASCEND-HF.” J Card Fail 19, no. 9 (September 2013): 611–20. https://doi.org/10.1016/j.cardfail.2013.07.003.
    Full Text Link to Item
  - Roe, Matthew T., Shaun G. Goodman, E Magnus Ohman, Susanna R. Stevens, Judith S. Hochman, Shmuel Gottlieb, Felipe Martinez, et al. “Elderly patients with acute coronary syndromes managed without revascularization: insights into the safety of long-term dual antiplatelet therapy with reduced-dose prasugrel versus standard-dose clopidogrel.” Circulation 128, no. 8 (August 20, 2013): 823–33. https://doi.org/10.1161/CIRCULATIONAHA.113.002303.
    Full Text Link to Item
  - Wiviott, Stephen D., Harvey D. White, E Magnus Ohman, Keith A. A. Fox, Paul W. Armstrong, Dorairaj Prabhakaran, Gail Hafley, et al. “Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: a secondary, prespecified analysis of the TRILOGY ACS trial.” Lancet 382, no. 9892 (August 17, 2013): 605–13. https://doi.org/10.1016/S0140-6736(13)61451-8.
    Full Text Link to Item
  - Alherbish, Aws, Cynthia M. Westerhout, Yuling Fu, Harvey D. White, Christopher B. Granger, Galen Wagner, and Paul W. Armstrong. “The forgotten lead: does aVR ST-deviation add insight into the outcomes of ST-elevation myocardial infarction patients?” Am Heart J 166, no. 2 (August 2013): 333–39. https://doi.org/10.1016/j.ahj.2013.05.018.
    Full Text Link to Item
  - Armstrong, Paul W., Cynthia M. Westerhout, Yuling Fu, Robert A. Harrington, Robert F. Storey, Hugo Katus, Stefan James, and Lars Wallentin. “Quantitative ST-depression in acute coronary syndromes: the PLATO electrocardiographic substudy.” Am J Med 126, no. 8 (August 2013): 723-729.e1. https://doi.org/10.1016/j.amjmed.2013.01.038.
    Full Text Link to Item
  - Chan, Mark Y., Jie-Lena Sun, L Kristin Newby, Yuliya Lokhnygina, Harvey D. White, David J. Moliterno, Pierre Théroux, et al. “Trends in clinical trials of non-ST-segment elevation acute coronary syndromes over 15 years.” Int J Cardiol 167, no. 2 (July 31, 2013): 548–54. https://doi.org/10.1016/j.ijcard.2012.01.065.
    Full Text Link to Item
  - Armstrong, Paul W., Anthony H. Gershlick, Frans Van de Werf, and Frans STREAM Study Group. “Fibrinolysis or primary PCI in myocardial infarction.” N Engl J Med 369, no. 3 (July 18, 2013): 280–81. https://doi.org/10.1056/NEJMc1305999.
    Full Text Link to Item
  - Tricoci, Pierluigi, Sergio Leonardi, Jennifer White, Harvey D. White, Paul W. Armstrong, Gilles Montalescot, Robert P. Giugliano, et al. “Cardiac troponin after percutaneous coronary intervention and 1-year mortality in non-ST-segment elevation acute coronary syndrome using systematic evaluation of biomarker trends.” J Am Coll Cardiol 62, no. 3 (July 16, 2013): 242–51. https://doi.org/10.1016/j.jacc.2013.04.043.
    Full Text Link to Item
  - Eapen, Zubin J., Shelby D. Reed, Yanhong Li, Robb D. Kociol, Paul W. Armstrong, Randall C. Starling, John J. McMurray, et al. “Do countries or hospitals with longer hospital stays for acute heart failure have lower readmission rates?: Findings from ASCEND-HF.” Circ Heart Fail 6, no. 4 (July 2013): 727–32. https://doi.org/10.1161/CIRCHEARTFAILURE.112.000265.
    Full Text Link to Item
  - Leonardi, Sergio, Pierluigi Tricoci, Harvey D. White, Paul W. Armstrong, Zhen Huang, Lars Wallentin, Philip E. Aylward, et al. “Effect of vorapaxar on myocardial infarction in the thrombin receptor antagonist for clinical event reduction in acute coronary syndrome (TRA·CER) trial.” Eur Heart J 34, no. 23 (June 2013): 1723–31. https://doi.org/10.1093/eurheartj/eht104.
    Full Text Link to Item
  - Bahit, Maria Cecilia, Renato D. Lopes, Robert M. Clare, L Kristin Newby, Karen S. Pieper, Frans Van de Werf, Paul W. Armstrong, et al. “Heart failure complicating non-ST-segment elevation acute coronary syndrome: timing, predictors, and clinical outcomes.” Jacc Heart Fail 1, no. 3 (June 2013): 223–29. https://doi.org/10.1016/j.jchf.2013.02.007.
    Full Text Link to Item
  - Nicolau, José C., Ramon Corbalan, Rafael Diaz, Cecilia Bahit, Paul W. Armstrong, Christopher B. Granger, and Renato D. Lopes. “Cardiovascular clinical research in South America.” Am Heart J 165, no. 6 (June 2013): 848–53. https://doi.org/10.1016/j.ahj.2013.02.004.
    Full Text Link to Item
  - Lopes, Renato D., Yuliya Lokhnygina, Victor Hasselblad, Kristin L. Newby, Eric Yow, Christopher B. Granger, Paul W. Armstrong, et al. “Methods of creatine kinase-MB analysis to predict mortality in patients with myocardial infarction treated with reperfusion therapy.” Trials 14 (May 2, 2013): 123. https://doi.org/10.1186/1745-6215-14-123.
    Full Text Open Access Copy Link to Item
  - Bakal, Jeffrey A., Justin A. Ezekowitz, Cynthia M. Westerhout, Eric Boersma, and Paul W. Armstrong. “Association of global weather changes with acute coronary syndromes: gaining insights from clinical trials data.” Int J Biometeorol 57, no. 3 (May 2013): 401–8. https://doi.org/10.1007/s00484-012-0565-3.
    Full Text Link to Item
  - Armstrong, Paul W., Anthony H. Gershlick, Patrick Goldstein, Robert Wilcox, Thierry Danays, Yves Lambert, Vitaly Sulimov, et al. “Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction.” N Engl J Med 368, no. 15 (April 11, 2013): 1379–87. https://doi.org/10.1056/NEJMoa1301092.
    Full Text Link to Item
  - Rose, Jason J., L Kristin Newby, Samuel Broderick, Karen Chiswell, Frans Van de Werf, Paul W. Armstrong, Kenneth W. Mahaffey, et al. “Left bundle branch block in non-ST-segment elevation acute coronary syndromes. Incidence, angiographic characteristics, and clinical outcomes.” J Am Coll Cardiol 61, no. 13 (April 2, 2013): 1461–63. https://doi.org/10.1016/j.jacc.2012.12.032.
    Full Text Link to Item
  - Guptill, Jeffrey T., Rajendra H. Mehta, Paul W. Armstrong, John Horton, Daniel Laskowitz, Stefan James, Christopher B. Granger, and Renato D. Lopes. “Stroke after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction: timing, characteristics, and clinical outcomes.” Circ Cardiovasc Interv 6, no. 2 (April 2013): 176–83. https://doi.org/10.1161/CIRCINTERVENTIONS.112.000159.
    Full Text Link to Item
  - Klutstein, Marc W., Cynthia M. Westerhout, Paul W. Armstrong, Robert P. Giugliano, Basil S. Lewis, C Michael Gibson, Sohrab Lutchmedial, et al. “Radial versus femoral access, bleeding and ischemic events in patients with non-ST-segment elevation acute coronary syndrome managed with an invasive strategy.” Am Heart J 165, no. 4 (April 2013): 583-590.e1. https://doi.org/10.1016/j.ahj.2013.01.009.
    Full Text Link to Item
  - Bakal, Jeffrey A., Cynthia M. Westerhout, Warren J. Cantor, Francisco Fernández-Avilés, Robert C. Welsh, David Fitchett, Shaun G. Goodman, and Paul W. Armstrong. “Evaluation of early percutaneous coronary intervention vs. standard therapy after fibrinolysis for ST-segment elevation myocardial infarction: contribution of weighting the composite endpoint.” Eur Heart J 34, no. 12 (March 2013): 903–8. https://doi.org/10.1093/eurheartj/ehs438.
    Full Text Link to Item
  - Kaul, Padma, Justin A. Ezekowitz, Paul W. Armstrong, Becky K. Leung, Anamaria Savu, Robert C. Welsh, Hude Quan, Merril L. Knudtson, and Finlay A. McAlister. “Incidence of heart failure and mortality after acute coronary syndromes.” Am Heart J 165, no. 3 (March 2013): 379-85.e2. https://doi.org/10.1016/j.ahj.2012.12.005.
    Full Text Link to Item
  - Leonardi, Sergio, Paul W. Armstrong, Phillip J. Schulte, E Magnus Ohman, and L Kristin Newby. “Implementation of standardized assessment and reporting of myocardial infarction in contemporary randomized controlled trials: a systematic review.” Eur Heart J 34, no. 12 (March 2013): 894-902d. https://doi.org/10.1093/eurheartj/eht003.
    Full Text Link to Item
  - Westerhout, Cynthia M., Karen S. Pieper, Stefan K. James, Kenneth W. Mahaffey, Frans Van de Werf, Robert M. Califf, Christopher B. Granger, and Paul W. Armstrong. “Dynamic modeling of 90-day mortality in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention.” Am Heart J 165, no. 3 (March 2013): 354-62.e2. https://doi.org/10.1016/j.ahj.2012.12.001.
    Full Text Link to Item
  - Armstrong, Paul W., and Cynthia M. Westerhout. “The power of more than one.” Circulation 127, no. 6 (February 12, 2013): 665–67. https://doi.org/10.1161/CIRCULATIONAHA.112.000627.
    Full Text Link to Item
  - Patel, Manesh R., Cynthia M. Westerhout, Christopher B. Granger, Sorin J. Brener, Yuling Fu, Hany Siha, Raymond J. Kim, and Paul W. Armstrong. “Aborted myocardial infarction after primary percutaneous coronary intervention: magnetic resonance imaging insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.” Am Heart J 165, no. 2 (February 2013): 226–33. https://doi.org/10.1016/j.ahj.2012.10.028.
    Full Text Link to Item
  - Leonardi, Sergio, Laine Thomas, Megan L. Neely, Pierluigi Tricoci, Renato D. Lopes, Harvey D. White, Paul W. Armstrong, et al. “Comparison of the prognosis of spontaneous and percutaneous coronary intervention-related myocardial infarction.” J Am Coll Cardiol 60, no. 22 (December 4, 2012): 2296–2304. https://doi.org/10.1016/j.jacc.2012.09.005.
    Full Text Link to Item
  - Kaul, Padma, Yuling Fu, Cynthia M. Westerhout, Christopher B. Granger, and Paul W. Armstrong. “Relative prognostic value of baseline Q wave and time from symptom onset among men and women with ST-elevation myocardial infarction undergoing percutaneous coronary intervention.” Am J Cardiol 110, no. 11 (December 1, 2012): 1555–60. https://doi.org/10.1016/j.amjcard.2012.07.020.
    Full Text Link to Item
  - Gurbel, P. A., D. Erlinge, E. M. Ohman, B. Neely, M. Neely, S. G. Goodman, K. Huber, et al. “Platelet Function During Extended Prasugrel and Clopidogrel Therapy for Patients With ACS Treated Without Revascularization: The TRILOGY ACS Platelet Function Substudy.” Jama, November 4, 2012, 1–10. https://doi.org/10.1001/jama.2012.17312.
    Full Text Link to Item
  - Ezekowitz, Justin A., Jia Hu, Diego Delgado, Adrian F. Hernandez, Padma Kaul, Rolland Leader, Guy Proulx, et al. “Acute heart failure: perspectives from a randomized trial and a simultaneous registry.” Circ Heart Fail 5, no. 6 (November 2012): 735–41. https://doi.org/10.1161/CIRCHEARTFAILURE.112.968974.
    Full Text Link to Item
  - Felker, G Michael, Vic Hasselblad, WH Wilson Tang, Adrian F. Hernandez, Paul W. Armstrong, Gregg C. Fonarow, Adriaan A. Voors, et al. “Troponin I in acute decompensated heart failure: insights from the ASCEND-HF study.” Eur J Heart Fail 14, no. 11 (November 2012): 1257–64. https://doi.org/10.1093/eurjhf/hfs110.
    Full Text Link to Item
  - Thygesen, Kristian, Joseph S. Alpert, Allan S. Jaffe, Maarten L. Simoons, Bernard R. Chaitman, Harvey D. White, Harvey D. Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction, et al. “Third universal definition of myocardial infarction.” Circulation 126, no. 16 (October 16, 2012): 2020–35. https://doi.org/10.1161/CIR.0b013e31826e1058.
    Full Text Link to Item
  - Roe, Matthew T., Paul W. Armstrong, Keith A. A. Fox, Harvey D. White, Dorairaj Prabhakaran, Shaun G. Goodman, Jan H. Cornel, et al. “Prasugrel versus clopidogrel for acute coronary syndromes without revascularization.” N Engl J Med 367, no. 14 (October 4, 2012): 1297–1309. https://doi.org/10.1056/NEJMoa1205512.
    Full Text Link to Item
  - Armstrong, Paul W., and Robert A. Harrington. “Road mapping ATLAS ACS 2: are we there yet?” Eur Heart J 33, no. 20 (October 2012): 2510–12. https://doi.org/10.1093/eurheartj/ehs015.
    Full Text Link to Item
  - Thygesen, Kristian, Joseph S. Alpert, Allan S. Jaffe, Maarten L. Simoons, Bernard R. Chaitman, Harvey D. White, Harvey D. Writing Group on the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction, et al. “Third universal definition of myocardial infarction.” Eur Heart J 33, no. 20 (October 2012): 2551–67. https://doi.org/10.1093/eurheartj/ehs184.
    Full Text Link to Item
  - Siha, Hany, Debraj Das, Yuling Fu, Yinggan Zheng, Cynthia M. Westerhout, Robert F. Storey, Stefan James, Lars Wallentin, and Paul W. Armstrong. “Baseline Q waves as a prognostic modulator in patients with ST-segment elevation: insights from the PLATO trial.” Cmaj 184, no. 10 (July 10, 2012): 1135–42. https://doi.org/10.1503/cmaj.111683.
    Full Text Link to Item
  - Diepen, Sean van, Petr Widimsky, Renato D. Lopes, Kyle R. White, W Douglas Weaver, Frans Van de Werf, Diego Ardissino, Arnoud W. J. van’t Hof, Paul W. Armstrong, and Christopher B. Granger. “Transfer times and outcomes in patients with ST-segment-elevation myocardial infarction undergoing interhospital transfer for primary percutaneous coronary intervention: APEX-AMI insights.” Circ Cardiovasc Qual Outcomes 5, no. 4 (July 1, 2012): 437–44. https://doi.org/10.1161/CIRCOUTCOMES.112.965160.
    Full Text Link to Item
  - Martel, Catherine, Christopher B. Granger, Marta Ghitescu, Amanda Stebbins, Annik Fortier, Paul W. Armstrong, Arnaud Bonnefoy, and Pierre Theroux. “Pexelizumab fails to inhibit assembly of the terminal complement complex in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Insight from a substudy of the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.” Am Heart J 164, no. 1 (July 2012): 43–51. https://doi.org/10.1016/j.ahj.2012.04.007.
    Full Text Link to Item
  - Welsh, Robert C., Cynthia M. Westerhout, Christopher E. Buller, Blair O’Neill, Phillip Gordon, and Paul W. Armstrong. “Anticoagulation after subcutaneous enoxaparin is time sensitive in STEMI patients treated with tenecteplase.” J Thromb Thrombolysis 34, no. 1 (July 2012): 126–31. https://doi.org/10.1007/s11239-012-0697-7.
    Full Text Link to Item
  - Welsh, Robert C., and Paul W. Armstrong. “Contemporary pharmacological reperfusion in ST elevation myocardial infarction.” Curr Opin Cardiol 27, no. 4 (July 2012): 340–46. https://doi.org/10.1097/HCO.0b013e3283546670.
    Full Text Link to Item
  - Diepen, Sean van, Matthew T. Roe, Renato D. Lopes, Amanda Stebbins, Stefan James, L Kristin Newby, David J. Moliterno, et al. “Baseline NT-proBNP and biomarkers of inflammation and necrosis in patients with ST-segment elevation myocardial infarction: insights from the APEX-AMI trial.” J Thromb Thrombolysis 34, no. 1 (July 2012): 106–13. https://doi.org/10.1007/s11239-012-0691-0.
    Full Text Link to Item
  - Truffa, Adriano A. M., Christopher B. Granger, Kyle R. White, L Kristin Newby, Rajendra H. Mehta, Judith S. Hochman, Manesh R. Patel, et al. “Serious infection after acute myocardial infarction: incidence, clinical features, and outcomes.” Jacc Cardiovasc Interv 5, no. 7 (July 2012): 769–76. https://doi.org/10.1016/j.jcin.2012.03.018.
    Full Text Link to Item
  - Armstrong, Paul W. “Estimating the length of waits: a description of the period lifetable method and comparison with census and event based methods.” Health Serv Manage Res 25, no. 2 (May 2012): 97–109. https://doi.org/10.1258/hsmr.2012.011031.
    Full Text Link to Item
  - Mehta, Rajendra H., Padma Kaul, Renato D. Lopes, Manesh R. Patel, Yinggan Zheng, Karen S. Pieper, Robert C. Welsh, Paul W. Armstrong, and Christopher B. Granger. “Variations in practice and outcomes in patients undergoing primary percutaneous coronary intervention in the United States and Canada: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI) trial.” Am Heart J 163, no. 5 (May 2012): 797–803. https://doi.org/10.1016/j.ahj.2012.03.001.
    Full Text Link to Item
  - Toma, Mustafa, Finlay A. McAlister, Erin E. Coglianese, Venkatesan Vidi, Samip Vasaiwala, Jeffrey A. Bakal, Paul W. Armstrong, and Justin A. Ezekowitz. “Testosterone supplementation in heart failure: a meta-analysis.” Circ Heart Fail 5, no. 3 (May 1, 2012): 315–21. https://doi.org/10.1161/CIRCHEARTFAILURE.111.965632.
    Full Text Link to Item
  - Ezekowitz, Justin A., Adrian F. Hernandez, Christopher M. O’Connor, Randall C. Starling, Guy Proulx, Mason H. Weiss, Jeffrey A. Bakal, Robert M. Califf, John J. V. McMurray, and Paul W. Armstrong. “Assessment of dyspnea in acute decompensated heart failure: insights from ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure) on the contributions of peak expiratory flow.” J Am Coll Cardiol 59, no. 16 (April 17, 2012): 1441–48. https://doi.org/10.1016/j.jacc.2011.11.061.
    Full Text Link to Item
  - Mills, James S., Kenneth W. Mahaffey, Yuliya Lokhnygina, Jose C. Nicolau, Witold Ruzyllo, Peter X. Adams, Thomas G. Todaro, Paul W. Armstrong, Christopher B. Granger, and Christopher B. CARDINAL investigators. “Prediction of enzymatic infarct size in ST-segment elevation myocardial infarction.” Coron Artery Dis 23, no. 2 (March 2012): 118–25. https://doi.org/10.1097/MCA.0b013e32834e4f8f.
    Full Text Link to Item
  - Roe, Matthew T., Jennifer A. White, Padma Kaul, Pierluigi Tricoci, Yuliya Lokhnygina, Chadwick D. Miller, Arnoud W. van’t Hof, et al. “Regional patterns of use of a medical management strategy for patients with non-ST-segment elevation acute coronary syndromes: insights from the EARLY ACS Trial.” Circ Cardiovasc Qual Outcomes 5, no. 2 (March 1, 2012): 205–13. https://doi.org/10.1161/CIRCOUTCOMES.111.962332.
    Full Text Link to Item
  - Mehta, Rajendra H., Amanda S. Stebbins, Renato D. Lopes, Robert M. Califf, Karen S. Pieper, Paul W. Armstrong, Frans Van de Werf, et al. “Comparison of incidence of bleeding and mortality of men versus women with ST-elevation myocardial infarction treated with fibrinolysis.” Am J Cardiol 109, no. 3 (February 1, 2012): 320–26. https://doi.org/10.1016/j.amjcard.2011.09.012.
    Full Text Link to Item
  - Armstrong, Paul W., Hany Siha, Yuling Fu, Cynthia M. Westerhout, Ph Gabriel Steg, Stefan K. James, Robert F. Storey, et al. “ST-elevation acute coronary syndromes in the Platelet Inhibition and Patient Outcomes (PLATO) trial: insights from the ECG substudy.” Circulation 125, no. 3 (January 24, 2012): 514–21. https://doi.org/10.1161/CIRCULATIONAHA.111.047530.
    Full Text Link to Item
  - Tricoci, Pierluigi, Zhen Huang, Claes Held, David J. Moliterno, Paul W. Armstrong, Frans Van de Werf, Harvey D. White, et al. “Thrombin-receptor antagonist vorapaxar in acute coronary syndromes.” N Engl J Med 366, no. 1 (January 5, 2012): 20–33. https://doi.org/10.1056/NEJMoa1109719.
    Full Text Link to Item
  - Kociol, Robb D., Renato D. Lopes, Robert Clare, Laine Thomas, Rajendra H. Mehta, Padma Kaul, Karen S. Pieper, et al. “International variation in and factors associated with hospital readmission after myocardial infarction.” Jama 307, no. 1 (January 4, 2012): 66–74. https://doi.org/10.1001/jama.2011.1926.
    Full Text Link to Item
  - Lofthus, David M., Susanna R. Stevens, Paul W. Armstrong, Christopher B. Granger, and Kenneth W. Mahaffey. “Pattern of liver enzyme elevations in acute ST-elevation myocardial infarction.” Coron Artery Dis 23, no. 1 (January 2012): 22–30. https://doi.org/10.1097/MCA.0b013e32834e4ef1.
    Full Text Link to Item
  - Zeymer, U., K. Huber, Y. fu, A. Ross, C. Granger, P. Goldstein, F. Van de Werf, and P. Armstrong. “Impact of TIMI 3 patency before primary percutaneous coronary intervention for ST-elevation myocardial infarction on clinical outcome: Results from the ASSENT-4 PCI study.” European Heart Journal: Acute Cardiovascular Care 1, no. 2 (January 1, 2012): 136–42. https://doi.org/10.1177/2048872612447069.
    Full Text
  - Melloni, Chiara, Stefan K. James, Jennifer A. White, Robert P. Giugliano, Robert A. Harrington, Kurt Huber, Pierluigi Tricoci, et al. “Safety and efficacy of adjusted-dose eptifibatide in patients with acute coronary syndromes and reduced renal function.” Am Heart J 162, no. 5 (November 2011): 884-892.e1. https://doi.org/10.1016/j.ahj.2011.08.020.
    Full Text Link to Item
  - Armstrong, Paul W., and William E. Boden. “Reperfusion paradox in ST-segment elevation myocardial infarction.” Ann Intern Med 155, no. 6 (September 20, 2011): 389–91. https://doi.org/10.7326/0003-4819-155-6-201109200-00008.
    Full Text Link to Item
  - Lopes, Renato D., Hany Siha, Yuling Fu, Rajendra H. Mehta, Manesh R. Patel, Paul W. Armstrong, and Christopher B. Granger. “Diagnosing acute myocardial infarction in patients with left bundle branch block.” Am J Cardiol 108, no. 6 (September 15, 2011): 782–88. https://doi.org/10.1016/j.amjcard.2011.05.006.
    Full Text Link to Item
  - Tymchak, Wayne, Paul W. Armstrong, Cynthia M. Westerhout, Sunil Sookram, Neil Brass, Yuling Fu, and Robert C. Welsh. “Mode of hospital presentation in patients with non-ST-elevation myocardial infarction: implications for strategic management.” Am Heart J 162, no. 3 (September 2011): 436–43. https://doi.org/10.1016/j.ahj.2011.06.011.
    Full Text Link to Item
  - Lopes, Renato D., Richard C. Becker, John H. Alexander, Paul W. Armstrong, Robert M. Califf, Mark Y. Chan, Mark Crowther, et al. “Highlights from the III International Symposium of Thrombosis and Anticoagulation (ISTA), October 14-16, 2010, São Paulo, Brazil.” J Thromb Thrombolysis 32, no. 2 (August 2011): 242–66. https://doi.org/10.1007/s11239-011-0592-7.
    Full Text Link to Item
  - O’Connor, C. M., R. C. Starling, A. F. Hernandez, P. W. Armstrong, K. Dickstein, V. Hasselblad, G. M. Heizer, et al. “Effect of nesiritide in patients with acute decompensated heart failure.” N Engl J Med 365, no. 1 (July 7, 2011): 32–43. https://doi.org/10.1056/NEJMoa1100171.
    Full Text Link to Item
  - Bueno, Héctor, Paul W. Armstrong, Martin J. Buxton, Nicolas Danchin, Jacobus Lubsen, Edmond Roland, Freek W. Verheugt, et al. “The future of clinical trials in secondary prevention after acute coronary syndromes.” Eur Heart J 32, no. 13 (July 2011): 1583–89. https://doi.org/10.1093/eurheartj/ehq388.
    Full Text Link to Item
  - French, John K., Paul W. Armstrong, Eric Cohen, Neal S. Kleiman, Christopher M. O’Connor, Anne S. Hellkamp, Amanda Stebbins, et al. “Cardiogenic shock and heart failure post-percutaneous coronary intervention in ST-elevation myocardial infarction: observations from "Assessment of Pexelizumab in Acute Myocardial Infarction".” Am Heart J 162, no. 1 (July 2011): 89–97. https://doi.org/10.1016/j.ahj.2011.04.009.
    Full Text Link to Item
  - Tricoci, Pierluigi, L Kristin Newby, Vic Hasselblad, David F. Kong, Robert P. Giugliano, Harvey D. White, Pierre Théroux, et al. “Upstream use of small-molecule glycoprotein iib/iiia inhibitors in patients with non-ST-segment elevation acute coronary syndromes: a systematic overview of randomized clinical trials.” Circ Cardiovasc Qual Outcomes 4, no. 4 (July 2011): 448–58. https://doi.org/10.1161/CIRCOUTCOMES.110.960294.
    Full Text Link to Item
  - Zalewski, Jaroslaw, Kris Bogaerts, Walter Desmet, Peter Sinnaeve, Peter Berger, Cindy Grines, Thierry Danays, Paul Armstrong, and Frans Van de Werf. “Intraluminal thrombus in facilitated versus primary percutaneous coronary intervention: an angiographic substudy of the ASSENT-4 PCI (Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention) trial.” J Am Coll Cardiol 57, no. 19 (May 10, 2011): 1867–73. https://doi.org/10.1016/j.jacc.2010.10.061.
    Full Text Link to Item
  - Armstrong, Paul W., Cynthia M. Westerhout, Frans Van de Werf, Robert M. Califf, Robert C. Welsh, Robert G. Wilcox, and Jeffrey A. Bakal. “Refining clinical trial composite outcomes: an application to the Assessment of the Safety and Efficacy of a New Thrombolytic-3 (ASSENT-3) trial.” Am Heart J 161, no. 5 (May 2011): 848–54. https://doi.org/10.1016/j.ahj.2010.12.026.
    Full Text Link to Item
  - Mehta, Rajendra H., Aijing Z. Starr, Renato D. Lopes, Jonathan P. Piccini, Manesh R. Patel, Karen S. Pieper, Paul W. Armstrong, and Christopher B. Granger. “Relationship of sustained ventricular tachyarrhythmias to outcomes in patients undergoing primary percutaneous coronary intervention with varying underlying baseline risk.” Am Heart J 161, no. 4 (April 2011): 782–89. https://doi.org/10.1016/j.ahj.2011.01.005.
    Full Text Link to Item
  - Gharacholou, S Michael, Renato D. Lopes, Karen P. Alexander, Rajendra H. Mehta, Amanda L. Stebbins, Karen S. Pieper, Stefan K. James, Paul W. Armstrong, and Christopher B. Granger. “Age and outcomes in ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: findings from the APEX-AMI trial.” Arch Intern Med 171, no. 6 (March 28, 2011): 559–67. https://doi.org/10.1001/archinternmed.2011.36.
    Full Text Link to Item
  - McAlister, Finlay A., Fiona M. E. Lawson, A Heather Good, and Paul W. Armstrong. “Evaluating research in cardiovascular medicine: citation counts are not sufficient.” Circulation 123, no. 9 (March 8, 2011): 1038–43. https://doi.org/10.1161/CIRCULATIONAHA.110.989772.
    Full Text Link to Item
  - Hudson, Michael P., Paul W. Armstrong, William W. O’Neil, Amanda L. Stebbins, W Douglas Weaver, Petr Widimsky, Philip E. Aylward, et al. “Mortality implications of primary percutaneous coronary intervention treatment delays: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction trial.” Circ Cardiovasc Qual Outcomes 4, no. 2 (March 2011): 183–92. https://doi.org/10.1161/CIRCOUTCOMES.110.945311.
    Full Text Link to Item
  - Mahaffey, Kenneth W., June L. Wampole, Amanda Stebbins, Lisa G. Berdan, Donna McAfee, Tyrus L. Rorick, John K. French, et al. “Strategic lessons from the clinical event classification process for the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.” Contemp Clin Trials 32, no. 2 (March 2011): 178–87. https://doi.org/10.1016/j.cct.2010.12.013.
    Full Text Link to Item
  - Wang, Tracy Y., Jennifer A. White, Pierluigi Tricoci, Robert P. Giugliano, Uwe Zeymer, Robert A. Harrington, Gilles Montalescot, et al. “Upstream clopidogrel use and the efficacy and safety of early eptifibatide treatment in patients with acute coronary syndrome: an analysis from the Early Glycoprotein IIb/IIIa Inhibition in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome (EARLY ACS) trial.” Circulation 123, no. 7 (February 22, 2011): 722–30. https://doi.org/10.1161/CIRCULATIONAHA.110.958041.
    Full Text Link to Item
  - Kaul, Padma, Finlay A. McAlister, Justin A. Ezekowitz, Jeffrey A. Bakal, Lesley H. Curtis, Hude Quan, Merril L. Knudtson, and Paul W. Armstrong. “Resource use in the last 6 months of life among patients with heart failure in Canada.” Arch Intern Med 171, no. 3 (February 14, 2011): 211–17. https://doi.org/10.1001/archinternmed.2010.365.
    Full Text Link to Item
  - Westerhout, Cynthia M., Eric Bonnefoy, Robert C. Welsh, Philippe Gabriel Steg, Florent Boutitie, and Paul W. Armstrong. “The influence of time from symptom onset and reperfusion strategy on 1-year survival in ST-elevation myocardial infarction: a pooled analysis of an early fibrinolytic strategy versus primary percutaneous coronary intervention from CAPTIM and WEST.” Am Heart J 161, no. 2 (February 2011): 283–90. https://doi.org/10.1016/j.ahj.2010.10.033.
    Full Text Link to Item
  - Mehta, Rajendra H., J Conor O’Shea, Amanda L. Stebbins, Christopher B. Granger, Paul W. Armstrong, Harvey D. White, Eric J. Topol, Robert M. Califf, and E Magnus Ohman. “Association of mortality with years of education in patients with ST-segment elevation myocardial infarction treated with fibrinolysis.” J Am Coll Cardiol 57, no. 2 (January 11, 2011): 138–46. https://doi.org/10.1016/j.jacc.2010.09.021.
    Full Text Link to Item
  - Armstrong, Paul W. “Aldosterone antagonists--last man standing?” N Engl J Med 364, no. 1 (January 6, 2011): 79–80. https://doi.org/10.1056/NEJMe1012547.
    Full Text Link to Item
  - Kaul, Padma, Paul W. Armstrong, Sunil Sookram, Becky K. Leung, Neil Brass, and Robert C. Welsh. “Temporal trends in patient and treatment delay among men and women presenting with ST-elevation myocardial infarction.” Am Heart J 161, no. 1 (January 2011): 91–97. https://doi.org/10.1016/j.ahj.2010.09.016.
    Full Text Link to Item
  - Wilson, Donna M., Joachim Cohen, Stephen Birch, Rod Macleod, Deepthi Mohankumar, Paul Armstrong, Katherine Froggatt, et al. “"No one dies of old age": implications for research, practice, and policy.” J Palliat Care 27, no. 2 (2011): 148–56.
    Link to Item
  - Bakal, Jeffrey A., Padma Kaul, Robert C. Welsh, David Johnstone, and Paul W. Armstrong. “Determining the cost economic "tipping point" for the addition of a regional percutaneous coronary intervention facility.” Can J Cardiol 27, no. 5 (2011): 567–72. https://doi.org/10.1016/j.cjca.2011.03.007.
    Full Text Link to Item
  - Mehta, Rajendra H., Amanda Stebbins, Renato D. Lopes, Sunil V. Rao, Eric R. Bates, Karen S. Pieper, Paul W. Armstrong, et al. “Race, Bleeding, and Outcomes in STEMI Patients Treated with Fibrinolytic Therapy.” Am J Med 124, no. 1 (January 2011): 48–57. https://doi.org/10.1016/j.amjmed.2010.07.028.
    Full Text Link to Item
  - Armstrong, Paul W., and Robert C. Welsh. “Rear-view mirror observations on bleeding in acute coronary syndromes.” Jacc Cardiovasc Interv 3, no. 11 (November 2010): 1178–80. https://doi.org/10.1016/j.jcin.2010.09.011.
    Full Text Link to Item
  - Armstrong, Paul W., and Justin A. Ezekowitz. “Testosterone therapy in women with heart failure "why can't a woman be more like a man?".” J Am Coll Cardiol 56, no. 16 (October 12, 2010): 1317–19. https://doi.org/10.1016/j.jacc.2010.03.091.
    Full Text Link to Item
  - Stebbins, Amanda, Rajendra H. Mehta, Paul W. Armstrong, Kerry L. Lee, Christian Hamm, Frans Van de Werf, Stefan James, et al. “A model for predicting mortality in acute ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: results from the Assessment of Pexelizumab in Acute Myocardial Infarction Trial.” Circ Cardiovasc Interv 3, no. 5 (October 2010): 414–22. https://doi.org/10.1161/CIRCINTERVENTIONS.109.925180.
    Full Text Link to Item
  - Toma, Mustafa, Yuling Fu, Justin A. Ezekowitz, Finlay A. McAlister, Cynthia M. Westerhout, Christopher B. Granger, and Paul W. Armstrong. “Does silent myocardial infarction add prognostic value in ST-elevation myocardial infarction patients without a history of prior myocardial infarction? Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Trial.” Am Heart J 160, no. 4 (October 2010): 671–77. https://doi.org/10.1016/j.ahj.2010.06.054.
    Full Text Link to Item
  - Borgia, Francesco, Shaun G. Goodman, Sigrun Halvorsen, Warren J. Cantor, Federico Piscione, Michel R. Le May, Francisco Fernández-Avilés, et al. “Early routine percutaneous coronary intervention after fibrinolysis vs. standard therapy in ST-segment elevation myocardial infarction: a meta-analysis.” Eur Heart J 31, no. 17 (September 2010): 2156–69. https://doi.org/10.1093/eurheartj/ehq204.
    Full Text Link to Item
  - Jarai, Rudolf, Kurt Huber, Kris Bogaerts, Peter R. Sinnaeve, Justin Ezekowitz, Allan M. Ross, Uwe Zeymer, Paul W. Armstrong, Frans J. Van de Werf, and Frans J. ASSENT-4 PCI investigators. “Prediction of cardiogenic shock using plasma B-type natriuretic peptide and the N-terminal fragment of its pro-hormone [corrected] concentrations in ST elevation myocardial infarction: an analysis from the ASSENT-4 Percutaneous Coronary Intervention Trial.” Crit Care Med 38, no. 9 (September 2010): 1793–1801. https://doi.org/10.1097/CCM.0b013e3181eaaf2a.
    Full Text Link to Item
  - Tjandrawidjaja, Michael C., Yuling Fu, Cynthia M. Westerhout, Galen S. Wagner, Christopher B. Granger, Paul W. Armstrong, and Paul W. APEX-AMI Investigators. “Usefulness of the QRS score as a strong prognostic marker in patients discharged after undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.” Am J Cardiol 106, no. 5 (September 1, 2010): 630–34. https://doi.org/10.1016/j.amjcard.2010.04.013.
    Full Text Link to Item
  - Armstrong, Paul W. “Spotting the pantomime villain: do the usual approaches correctly indicate when waiting times got shorter?” Health Serv Manage Res 23, no. 3 (August 2010): 103–15. https://doi.org/10.1258/hsmr.2009.009021.
    Full Text Link to Item
  - Ezekowitz, Justin A., Paul W. Armstrong, Christopher B. Granger, Pierre Theroux, Amanda Stebbins, Raymond J. Kim, and Manesh R. Patel. “Predicting chronic left ventricular dysfunction 90 days after ST-segment elevation myocardial infarction: An Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Substudy.” Am Heart J 160, no. 2 (August 2010): 272–78. https://doi.org/10.1016/j.ahj.2010.05.035.
    Full Text Link to Item
  - Chin, Chee Tang, Matthew T. Roe, Keith A. A. Fox, Dorairaj Prabhakaran, Debra A. Marshall, Helene Petitjean, Yuliya Lokhnygina, et al. “Study design and rationale of a comparison of prasugrel and clopidogrel in medically managed patients with unstable angina/non-ST-segment elevation myocardial infarction: the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trial.” Am Heart J 160, no. 1 (July 2010): 16-22.e1. https://doi.org/10.1016/j.ahj.2010.04.022.
    Full Text Link to Item
  - Patel, M. R., S. G. Worthley, A. Stebbins, T. Dill, F. E. Rademakers, U. S. Velleti, G. W. Barsness, et al. “Erratum: Pexelizumab and infarct size in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: A delayed enhancement cardiac magnetic resonance substudy from the APEX-AMI trial (J Am Coll Cardiol Img (2010) 3 (52-60)).” Jacc: Cardiovascular Imaging 3, no. 7 (July 1, 2010): 796. https://doi.org/10.1016/j.jcmg.2010.05.006.
    Full Text
  - Armstrong, Paul W., Anthony Gershlick, Patrick Goldstein, Robert Wilcox, Thierry Danays, Erich Bluhmki, Frans Van de Werf, and Frans STREAM Steering Committee. “The Strategic Reperfusion Early After Myocardial Infarction (STREAM) study.” Am Heart J 160, no. 1 (July 2010): 30-35.e1. https://doi.org/10.1016/j.ahj.2010.04.007.
    Full Text Link to Item
  - Huber, Kurt, David R. Holmes, Arnoud W. van ’t Hof, Gilles Montalescot, Philip E. Aylward, G Amadeo Betriu, Petr Widimsky, Cynthia M. Westerhout, Christopher B. Granger, and Paul W. Armstrong. “Use of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention: insights from the APEX-AMI trial.” Eur Heart J 31, no. 14 (July 2010): 1708–16. https://doi.org/10.1093/eurheartj/ehq143.
    Full Text Link to Item
  - Toma, Mustafa, Christopher E. Buller, Cynthia M. Westerhout, Yuling Fu, William W. O’Neill, David R. Holmes, Christian W. Hamm, Christopher B. Granger, Paul W. Armstrong, and Paul W. APEX-AMI Investigators. “Non-culprit coronary artery percutaneous coronary intervention during acute ST-segment elevation myocardial infarction: insights from the APEX-AMI trial.” Eur Heart J 31, no. 14 (July 2010): 1701–7. https://doi.org/10.1093/eurheartj/ehq129.
    Full Text Link to Item
  - Ohman, E Magnus, Matthew T. Roe, Paul W. Armstrong, Keith A. Fox, Dorairaj Prabhakaran, and Harvey D. White. “Public sensationalism and clinical trials: how to address the challenges of science?” Am J Med 123, no. 6 (June 2010): 481–83. https://doi.org/10.1016/j.amjmed.2009.12.012.
    Full Text Link to Item
  - Simes, R John, Rachel L. O’Connell, Philip E. Aylward, Sergei Varshavsky, Rafael Diaz, Robert G. Wilcox, Paul W. Armstrong, et al. “Unexplained international differences in clinical outcomes after acute myocardial infarction and fibrinolytic therapy: lessons from the Hirulog and Early Reperfusion or Occlusion (HERO)-2 trial.” Am Heart J 159, no. 6 (June 2010): 988–97. https://doi.org/10.1016/j.ahj.2009.12.044.
    Full Text Link to Item
  - Trendelenburg, Marten, Pierre Theroux, Amanda Stebbins, Christopher Granger, Paul Armstrong, and Matthias Pfisterer. “Influence of functional deficiency of complement mannose-binding lectin on outcome of patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.” Eur Heart J 31, no. 10 (May 2010): 1181–87. https://doi.org/10.1093/eurheartj/ehp597.
    Full Text Link to Item
  - Alhadramy, Osama, Cynthia M. Westerhout, Sorin J. Brener, Christopher B. Granger, Paul W. Armstrong, and Paul W. APEX AMI Investigators. “Is visual interpretation of coronary epicardial flow reliable in patients with ST-elevation myocardial infarction undergoing primary angioplasty? Insights from the angiographic substudy of the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.” Am Heart J 159, no. 5 (May 2010): 899–904. https://doi.org/10.1016/j.ahj.2010.02.028.
    Full Text Link to Item
  - Eggers, Kai M., Paul W. Armstrong, Robert M. Califf, Maarten L. Simoons, Per Venge, Lars Wallentin, and Stefan K. James. “ST2 and mortality in non-ST-segment elevation acute coronary syndrome.” Am Heart J 159, no. 5 (May 2010): 788–94. https://doi.org/10.1016/j.ahj.2010.02.022.
    Full Text Link to Item
  - Buller, Christopher E., Cynthia M. Westerhout, and Paul W. Armstrong. “ST-segment resolution and outcome in myocardial infarction.” J Am Coll Cardiol 55, no. 15 (April 13, 2010): 1646–47. https://doi.org/10.1016/j.jacc.2009.12.033.
    Full Text Link to Item
  - Califf, Robert M., Paul W. Armstrong, Christopher B. Granger, Robert A. Harrington, Kerry Lee, R John Simes, Frans Van de Werf, Lars Wallentin, Harvey D. White, and Harvey D. Virtual Coordinating Centre for Global Collaborative Cardiovascular Research Organization. “Towards a new order in cardiovascular medicine: re-engineering through global collaboration.” Eur Heart J 31, no. 8 (April 2010): 911–17. https://doi.org/10.1093/eurheartj/ehp550.
    Full Text Link to Item
  - Tjandrawidjaja, Michael C., Yuling Fu, Cynthia M. Westerhout, Harvey D. White, Thomas G. Todaro, Frans Van de Werf, Kenneth W. Mahaffey, et al. “Resolution of ST-segment depression: A new prognostic marker in ST-segment elevation myocardial infarction.” Eur Heart J 31, no. 5 (March 2010): 573–81. https://doi.org/10.1093/eurheartj/ehp494.
    Full Text Link to Item
  - Welsh, Robert C., Christopher B. Granger, Cynthia M. Westerhout, James C. Blankenship, David R. Holmes, William W. O’Neill, Christian W. Hamm, Frans Van de Werf, Paul W. Armstrong, and Paul W. APEX AMI Investigators. “Prior coronary artery bypass graft patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.” Jacc Cardiovasc Interv 3, no. 3 (March 2010): 343–51. https://doi.org/10.1016/j.jcin.2009.12.008.
    Full Text Link to Item
  - Armstrong, Paul W. “Pharmacotherapy: Intracoronary streptokinase in acute myocardial infarction.” Nat Rev Cardiol 7, no. 2 (February 2010): 67–69. https://doi.org/10.1038/nrcardio.2009.230.
    Full Text Link to Item
  - Armstrong, Paul W. “One question, two answers: do the two most commonly used methods of sampling describe the length of the prospective wait for admission to hospital?” Health Serv Manage Res 23, no. 1 (February 2010): 18–24. https://doi.org/10.1258/hsmr.2009.009013.
    Full Text Link to Item
  - Lopes, Renato D., Aijing Starr, Carl F. Pieper, Sana M. Al-Khatib, L Kristin Newby, Rajendra H. Mehta, Frans Van de Werf, et al. “Warfarin use and outcomes in patients with atrial fibrillation complicating acute coronary syndromes.” Am J Med 123, no. 2 (February 2010): 134–40. https://doi.org/10.1016/j.amjmed.2009.09.015.
    Full Text Link to Item
  - Montalescot, Gilles, Stephen G. Ellis, Mark A. de Belder, Luc Janssens, Olivier Katz, Wladyslaw Pluta, Patrick Ecollan, et al. “Enoxaparin in primary and facilitated percutaneous coronary intervention A formal prospective nonrandomized substudy of the FINESSE trial (Facilitated INtervention with Enhanced Reperfusion Speed to Stop Events).” Jacc Cardiovasc Interv 3, no. 2 (February 2010): 203–12. https://doi.org/10.1016/j.jcin.2009.11.012.
    Full Text Link to Item
  - Almansori, Mohammed, Paul Armstrong, Yuling Fu, and Padma Kaul. “Electrocardiographic identification of the culprit coronary artery in inferior wall ST elevation myocardial infarction.” Can J Cardiol 26, no. 6 (2010): 293–96. https://doi.org/10.1016/s0828-282x(10)70392-5.
    Full Text Link to Item
  - Diepen, Sean van, Hany Siha, Yuling Fu, Cynthia M. Westerhout, Renato D. Lopes, Christopher B. Granger, Paul W. Armstrong, and Paul W. APEX AMI Investigators. “Do baseline atrial electrocardiographic and infarction patterns predict new-onset atrial fibrillation after ST-elevation myocardial infarction? Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction Trial.” J Electrocardiol 43, no. 4 (2010): 351–58. https://doi.org/10.1016/j.jelectrocard.2010.04.001.
    Full Text Link to Item
  - French, John K., Anne S. Hellkamp, Paul W. Armstrong, Eric Cohen, Neil S. Kleiman, Christopher M. O’Connor, David R. Holmes, Judith S. Hochman, Christopher B. Granger, and Kenneth W. Mahaffey. “Mechanical complications after percutaneous coronary intervention in ST-elevation myocardial infarction (from APEX-AMI).” Am J Cardiol 105, no. 1 (January 1, 2010): 59–63. https://doi.org/10.1016/j.amjcard.2009.08.653.
    Full Text Link to Item
  - Jarai, Rudolf, Kurt Huber, Kris Bogaerts, Walter Droogne, Justin Ezekowitz, Christopher B. Granger, Peter R. Sinnaeve, et al. “Plasma N-terminal fragment of the prohormone B-type natriuretic peptide concentrations in relation to time to treatment and Thrombolysis in Myocardial Infarction (TIMI) flow: a substudy of the Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT IV-PCI) trial.” Am Heart J 159, no. 1 (January 2010): 131–40. https://doi.org/10.1016/j.ahj.2009.11.001.
    Full Text Link to Item
  - Patel, Manesh R., Stephen G. Worthley, Amanda Stebbins, Thorsten Dill, Frank E. Rademakers, Uma S. Valeti, Gregory W. Barsness, et al. “Pexelizumab and infarct size in patients with acute myocardial infarction undergoing primary percutaneous coronary Intervention: a delayed enhancement cardiac magnetic resonance substudy from the APEX-AMI trial.” Jacc Cardiovasc Imaging 3, no. 1 (January 2010): 52–60. https://doi.org/10.1016/j.jcmg.2009.09.014.
    Full Text Link to Item
  - Ezekowitz, J. A., P. Kaul, J. A. Bakal, P. W. Armstrong, R. C. Welsh, and F. A. McAlister. “Reply.” Journal of the American College of Cardiology 55, no. 1 (December 29, 2009): 81. https://doi.org/10.1016/j.jacc.2009.08.034.
    Full Text
  - Patterson, Mark E., William C. Grant, Seth W. Glickman, Barry M. Massie, Susan E. Ammon, Paul W. Armstrong, John G. F. Cleland, et al. “Resource use and costs of treatment with anticoagulation and antiplatelet agents: results of the WATCH trial economic evaluation.” J Card Fail 15, no. 10 (December 2009): 819–27. https://doi.org/10.1016/j.cardfail.2009.07.004.
    Full Text Link to Item
  - Berger, Jeffrey S., Matthew T. Roe, C Michael Gibson, Rakhi Kilaru, Cynthia L. Green, Laura Melton, James D. Blankenship, et al. “Safety and feasibility of adjunctive antiplatelet therapy with intravenous elinogrel, a direct-acting and reversible P2Y12 ADP-receptor antagonist, before primary percutaneous intervention in patients with ST-elevation myocardial infarction: the Early Rapid ReversAl of platelet thromboSis with intravenous Elinogrel before PCI to optimize reperfusion in acute Myocardial Infarction (ERASE MI) pilot trial.” Am Heart J 158, no. 6 (December 2009): 998-1004.e1. https://doi.org/10.1016/j.ahj.2009.10.010.
    Full Text Link to Item
  - Jolicoeur, E Marc, William W. O’Neill, Anne Hellkamp, Christian W. Hamm, David R. Holmes, Hussein R. Al-Khalidi, Manesh R. Patel, et al. “Transfusion and mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.” Eur Heart J 30, no. 21 (November 2009): 2575–83. https://doi.org/10.1093/eurheartj/ehp279.
    Full Text Link to Item
  - Massie, B. M., S. E. Ammon, J. F. Collins, W. F. Krol, P. W. Armstrong, J. G. F. Cleland, M. Ezekowitz, et al. “Response to letter regarding article, randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: The warfarin and antiplatelet therapy in chronic heart failure (WATCH) trial.” Circulation 120, no. 20 (November 1, 2009). https://doi.org/10.1161/CIRCULATIONAHA.109.884650.
    Full Text
  - Brener, Sorin J., Cynthia M. Westerhout, Yuling Fu, Thomas G. Todaro, David J. Moliterno, Galen S. Wagner, Christopher B. Granger, Paul W. Armstrong, and Paul W. APEX-AMI Investigators. “Contribution of angiographic and electrocardiographic parameters of reperfusion to prediction of mortality and morbidity after acute ST-elevation myocardial infarction: Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction trial.” Am Heart J 158, no. 5 (November 2009): 755–60. https://doi.org/10.1016/j.ahj.2009.09.009.
    Full Text Link to Item
  - Herrmann, Howard C., Jiandong Lu, Bruce R. Brodie, Paul W. Armstrong, Gilles Montalescot, Amadeo Betriu, Franz-Joseph Neuman, et al. “Benefit of facilitated percutaneous coronary intervention in high-risk ST-segment elevation myocardial infarction patients presenting to nonpercutaneous coronary intervention hospitals.” Jacc Cardiovasc Interv 2, no. 10 (October 2009): 917–24. https://doi.org/10.1016/j.jcin.2009.06.018.
    Full Text Link to Item
  - Ellis, Stephen G., Michal Tendera, Mark A. de Belder, Ad J. van Boven, Petr Widimsky, Henning R. Andersen, Amadeo Betriu, et al. “1-year survival in a randomized trial of facilitated reperfusion: results from the FINESSE (Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events) trial.” Jacc Cardiovasc Interv 2, no. 10 (October 2009): 909–16. https://doi.org/10.1016/j.jcin.2009.07.009.
    Full Text Link to Item
  - Ross, Allan M., Kurt Huber, Uwe Zeymer, Paul W. Armstrong, Christopher B. Granger, Patrick Goldstein, Kris Bogaerts, and Frans Van de Werf. “The impact of place of enrollment and delay to reperfusion on 90-day post-infarction mortality in the ASSENT-4 PCI trial: assessment of the safety and efficacy of a new treatment strategy with percutaneous coronary intervention.” Jacc Cardiovasc Interv 2, no. 10 (October 2009): 925–30. https://doi.org/10.1016/j.jcin.2009.08.009.
    Full Text Link to Item
  - Mehta, R. H., P. W. Armstrong, and C. B. Granger. “In reply.” Jama 302, no. 9 (September 2, 2009): 944–45. https://doi.org/10.1001/jama.2009.1239.
    Full Text
  - Sinnaeve, Peter R., Justin A. Ezekowitz, Kris Bogaerts, Walter Droogne, Rudolf Jarai, Kurt Huber, Christopher B. Granger, et al. “Reperfusion before percutaneous coronary intervention in ST-elevation myocardial infarction patients is associated with lower N-terminal pro-brain natriuretic peptide levels during follow-up, irrespective of pre-treatment with full-dose fibrinolysis.” Eur Heart J 30, no. 18 (September 2009): 2213–19. https://doi.org/10.1093/eurheartj/ehp246.
    Full Text Link to Item
  - Berger, Jeffrey S., Laine Elliott, Dianne Gallup, Matthew Roe, Christopher B. Granger, Paul W. Armstrong, R John Simes, et al. “Sex differences in mortality following acute coronary syndromes.” Jama 302, no. 8 (August 26, 2009): 874–82. https://doi.org/10.1001/jama.2009.1227.
    Full Text Link to Item
  - Bata, Iqbal, Paul W. Armstrong, Cynthia M. Westerhout, Andrew Travers, Sunil Sookram, Edward Caine, James Christenson, Robert C. Welsh, and Robert C. WEST Study Group. “Time from first medical contact to reperfusion in ST elevation myocardial infarction: a Which Early ST Elevation Myocardial Infarction Therapy (WEST) substudy.” Can J Cardiol 25, no. 8 (August 2009): 463–68. https://doi.org/10.1016/s0828-282x(09)70118-7.
    Full Text Link to Item
  - Bainey, K. R., Y. Fu, C. B. Granger, C. W. Hamm, D. R. Holmes, W. W. O’Neill, R. Seabra-Gomes, et al. “Benefit of angiographic spontaneous reperfusion in STEMI: does it extend to diabetic patients?” Heart 95, no. 16 (August 2009): 1331–36. https://doi.org/10.1136/hrt.2008.160390.
    Full Text Link to Item
  - Lopes, Renato D., Laine E. Elliott, Harvey D. White, Judith S. Hochman, Frans Van de Werf, Diego Ardissino, Torsten T. Nielsen, et al. “Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trial.” Eur Heart J 30, no. 16 (August 2009): 2019–28. https://doi.org/10.1093/eurheartj/ehp213.
    Full Text Link to Item
  - Kaul, Padma, C David Naylor, Paul W. Armstrong, Daniel B. Mark, Pierre Theroux, and Gilles R. Dagenais. “Assessment of activity status and survival according to the Canadian Cardiovascular Society angina classification.” Can J Cardiol 25, no. 7 (July 2009): e225–31. https://doi.org/10.1016/s0828-282x(09)70506-9.
    Full Text Link to Item
  - Armstrong, Paul W., and Karen P. Alexander. “Nebivolol in older adults with heart failure: reduced rates for seniors?” J Am Coll Cardiol 53, no. 23 (June 9, 2009): 2159–61. https://doi.org/10.1016/j.jacc.2009.03.019.
    Full Text Link to Item
  - McAlister, Finlay A., Natasha Wiebe, Justin A. Ezekowitz, Alexander A. Leung, and Paul W. Armstrong. “Meta-analysis: beta-blocker dose, heart rate reduction, and death in patients with heart failure.” Ann Intern Med 150, no. 11 (June 2, 2009): 784–94. https://doi.org/10.7326/0003-4819-150-11-200906020-00006.
    Full Text Link to Item
  - Clark, Alexander M., C Nicole Freydberg, Finlay A. McAlister, Ross T. Tsuyuki, Paul W. Armstrong, and Laurel A. Strain. “Patient and informal caregivers' knowledge of heart failure: necessary but insufficient for effective self-care.” Eur J Heart Fail 11, no. 6 (June 2009): 617–21. https://doi.org/10.1093/eurjhf/hfp058.
    Full Text Link to Item
  - Giugliano, Robert P., Jennifer A. White, Christoph Bode, Paul W. Armstrong, Gilles Montalescot, Basil S. Lewis, Arnoud van ’t Hof, et al. “Early versus delayed, provisional eptifibatide in acute coronary syndromes.” N Engl J Med 360, no. 21 (May 21, 2009): 2176–90. https://doi.org/10.1056/NEJMoa0901316.
    Full Text Link to Item
  - Mehta, Rajendra H., Aijing Z. Starr, Renato D. Lopes, Judith S. Hochman, Petr Widimsky, Karen S. Pieper, Paul W. Armstrong, Christopher B. Granger, and Christopher B. APEX AMI Investigators. “Incidence of and outcomes associated with ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention.” Jama 301, no. 17 (May 6, 2009): 1779–89. https://doi.org/10.1001/jama.2009.600.
    Full Text Link to Item
  - Armstrong, Paul W., Yuling Fu, Cynthia M. Westerhout, Michael P. Hudson, Kenneth W. Mahaffey, Harvey D. White, Thomas G. Todaro, Peter X. Adams, Philip E. G. Aylward, and Christopher B. Granger. “Baseline Q-wave surpasses time from symptom onset as a prognostic marker in ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention.” J Am Coll Cardiol 53, no. 17 (April 28, 2009): 1503–9. https://doi.org/10.1016/j.jacc.2009.01.046.
    Full Text Link to Item
  - Giugliano, R. P., J. A. White, C. Bode, P. W. Armstrong, G. Montalescot, B. S. Lewis, A. Van’t Hof, et al. “Early versus delayed, provisional eptifibatide in acute coronary syndromes.” Revista Portuguesa De Cardiologia 28, no. 4 (April 1, 2009): 487–89.
  - Wang, Tracy Y., Min Zhang, Yuling Fu, Paul W. Armstrong, L Kristin Newby, C Michael Gibson, David J. Moliterno, et al. “Incidence, distribution, and prognostic impact of occluded culprit arteries among patients with non-ST-elevation acute coronary syndromes undergoing diagnostic angiography.” Am Heart J 157, no. 4 (April 2009): 716–23. https://doi.org/10.1016/j.ahj.2009.01.004.
    Full Text Link to Item
  - Massie, Barry M., Joseph F. Collins, Susan E. Ammon, Paul W. Armstrong, John G. F. Cleland, Michael Ezekowitz, Syed M. Jafri, et al. “Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial.” Circulation 119, no. 12 (March 31, 2009): 1616–24. https://doi.org/10.1161/CIRCULATIONAHA.108.801753.
    Full Text Link to Item
  - Armstrong, P. W., C. M. Westerhout, and R. C. Welsh. “Response to bogaty.” Circulation 119, no. 9 (March 10, 2009): 1310.
  - Armstrong, Paul W., Cynthia M. Westerhout, and Robert C. Welsh. “Duration of symptoms is the key modulator of the choice of reperfusion for ST-elevation myocardial infarction.” Circulation 119, no. 9 (March 10, 2009): 1293–1303. https://doi.org/10.1161/CIRCULATIONAHA.108.796383.
    Full Text Link to Item
  - Armstrong, Paul W. “What do we know? Limitations of the two methods most commonly used to estimate the length of the prospective wait.” Health Serv Manage Res 22, no. 1 (February 2009): 8–16. https://doi.org/10.1258/hsmr.2008.008014.
    Full Text Link to Item
  - Hernandez, Adrian F., Christopher M. O’Connor, Randall C. Starling, Craig J. Reist, Paul W. Armstrong, Kenneth Dickstein, Todd J. Lorenz, et al. “Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF).” Am Heart J 157, no. 2 (February 2009): 271–77. https://doi.org/10.1016/j.ahj.2008.07.031.
    Full Text Link to Item
  - Patel, Manesh R., Matthias E. Pfisterer, Amadeo Betriu, Petr Widmisky, David R. Holmes, William W. O’Neill, Amanda Stebbins, et al. “Comparison of six-month outcomes for primary percutaneous revascularization for acute myocardial infarction with drug-eluting versus bare metal stents (from the APEX-AMI study).” Am J Cardiol 103, no. 2 (January 15, 2009): 181–86. https://doi.org/10.1016/j.amjcard.2008.08.066.
    Full Text Link to Item
  - Johanson, Per, Yuling Fu, Galen S. Wagner, Shaun G. Goodman, Chris B. Granger, Lars Wallentin, Frans Van de Werf, Paul W. Armstrong, and Paul W. ASSENT 3 Investigators. “ST resolution 1 hour after fibrinolysis for prediction of myocardial infarct size: insights from ASSENT 3.” Am J Cardiol 103, no. 2 (January 15, 2009): 154–58. https://doi.org/10.1016/j.amjcard.2008.08.054.
    Full Text Link to Item
  - Ezekowitz, Justin A., Padma Kaul, Jeffery A. Bakal, Paul W. Armstrong, Robert C. Welsh, and Finlay A. McAlister. “Declining in-hospital mortality and increasing heart failure incidence in elderly patients with first myocardial infarction.” J Am Coll Cardiol 53, no. 1 (January 6, 2009): 13–20. https://doi.org/10.1016/j.jacc.2008.08.067.
    Full Text Link to Item
  - Armstrong, Paul W. “Contemporary therapy of acute ST-elevation myocardial infarction.” Tex Heart Inst J 36, no. 4 (2009): 273–81.
    Link to Item
  - Graham, Michelle M., Cynthia M. Westerhout, Padma Kaul, Colleen M. Norris, and Paul W. Armstrong. “Sex differences in patients seeking medical attention for prodromal symptoms before an acute coronary event.” Am Heart J 156, no. 6 (December 2008): 1210-1216.e1. https://doi.org/10.1016/j.ahj.2008.07.016.
    Full Text Link to Item
  - Mahaffey, Kenneth W., Craig J. Reist, Yuling Fu, Sorin J. Brener, Pierre Theroux, Manesh R. Patel, Amanda Stebbins, et al. “Integrating ancillary studies in a large clinical trial: the design and rationale of the APEX library.” Contemp Clin Trials 29, no. 6 (November 2008): 887–95. https://doi.org/10.1016/j.cct.2008.06.003.
    Full Text Link to Item
  - Buller, Christopher E., Yuling Fu, Kenneth W. Mahaffey, Thomas G. Todaro, Peter Adams, Cynthia M. Westerhout, Harvey D. White, et al. “ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.” Circulation 118, no. 13 (September 23, 2008): 1335–46. https://doi.org/10.1161/CIRCULATIONAHA.108.767772.
    Full Text Link to Item
  - Armstrong, Paul W. “Defining myocardial infarction: a work in progress: Ischaemic heart disease.” Heart 94, no. 8 (August 2008): 1076–79. https://doi.org/10.1136/hrt.2007.135202.
    Full Text Link to Item
  - Bainey, Kevin R., Yuling Fu, Galen S. Wagner, Shaun G. Goodman, Allan Ross, Christopher B. Granger, Frans Van de Werf, Paul W. Armstrong, and Paul W. ASSENT 4 PCI Investigators. “Spontaneous reperfusion in ST-elevation myocardial infarction: comparison of angiographic and electrocardiographic assessments.” Am Heart J 156, no. 2 (August 2008): 248–55. https://doi.org/10.1016/j.ahj.2008.03.018.
    Full Text Link to Item
  - Lopes, R. D., K. S. Pieper, J. R. Horton, S. M. Al-Khatib, L. K. Newby, R. H. Mehta, F. Van de Werf, et al. “Short- and long-term outcomes following atrial fibrillation in patients with acute coronary syndromes with or without ST-segment elevation.” Heart 94, no. 7 (July 2008): 867–73. https://doi.org/10.1136/hrt.2007.134486.
    Full Text Link to Item
  - Armstrong, Paul W., and Jean-Lucien Rouleau. “A Canadian context for the Acute Study of Clinical Effectiveness of Nesiritide and Decompensated Heart Failure (ASCEND-HF) trial.” Can J Cardiol 24 Suppl B, no. Suppl B (July 2008): 30B-32B. https://doi.org/10.1016/s0828-282x(08)71028-6.
    Full Text Link to Item
  - Ellis, Stephen G., Michal Tendera, Mark A. de Belder, Ad J. van Boven, Petr Widimsky, Luc Janssens, H. R. Andersen, et al. “Facilitated PCI in patients with ST-elevation myocardial infarction.” N Engl J Med 358, no. 21 (May 22, 2008): 2205–17. https://doi.org/10.1056/NEJMoa0706816.
    Full Text Link to Item
  - Brener, Sorin J., David J. Moliterno, Philip E. Aylward, Arnoud W. J. van’t Hof, Witold Ruźyllo, William W. O’Neill, Christian W. Hamm, et al. “Reperfusion after primary angioplasty for ST-elevation myocardial infarction: predictors of success and relationship to clinical outcomes in the APEX-AMI angiographic study.” Eur Heart J 29, no. 9 (May 2008): 1127–35. https://doi.org/10.1093/eurheartj/ehn125.
    Full Text Link to Item
  - Armstrong, Paul W. “Requiem for the sounds of silence.” Cmaj 178, no. 8 (April 8, 2008): 1104. https://doi.org/10.1503/cmaj.071780.
    Full Text Link to Item
  - Schechter, Martin T., and Paul W. Armstrong. “The Canadian Academy of Health Sciences: coming of age at the right time.” Cmaj 178, no. 8 (April 8, 2008): 1029–31. https://doi.org/10.1503/cmaj.071800.
    Full Text Link to Item
  - McDonald, Michael A., Yuling Fu, Uwe Zeymer, Galen Wagner, Shaun G. Goodman, Allan Ross, Christopher B. Granger, Frans Van de Werf, Paul W. Armstrong, and Paul W. ASSENT-4 PCI Investigators. “Adverse outcomes in fibrinolytic-based facilitated percutaneous coronary intervention: insights from the ASSENT-4 PCI electrocardiographic substudy.” Eur Heart J 29, no. 7 (April 2008): 871–79. https://doi.org/10.1093/eurheartj/ehn078.
    Full Text Link to Item
  - Mehta, Rajendra H., Sunil V. Rao, E Magnus Ohman, Eric R. Bates, Gretchen Marcucci, Min Zhang, Karen S. Pieper, et al. “Variation in the use of stress testing and outcomes in patients with non-ST-elevation acute coronary syndromes: insights from GUSTO IIb.” Eur Heart J 29, no. 7 (April 2008): 880–87. https://doi.org/10.1093/eurheartj/ehn100.
    Full Text Link to Item
  - Majumdar, Sumit R., Matthew T. Roe, Eric D. Peterson, Anita Y. Chen, W Brian Gibler, and Paul W. Armstrong. “Better outcomes for patients treated at hospitals that participate in clinical trials.” Arch Intern Med 168, no. 6 (March 24, 2008): 657–62. https://doi.org/10.1001/archinternmed.2007.124.
    Full Text Link to Item
  - Ezekowitz, Justin A., Jeffery A. Bakal, Padma Kaul, Cynthia M. Westerhout, and Paul W. Armstrong. “Acute heart failure in the emergency department: short and long-term outcomes of elderly patients with heart failure.” Eur J Heart Fail 10, no. 3 (March 2008): 308–14. https://doi.org/10.1016/j.ejheart.2008.01.014.
    Full Text Link to Item
  - Toma, M., Y. Fu, G. Wagner, S. G. Goodman, C. Granger, L. Wallentin, F. Van de Werf, and P. Armstrong. “Risk stratification in ST-elevation myocardial infarction is enhanced by combining baseline ST deviation and subsequent ST-segment resolution.” Heart 94, no. 3 (March 2008): e6. https://doi.org/10.1136/hrt.2007.118166.
    Full Text Link to Item
  - Chan, Mark Y., Richard C. Becker, Robert A. Harrington, Eric D. Peterson, Paul W. Armstrong, Harvey White, Keith A. A. Fox, E Magnus Ohman, and Matthew T. Roe. “Noninvasive, medical management for non-ST-elevation acute coronary syndromes.” Am Heart J 155, no. 3 (March 2008): 397–407. https://doi.org/10.1016/j.ahj.2007.11.014.
    Full Text Link to Item
  - Danchin, Nicolas, and Paul W. Armstrong. “PCI at non-PCI centres: immediate or rescue?” Lancet 371, no. 9612 (February 16, 2008): 534–36. https://doi.org/10.1016/S0140-6736(08)60246-9.
    Full Text Link to Item
  - Rao, Sunil V., Padma R. Kaul, Lawrence Liao, Paul W. Armstrong, E Magnus Ohman, Christopher B. Granger, Robert M. Califf, Robert A. Harrington, Eric L. Eisenstein, and Daniel B. Mark. “Association between bleeding, blood transfusion, and costs among patients with non-ST-segment elevation acute coronary syndromes.” Am Heart J 155, no. 2 (February 2008): 369–74. https://doi.org/10.1016/j.ahj.2007.10.014.
    Full Text Link to Item
  - Ghali, Jalal K., Inder S. Anand, William T. Abraham, Gregg C. Fonarow, Barry Greenberg, Henry Krum, Barry M. Massie, et al. “Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemia.” Circulation 117, no. 4 (January 29, 2008): 526–35. https://doi.org/10.1161/CIRCULATIONAHA.107.698514.
    Full Text Link to Item
  - Antman, Elliott M., Mary Hand, Paul W. Armstrong, Eric R. Bates, Lee A. Green, Lakshmi K. Halasyamani, Judith S. Hochman, et al. “2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration With the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee.” Circulation 117, no. 2 (January 15, 2008): 296–329. https://doi.org/10.1161/CIRCULATIONAHA.107.188209.
    Full Text Link to Item
  - Berger, Jeffrey S., Amanda Stebbins, Christopher B. Granger, Eric M. Ohman, Paul W. Armstrong, Frans Van de Werf, Harvey D. White, et al. “Initial aspirin dose and outcome among ST-elevation myocardial infarction patients treated with fibrinolytic therapy.” Circulation 117, no. 2 (January 15, 2008): 192–99. https://doi.org/10.1161/CIRCULATIONAHA.107.729558.
    Full Text Link to Item
  - Buller, Christopher E., Robert C. Welsh, Cynthia M. Westerhout, John G. Webb, Blair O’Neill, Richard Gallo, and Paul W. Armstrong. “Guideline adjudicated fibrinolytic failure: incidence, findings, and management in a contemporary clinical trial.” Am Heart J 155, no. 1 (January 2008): 121–27. https://doi.org/10.1016/j.ahj.2007.08.027.
    Full Text Link to Item
  - Tjandrawidjaja, Michael C., Yuling Fu, Hussein Al-Khalidi, Thomas G. Todaro, Peter Adams, Frans Van de Werf, Christopher B. Granger, Paul W. Armstrong, and Paul W. APEX-AMI Investigators. “Failure of investigator adherence to electrocardiographic entry criteria is frequent and influences clinical outcomes: lessons from APEX-AMI.” Eur Heart J 28, no. 23 (December 2007): 2850–57. https://doi.org/10.1093/eurheartj/ehm453.
    Full Text Link to Item
  - Lewanczuk, Richard, and Paul W. Armstrong. “Physiologic straws in the wind: in which direction do they bend?” J Am Coll Cardiol 50, no. 21 (November 20, 2007): 2059–60. https://doi.org/10.1016/j.jacc.2007.08.022.
    Full Text Link to Item
  - Kaul, Padma, Wei-Ching Chang, Cynthia M. Westerhout, Michelle M. Graham, and Paul W. Armstrong. “Differences in admission rates and outcomes between men and women presenting to emergency departments with coronary syndromes.” Cmaj 177, no. 10 (November 6, 2007): 1193–99. https://doi.org/10.1503/cmaj.060711.
    Full Text Link to Item
  - Mark, Daniel B., Frans J. Van de Werf, R John Simes, Harvey D. White, Lars C. Wallentin, Robert M. Califf, Paul W. Armstrong, and Paul W. VIGOUR Group. “Cardiovascular disease on a global scale: defining the path forward for research and practice.” Eur Heart J 28, no. 21 (November 2007): 2678–84. https://doi.org/10.1093/eurheartj/ehm411.
    Full Text Link to Item
  - Mehta, Rajendra H., Adam B. Greenbaum, Yuliya Lokhnygina, L Kristin Newby, Frans Van De Werf, Paul W. Armstrong, Karen S. Pieper, Robert M. Califf, Christopher B. Granger, and Robert A. Harrington. “Timing of death and myocardial infarction in patients with non-ST elevation acute coronary syndromes: insights from randomized clinical trials.” J Interv Cardiol 20, no. 5 (October 2007): 299–306. https://doi.org/10.1111/j.1540-8183.2007.00277.x.
    Full Text Link to Item
  - Welsh, Robert C., Phillip Gordon, Cynthia M. Westerhout, Christopher E. Buller, Blair O’Neill, and Paul W. Armstrong. “A novel enoxaparin regime for ST elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: a WEST sub-study.” Catheter Cardiovasc Interv 70, no. 3 (September 2007): 341–48. https://doi.org/10.1002/ccd.21062.
    Full Text Link to Item
  - Westerhout, Cynthia M., Michael S. Lauer, Stefan James, Yuling Fu, Lars Wallentin, Paul W. Armstrong, and Paul W. GUSTO IV ACS Investigators. “Electrocardiographic left ventricular hypertrophy in GUSTO IV ACS: an important risk marker of mortality in women.” Eur Heart J 28, no. 17 (September 2007): 2064–69. https://doi.org/10.1093/eurheartj/ehm223.
    Full Text Link to Item
  - Westerhout, Cynthia M., Judy Gnarpe, Wei-Ching Chang, Susan FitzPatrick, Elliot S. Barnathan, Eric Boersma, Robert M. Califf, et al. “No prognostic significance of chronic infection with Chlamydia pneumoniae in acute coronary syndromes: insights from the Global Utilization of Strategies to Open Occluded Arteries IV Acute Coronary Syndromes trial.” Am Heart J 154, no. 2 (August 2007): 306–12. https://doi.org/10.1016/j.ahj.2007.04.010.
    Full Text Link to Item
  - Wong, Cheuk-Kit, L Kristin Newby, Manju V. Bhapker, Phil E. Aylward, Matthias Pfisterer, Karen P. Alexander, Paul W. Armstrong, et al. “Use of evidence-based medicine for acute coronary syndromes in the elderly and very elderly: insights from the Sibrafiban vs aspirin to Yield Maximum Protection from ischemic Heart events postacute cOroNary sYndromes trials.” Am Heart J 154, no. 2 (August 2007): 313–21. https://doi.org/10.1016/j.ahj.2007.04.031.
    Full Text Link to Item
  - Alexander, Karen P., L Kristin Newby, Christopher P. Cannon, Paul W. Armstrong, W Brian Gibler, Michael W. Rich, Frans Van de Werf, et al. “Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.” Circulation 115, no. 19 (May 15, 2007): 2549–69. https://doi.org/10.1161/CIRCULATIONAHA.107.182615.
    Full Text Link to Item
  - Alexander, Karen P., L Kristin Newby, Paul W. Armstrong, Christopher P. Cannon, W Brian Gibler, Michael W. Rich, Frans Van de Werf, et al. “Acute coronary care in the elderly, part II: ST-segment-elevation myocardial infarction: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.” Circulation 115, no. 19 (May 15, 2007): 2570–89. https://doi.org/10.1161/CIRCULATIONAHA.107.182616.
    Full Text Link to Item
  - Armstrong, Paul W., and Christopher B. Granger. “Pexelizumab and the APEX AMI trial.” Jama 297, no. 17 (May 2, 2007): 1881. https://doi.org/10.1001/jama.297.17.1881-b.
    Full Text Link to Item
  - Hernández, Adrián V., Cynthia M. Westerhout, Ewout W. Steyerberg, John P. A. Ioannidis, Héctor Bueno, Harvey White, Pierre Theroux, et al. “Effects of platelet glycoprotein IIb/IIIa receptor blockers in non-ST segment elevation acute coronary syndromes: benefit and harm in different age subgroups.” Heart 93, no. 4 (April 2007): 450–55. https://doi.org/10.1136/hrt.2006.098657.
    Full Text Link to Item
  - Armstrong, Paul W. “Ruminating on OAT: is the case closed?” Eur Heart J 28, no. 5 (March 2007): 531–32. https://doi.org/10.1093/eurheartj/ehl514.
    Full Text Link to Item
  - Wollert, Kai C., Tibor Kempf, Timo Peter, Sylvia Olofsson, Stefan James, Nina Johnston, Bertil Lindahl, et al. “Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome.” Circulation 115, no. 8 (February 27, 2007): 962–71. https://doi.org/10.1161/CIRCULATIONAHA.106.650846.
    Full Text Link to Item
  - Mehta, Rajendra H., Robert M. Califf, Jyotsna Garg, Harvey D. White, Frans Van de Werf, Paul W. Armstrong, Karen S. Pieper, Eric J. Topol, and Christopher B. Granger. “The impact of anthropomorphic indices on clinical outcomes in patients with acute ST-elevation myocardial infarction.” Eur Heart J 28, no. 4 (February 2007): 415–24. https://doi.org/10.1093/eurheartj/ehl329.
    Full Text Link to Item
  - Jolly, Sanjit, Mary Tan, Aurora Mendelsohn, David Fitchett, Paul W. Armstrong, Anatoly Langer, and Shaun G. Goodman. “Comparison of effectiveness of enoxaparin versus unfractionated heparin to reduce silent and clinically apparent acute myocardial infarction in patients presenting with non-ST-segment elevation acute coronary syndrome.” Am J Cardiol 99, no. 2 (January 15, 2007): 186–88. https://doi.org/10.1016/j.amjcard.2006.07.078.
    Full Text Link to Item
  - APEX AMI Investigators, Frans, Paul W. Armstrong, Christopher B. Granger, Peter X. Adams, Christian Hamm, David Holmes, William W. O’Neill, Thomas G. Todaro, Alec Vahanian, and Frans Van de Werf. “Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial.” Jama 297, no. 1 (January 3, 2007): 43–51. https://doi.org/10.1001/jama.297.1.43.
    Full Text Link to Item
  - Chang, Wei-Ching, Padma Kaul, Cynthia M. Westerhout, Michelle M. Graham, and Paul W. Armstrong. “Effects of socioeconomic status on mortality after acute myocardial infarction.” Am J Med 120, no. 1 (January 2007): 33–39. https://doi.org/10.1016/j.amjmed.2006.05.056.
    Full Text Link to Item
  - McAlister, F. A., W. A. Ghali, Y. Gong, J. Fang, J. V. Tu, and P. W. Armstrong. “Response to letter regarding article, "Aspirin use and outcomes in a community-based cohort of 7352 patients discharged after first hospitalization for heart failure" [2].” Circulation 115, no. 4 (January 1, 2007). https://doi.org/10.1161/CIRCULATIONAHA.106.657015.
    Full Text
  - Ezekowitz, Justin A., Pierre Théroux, Robert Welsh, Iqbal Bata, John Webb, and Paul W. Armstrong. “Insights into the change in brain natriuretic peptide after ST-elevation myocardial infarction (STEMI): why should it be better than baseline?” Can J Physiol Pharmacol 85, no. 1 (January 2007): 173–78. https://doi.org/10.1139/y06-102.
    Full Text Link to Item
  - Welsh, Robert C., Andrew Travers, Mano Senaratne, Randall Williams, and Paul W. Armstrong. “Feasibility and applicability of paramedic-based prehospital fibrinolysis in a large North American center.” Am Heart J 152, no. 6 (December 2006): 1007–14. https://doi.org/10.1016/j.ahj.2006.06.022.
    Full Text Link to Item
  - Westerhout, Cynthia M., Adrián V. Hernández, Ewout W. Steyerberg, Héctor Bueno, Harvey White, Pierre Théroux, David J. Moliterno, et al. “Predictors of stroke within 30 days in patients with non-ST-segment elevation acute coronary syndromes.” Eur Heart J 27, no. 24 (December 2006): 2956–61. https://doi.org/10.1093/eurheartj/ehl356.
    Full Text Link to Item
  - Sinnaeve, Peter R., Yao Huang, Kris Bogaerts, Alec Vahanian, Jennifer Adgey, Paul W. Armstrong, Lars Wallentin, Frans J. Van de Werf, Christopher B. Granger, and Christopher B. ASSENT-3 and ASSENT-3 PLUS investigators. “Age, outcomes, and treatment effects of fibrinolytic and antithrombotic combinations: findings from Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT)-3 and ASSENT-3 PLUS.” Am Heart J 152, no. 4 (October 2006): 684.e1-684.e9. https://doi.org/10.1016/j.ahj.2006.07.005.
    Full Text Link to Item
  - Armstrong, Paul W. “Advancing interdisciplinary health research: a synergism not to be denied.” Cmaj 175, no. 7 (September 26, 2006): 761. https://doi.org/10.1503/cmaj.060961.
    Full Text Link to Item
  - James, Stefan K., Johan Lindbäck, Johanna Tilly, Agneta Siegbahn, Per Venge, Paul Armstrong, Robert Califf, Maarten L. Simoons, Lars Wallentin, and Bertil Lindahl. “Troponin-T and N-terminal pro-B-type natriuretic peptide predict mortality benefit from coronary revascularization in acute coronary syndromes: a GUSTO-IV substudy.” J Am Coll Cardiol 48, no. 6 (September 19, 2006): 1146–54. https://doi.org/10.1016/j.jacc.2006.05.056.
    Full Text Link to Item
  - Westerhout, Cynthia M., Yuling Fu, Michael S. Lauer, Stefan James, Paul W. Armstrong, Eyad Al-Hattab, Robert M. Califf, et al. “Short- and long-term risk stratification in acute coronary syndromes: the added value of quantitative ST-segment depression and multiple biomarkers.” J Am Coll Cardiol 48, no. 5 (September 5, 2006): 939–47. https://doi.org/10.1016/j.jacc.2006.04.085.
    Full Text Link to Item
  - Armstrong, Paul W., and Christopher B. Granger. “Reflections on early stopping of a clinical trial.” Am Heart J 152, no. 3 (September 2006): 407–9. https://doi.org/10.1016/j.ahj.2006.06.006.
    Full Text Link to Item
  - Macdonald, Noni, Bruce Squires, David Hawkins, Jocelyn Downie, Arnold Aberman, Paul W. Armstrong, Frank Davidoff, et al. “Editorial independence for CMAJ: signposts along the road.” Cmaj 175, no. 5 (August 29, 2006): 453. https://doi.org/10.1503/cmaj.060985.
    Full Text Link to Item
  - Goodman, Shaun G., Yuling Fu, Anatoly Langer, Aiala Barr, Mary Tan, Galen S. Wagner, Alejandro Barbagelata, et al. “The prognostic value of the admission and predischarge electrocardiogram in acute coronary syndromes: the GUSTO-IIb ECG Core Laboratory experience.” Am Heart J 152, no. 2 (August 2006): 277–84. https://doi.org/10.1016/j.ahj.2005.12.022.
    Full Text Link to Item
  - Mahaffey, Kenneth W., Frans Van de Werf, Stanton K. Shernan, Christopher B. Granger, Edward D. Verrier, Thomas G. Filloon, Thomas G. Todaro, et al. “Effect of pexelizumab on mortality in patients with acute myocardial infarction or undergoing coronary artery bypass surgery: a systematic overview.” Am Heart J 152, no. 2 (August 2006): 291–96. https://doi.org/10.1016/j.ahj.2006.03.027.
    Full Text Link to Item
  - Hudson, Michael P., Paul W. Armstrong, Witold Ruzyllo, Jose Brum, Lisa Cusmano, Piotr Krzeski, Robert Lyon, et al. “Effects of selective matrix metalloproteinase inhibitor (PG-116800) to prevent ventricular remodeling after myocardial infarction: results of the PREMIER (Prevention of Myocardial Infarction Early Remodeling) trial.” J Am Coll Cardiol 48, no. 1 (July 4, 2006): 15–20. https://doi.org/10.1016/j.jacc.2006.02.055.
    Full Text Link to Item
  - Sande, A. J. M. van de, P. W. Armstrong, and P. Kaul. “The role of revascularization in older patients with acute coronary syndromes.” Geriatrics and Aging 9, no. 7 (July 1, 2006): 479–83.
  - Alexander, Karen P., Laura Kristin Newby, Manju V. Bhapkar, Harvey D. White, Judith S. Hochman, Matthias E. Pfisterer, David J. Moliterno, et al. “International variation in invasive care of the elderly with acute coronary syndromes.” Eur Heart J 27, no. 13 (July 2006): 1558–64. https://doi.org/10.1093/eurheartj/ehl067.
    Full Text Link to Item
  - Armstrong, Paul W., and Paul W. WEST Steering Committee. “A comparison of pharmacologic therapy with/without timely coronary intervention vs. primary percutaneous intervention early after ST-elevation myocardial infarction: the WEST (Which Early ST-elevation myocardial infarction Therapy) study.” Eur Heart J 27, no. 13 (July 2006): 1530–38. https://doi.org/10.1093/eurheartj/ehl088.
    Full Text Link to Item
  - Armstrong, P. W., W. C. Chang, and L. Wallentin. “Erratum: Efficacy and safety of unfractionated heparin versus enoxaparin: A pooled analysis of ASSENT-3 and -3 PLUS data (Canadian Medical Association Journal (2006) 174, 10 (1421-1426)).” Cmaj. Canadian Medical Association Journal 174, no. 13 (June 20, 2006): 1874. https://doi.org/10.1503/cmaj.060639.
    Full Text
  - McAlister, Finlay A., William A. Ghali, Yanyan Gong, Jiming Fang, Paul W. Armstrong, and Jack V. Tu. “Aspirin use and outcomes in a community-based cohort of 7352 patients discharged after first hospitalization for heart failure.” Circulation 113, no. 22 (June 6, 2006): 2572–78. https://doi.org/10.1161/CIRCULATIONAHA.105.602136.
    Full Text Link to Item
  - Viswanathan, Girish N. “Facilitated versus primary PCI for acute myocardial infarction.” Lancet 367, no. 9525 (June 3, 2006): 1813. https://doi.org/10.1016/S0140-6736(06)68792-8.
    Full Text Link to Item
  - Goyal, Abhinav, Kenneth W. Mahaffey, Jyotsna Garg, Jose C. Nicolau, Judith S. Hochman, W Douglas Weaver, Pierre Theroux, et al. “Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL study.” Eur Heart J 27, no. 11 (June 2006): 1289–97. https://doi.org/10.1093/eurheartj/ehi884.
    Full Text Link to Item
  - Armstrong, Paul W. “Balancing the cyclooxygenase portfolio.” Cmaj 174, no. 11 (May 23, 2006): 1581–82. https://doi.org/10.1503/cmaj.060471.
    Full Text Link to Item
  - Armstrong, Paul W., Wei-Ching Chang, Lars Wallentin, Patrick Goldstein, Christopher B. Granger, Kris Bogaerts, Thierry Danays, Frans Van de Werf, and Frans ASSENT-3 and ASSENT-3 PLUS Investigators. “Efficacy and safety of unfractionated heparin versus enoxaparin: a pooled analysis of ASSENT-3 and -3 PLUS data.” Cmaj 174, no. 10 (May 9, 2006): 1421–26. https://doi.org/10.1503/cmaj.051410.
    Full Text Link to Item
  - Buller, Christopher E., Gordon E. Pate, Paul W. Armstrong, Blair J. O’Neill, John G. Webb, Richard Gallo, and Robert C. Welsh. “Catheter thrombosis during primary percutaneous coronary intervention for acute ST elevation myocardial infarction despite subcutaneous low-molecular-weight heparin, acetylsalicylic acid, clopidogrel and abciximab pretreatment.” Can J Cardiol 22, no. 6 (May 1, 2006): 511–15. https://doi.org/10.1016/s0828-282x(06)70271-9.
    Full Text Link to Item
  - Kaul, Padma, Wei-Ching Chang, A Michael Lincoff, Philip Aylward, Amadeo Betriu, Christoph Bode, Robert M. Califf, et al. “Optimizing use of revascularization and clinical outcomes in ST-elevation myocardial infarction: insights from the GUSTO-V trial.” Eur Heart J 27, no. 10 (May 2006): 1198–1206. https://doi.org/10.1093/eurheartj/ehi854.
    Full Text Link to Item
  - Ezekowitz, Justin A., Pierre Théroux, Weiching Chang, Kenneth W. Mahaffey, Christopher B. Granger, W. D. Weaver, Judith S. Hochman, and Paul W. Armstrong. “N-terminal pro-brain natriuretic peptide and the timing, extent and mortality in ST elevation myocardial infarction.” Can J Cardiol 22, no. 5 (April 2006): 393–97. https://doi.org/10.1016/s0828-282x(06)70924-2.
    Full Text Link to Item
  - Verheugt, Freek W. A., Bernard J. Gersh, and Paul W. Armstrong. “Aborted myocardial infarction: a new target for reperfusion therapy.” Eur Heart J 27, no. 8 (April 2006): 901–4. https://doi.org/10.1093/eurheartj/ehi829.
    Full Text Link to Item
  - Armstrong, Paul W., Kenneth W. Mahaffey, Wei-Ching Chang, W Douglas Weaver, Judith S. Hochman, Pierre Theroux, Scott Rollins, Thomas G. Todaro, Christopher B. Granger, and Christopher B. COMMA Investigators. “Concerning the mechanism of pexelizumab's benefit in acute myocardial infarction.” Am Heart J 151, no. 4 (April 2006): 787–90. https://doi.org/10.1016/j.ahj.2005.06.008.
    Full Text Link to Item
  - Toma, Mustafa, Finlay A. McAlister, Justin Ezekowitz, Shane Kimber, Sajad Gulamhusein, Alfredo Pantano, Soori Sivakumaran, Bibiana Cujec, Ian Paterson, and Paul W. Armstrong. “Proportion of patients followed in a specialized heart failure clinic needing an implantable cardioverter defibrillator as determined by applying different trial eligibility criteria.” Am J Cardiol 97, no. 6 (March 15, 2006): 882–85. https://doi.org/10.1016/j.amjcard.2005.09.138.
    Full Text Link to Item
  - Toma, Mustafa, Finlay A. McAlister, Liza Bialy, Denise Adams, Ben Vandermeer, and Paul W. Armstrong. “Transition from meeting abstract to full-length journal article for randomized controlled trials.” Jama 295, no. 11 (March 15, 2006): 1281–87. https://doi.org/10.1001/jama.295.11.1281.
    Full Text Link to Item
  - Hersi, Ahmad, Paul W. Armstrong, Jonathan B. Choy, Sajad Gulamhusein, and Katherine M. Kavanagh. “Pulmonary edema post-cardioversion: a potential calcium signalling problem.” Can J Cardiol 22, no. 3 (March 1, 2006): 259–62. https://doi.org/10.1016/s0828-282x(06)70907-2.
    Full Text Link to Item
  - Kim, Daniel H., Jeffrey R. Burton, Yuling Fu, Lee Lindholm, Frans Van de Werf, Paul W. Armstrong, and Paul W. CAPTORS II Investigators. “What is the frequency and functional and clinical significance of complex lesions in non-infarct-related arteries after fibrinolysis for acute ST-elevation myocardial infarction?” Am Heart J 151, no. 3 (March 2006): 668–73. https://doi.org/10.1016/j.ahj.2005.05.006.
    Full Text Link to Item
  - Orlandini, Andrés, Rafael Díaz, Daniel Wojdyla, Karen Pieper, Frans Van de Werf, Christopher B. Granger, Robert A. Harrington, et al. “Outcomes of patients in clinical trials with ST-segment elevation myocardial infarction among countries with different gross national incomes.” Eur Heart J 27, no. 5 (March 2006): 527–33. https://doi.org/10.1093/eurheartj/ehi701.
    Full Text Link to Item
  - Rao, Sunil V., Kristi O’Grady, Karen S. Pieper, Christopher B. Granger, L Kristin Newby, Kenneth W. Mahaffey, David J. Moliterno, et al. “A comparison of the clinical impact of bleeding measured by two different classifications among patients with acute coronary syndromes.” J Am Coll Cardiol 47, no. 4 (February 21, 2006): 809–16. https://doi.org/10.1016/j.jacc.2005.09.060.
    Full Text Link to Item
  - Chang, Wei-Ching, Padma Kaul, Yuling Fu, Cynthia M. Westerhout, Christopher B. Granger, Kenneth W. Mahaffey, Lars Wallentin, Frans Van de Werf, Paul W. Armstrong, and Paul W. ASSENT-3 Investigators. “Forecasting mortality: dynamic assessment of risk in ST-segment elevation acute myocardial infarction.” Eur Heart J 27, no. 4 (February 2006): 419–26. https://doi.org/10.1093/eurheartj/ehi700.
    Full Text Link to Item
  - Fitchett, David H., Anatoly Langer, Paul W. Armstrong, Mary Tan, Aurora Mendelsohn, Shaun G. Goodman, and Shaun G. INTERACT Trial Long-Term Follow-Up Investigators. “Randomized evaluation of the efficacy of enoxaparin versus unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitor eptifibatide. Long-term results of the Integrilin and Enoxaparin Randomized Assessment of Acute Coronary Syndrome Treatment (INTERACT) trial.” Am Heart J 151, no. 2 (February 2006): 373–79. https://doi.org/10.1016/j.ahj.2005.05.003.
    Full Text Link to Item
  - McAlister, Finlay A., Jack V. Tu, Alice Newman, Douglas S. Lee, Shane Kimber, Bibiana Cujec, and Paul W. Armstrong. “How many patients with heart failure are eligible for cardiac resynchronization? Insights from two prospective cohorts.” Eur Heart J 27, no. 3 (February 2006): 323–29. https://doi.org/10.1093/eurheartj/ehi446.
    Full Text Link to Item
  - James, Stefan K., Bertil Lindahl, Jorik R. Timmer, Jan Paul Ottervanger, Agneta Siegbahn, Mats Stridsberg, Paul Armstrong, Robert Califf, Lars Wallentin, and Maarten L. Simoons. “Usefulness of biomarkers for predicting long-term mortality in patients with diabetes mellitus and non-ST-elevation acute coronary syndromes (a GUSTO IV substudy).” Am J Cardiol 97, no. 2 (January 15, 2006): 167–72. https://doi.org/10.1016/j.amjcard.2005.08.036.
    Full Text Link to Item
  - Al-Faleh, Hussam, Yuling Fu, Galen Wagner, Shaun Goodman, Elena Sgarbossa, Christopher Granger, Frans Van de Werf, Lars Wallentin, Paul W. Armstrong, and Paul W. ASSENT 2 and 3 Investigators. “Unraveling the spectrum of left bundle branch block in acute myocardial infarction: insights from the Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT 2 and 3) trials.” Am Heart J 151, no. 1 (January 2006): 10–15. https://doi.org/10.1016/j.ahj.2005.02.043.
    Full Text Link to Item
  - Galla, John M., Kenneth W. Mahaffey, Shelly K. Sapp, John H. Alexander, Matthew T. Roe, E Magnus Ohman, Christopher B. Granger, et al. “Elevated creatine kinase-MB with normal creatine kinase predicts worse outcomes in patients with acute coronary syndromes: results from 4 large clinical trials.” Am Heart J 151, no. 1 (January 2006): 16–24. https://doi.org/10.1016/j.ahj.2005.01.045.
    Full Text Link to Item
  - Frazier, Camille G., Svati H. Shah, Paul W. Armstrong, Manjushri V. Bhapkar, Darren K. McGuire, Zygmunt Sadowski, Arni Kristinsson, et al. “Prevalence and management of hypertension in acute coronary syndrome patients varies by sex: observations from the Sibrafiban versus aspirin to Yield Maximum Protection from ischemic Heart events postacute cOroNary sYndromes (SYMPHONY) randomized clinical trials.” Am Heart J 150, no. 6 (December 2005): 1260–67. https://doi.org/10.1016/j.ahj.2005.08.004.
    Full Text Link to Item
  - Haykowsky, Mark, Isabelle Vonder Muhll, Justin Ezekowitz, and Paul Armstrong. “Supervised exercise training improves aerobic capacity and muscle strength in older women with heart failure.” Can J Cardiol 21, no. 14 (December 2005): 1277–80.
    Link to Item
  - Welsh, R. C., and P. W. Armstrong. “It's a matter of time: contemporary pre-hospital management of acute ST elevation myocardial infarction.” Heart 91, no. 12 (December 2005): 1524–26. https://doi.org/10.1136/hrt.2004.055616.
    Full Text Link to Item
  - Armstrong, P., G. O’Mahony, P. J. Stevenson, and A. D. Walker. “Stereoselective synthesis of (8R,8aS)-8-methylhexahydroindolizin-5-one.” Tetrahedron Letters 46, no. 47 (November 21, 2005): 8109–11. https://doi.org/10.1016/j.tetlet.2005.09.133.
    Full Text
  - Kandzari, David E., Jean-Pierre Dery, Paul W. Armstrong, Deborah A. Douglas, Marjorie E. Zettler, G Karl-Gunnar Hidinger, Albert D. Friesen, and Robert A. Harrington. “MC-1 (pyridoxal 5'-phosphate): novel therapeutic applications to reduce ischaemic injury.” Expert Opin Investig Drugs 14, no. 11 (November 2005): 1435–42. https://doi.org/10.1517/13543784.14.11.1435.
    Full Text Link to Item
  - Welsh, R. C., W. Chang, P. Goldstein, J. Adgey, C. B. Granger, F. W. A. Verheugt, L. Wallentin, F. Van de Werf, P. W. Armstrong, and P. W. ASSENT-3 PLUS Investigators. “Time to treatment and the impact of a physician on prehospital management of acute ST elevation myocardial infarction: insights from the ASSENT-3 PLUS trial.” Heart 91, no. 11 (November 2005): 1400–1406. https://doi.org/10.1136/hrt.2004.054510.
    Full Text Link to Item
  - Georgescu, Alina, Yuling Fu, Cynthia Yau, Quamrul Hassan, Janna Luchansky, Paul W. Armstrong, Galen Wagner, Frans Van de Werf, Shaun G. Goodman, and Shaun G. Assessment of the Safety and Efficacy of a New Thrombolytic Regimen Trial (ASSENT-3) Investigators. “Short- and long-term outcomes of patients with electrocardiographic left ventricular hypertrophy after fibrinolysis for acute myocardial infarction.” Am J Cardiol 96, no. 8 (October 15, 2005): 1050–52. https://doi.org/10.1016/j.amjcard.2005.06.029.
    Full Text Link to Item
  - Armstrong, Paul W. “Moving proximally through the intersection between the process and the content of care in ST-elevation myocardial infarction.” Eur Heart J 26, no. 19 (October 2005): 1937–38. https://doi.org/10.1093/eurheartj/ehi462.
    Full Text Link to Item
  - Théroux, Pierre, Paul W. Armstrong, Kenneth W. Mahaffey, Judith S. Hochman, Kevin J. Malloy, Scott Rollins, Jose C. Nicolau, et al. “Prognostic significance of blood markers of inflammation in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty and effects of pexelizumab, a C5 inhibitor: a substudy of the COMMA trial.” Eur Heart J 26, no. 19 (October 2005): 1964–70. https://doi.org/10.1093/eurheartj/ehi292.
    Full Text Link to Item
  - Gibson, C. M., E. Braunwald, R. Giugliano, C. McCabe, L. Knight, S. Murphy, S. Marble, et al. “Erratum: Facilitated percutaneous coronary intervention for acute ST-segment elevation myocardial infarction: Results from the prematurely terminated ADdressing the Value of facilitated ANgioplasty after Combination therapy or Eptifibatide monotherapy in acute Myocardial Infarction (ADVANCE MI) trial ( American Heart Journal (2005) 150 (116-122) ).” American Heart Journal 150, no. 3 (September 1, 2005): 391. https://doi.org/10.1016/j.ahj.2005.08.013.
    Full Text
  - Johanson, Per, Yuling Fu, Shaun G. Goodman, Mikael Dellborg, Paul W. Armstrong, Mitchell W. Krucoff, Lars Wallentin, and Galen S. Wagner. “A dynamic model forecasting myocardial infarct size before, during, and after reperfusion therapy: an ASSENT-2 ECG/VCG substudy.” Eur Heart J 26, no. 17 (September 2005): 1726–33. https://doi.org/10.1093/eurheartj/ehi221.
    Full Text Link to Item
  - Finkelstein, Murray. “Time-dependent analysis in CHF follow-up.” Cmaj 173, no. 3 (August 2, 2005): 238–39. https://doi.org/10.1503/cmaj.1050043.
    Full Text Link to Item
  - Nallamothu, Brahmajee K., Eric R. Bates, Judith S. Hochman, Christopher B. Granger, Victor Guetta, Robert G. Wilcox, Harvey D. White, et al. “Prognostic implication of activated partial thromboplastin time after reteplase or half-dose reteplase plus abciximab: results from the GUSTO-V trial.” Eur Heart J 26, no. 15 (August 2005): 1506–12. https://doi.org/10.1093/eurheartj/ehi181.
    Full Text Link to Item
  - Wong, Cheuk-Kit, John K. French, Philip E. G. Aylward, Ralph A. H. Stewart, Wanzhen Gao, Paul W. Armstrong, Frans J. J. Van De Werf, et al. “Patients with prolonged ischemic chest pain and presumed-new left bundle branch block have heterogeneous outcomes depending on the presence of ST-segment changes.” J Am Coll Cardiol 46, no. 1 (July 5, 2005): 29–38. https://doi.org/10.1016/j.jacc.2005.02.084.
    Full Text Link to Item
  - Brener, Sorin J., A Michael Lincoff, Eric R. Bates, Gang Jia, Paul W. Armstrong, Victor Guetta, Judith S. Hochman, et al. “The relationship between baseline risk and mortality in ST-elevation acute myocardial infarction treated with pharmacological reperfusion: insights from the Global Utilization of Strategies To open Occluded arteries (GUSTO) V trial.” Am Heart J 150, no. 1 (July 2005): 89–93. https://doi.org/10.1016/j.ahj.2005.01.030.
    Full Text Link to Item
  - Kaul, P., L. K. Newby, Y. Fu, D. B. Mark, S. G. Goodman, G. S. Wagner, R. A. Harrington, et al. “Relation between baseline risk and treatment decisions in non-ST elevation acute coronary syndromes: an examination of international practice patterns.” Heart 91, no. 7 (July 2005): 876–81. https://doi.org/10.1136/hrt.2004.042887.
    Full Text Link to Item
  - Tjandrawidjaja, Michael C., Yuling Fu, Daniel H. Kim, Jeffrey R. Burton, Lee Lindholm, Paul W. Armstrong, and Paul W. CAPTORS II Investigators. “Compromised atrial coronary anatomy is associated with atrial arrhythmias and atrioventricular block complicating acute myocardial infarction.” J Electrocardiol 38, no. 3 (July 2005): 271–78. https://doi.org/10.1016/j.jelectrocard.2005.01.013.
    Full Text Link to Item
  - Giugliano, Robert P., L Kristin Newby, Robert A. Harrington, C Michael Gibson, Frans Van de Werf, Paul Armstrong, Gilles Montalescot, et al. “The early glycoprotein IIb/IIIa inhibition in non-ST-segment elevation acute coronary syndrome (EARLY ACS) trial: a randomized placebo-controlled trial evaluating the clinical benefits of early front-loaded eptifibatide in the treatment of patients with non-ST-segment elevation acute coronary syndrome--study design and rationale.” Am Heart J 149, no. 6 (June 2005): 994–1002. https://doi.org/10.1016/j.ahj.2005.03.029.
    Full Text Link to Item
  - Cantor, Warren J., and Laurie J. Morrison. “Guidelines for STEMI.” Cmaj 172, no. 11 (May 24, 2005): 1425. https://doi.org/10.1503/cmaj.1041728.
    Full Text Link to Item
  - Colquhoun, David. “Omega-3 fatty acids for secondary prevention.” J Am Coll Cardiol 45, no. 9 (May 3, 2005): 1552. https://doi.org/10.1016/j.jacc.2005.02.028.
    Full Text Link to Item
  - Chang, Wei-Ching, William K. Midodzi, Cynthia M. Westerhout, Eric Boersma, Judith Cooper, Elliot S. Barnathan, Maarten L. Simoons, Lars Wallentin, E Magnus Ohman, and Paul W. Armstrong. “Are international differences in the outcomes of acute coronary syndromes apparent or real? A multilevel analysis.” J Epidemiol Community Health 59, no. 5 (May 2005): 427–33. https://doi.org/10.1136/jech.2004.024984.
    Full Text Link to Item
  - Mehta, Rajendra H., John H. Alexander, Frans Van de Werf, Paul W. Armstrong, Karen S. Pieper, Jyotsna Garg, Robert M. Califf, and Christopher B. Granger. “Relationship of incorrect dosing of fibrinolytic therapy and clinical outcomes.” Jama 293, no. 14 (April 13, 2005): 1746–50. https://doi.org/10.1001/jama.293.14.1746.
    Full Text Link to Item
  - Armstrong, Paul W., Laura J. Dempster, David G. Hawkins, Mary Law, Timothy H. Ogilvie, Carole Orchard, Martin T. Schechter, Robert Sindelar, and Catharine Whiteside. “The birth of the Canadian Academy of Health Sciences.” Clin Invest Med 28, no. 2 (April 2005): 43–45.
    Link to Item
  - Willan, Andrew R., Eleanor M. Pinto, Bernie J. O’Brien, Padma Kaul, Ron Goeree, Larry Lynd, and Paul W. Armstrong. “Country specific cost comparisons from multinational clinical trials using empirical Bayesian shrinkage estimation: the Canadian ASSENT-3 economic analysis.” Health Econ 14, no. 4 (April 2005): 327–38. https://doi.org/10.1002/hec.969.
    Full Text Link to Item
  - Kaul, Padma, Paul W. Armstrong, Patricia A. Cowper, Eric L. Eisenstein, Christopher B. Granger, Frans Van de Werf, and Daniel B. Mark. “Economic analysis of the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT-3) study: costs of reperfusion strategies in acute myocardial infarction.” Am Heart J 149, no. 4 (April 2005): 637–44. https://doi.org/10.1016/j.ahj.2004.02.019.
    Full Text Link to Item
  - Alexander, J. H., H. Yang, R. C. Becker, K. Kodama, S. Goodman, C. K. Dyke, N. S. Kleiman, et al. “First experience with direct, selective factor Xa inhibition in patients with non-ST-elevation acute coronary syndromes: results of the XaNADU-ACS Trial.” J Thromb Haemost 3, no. 3 (March 2005): 439–47. https://doi.org/10.1111/j.1538-7836.2004.01081.x.
    Full Text Link to Item
  - Armstrong, Paul W., Peter X. Adams, Hussein R. Al-Khalidi, Christian Hamm, David Holmes, William O’Neill, Thomas G. Todaro, et al. “Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI): a multicenter, randomized, double-blind, parallel-group, placebo-controlled study of pexelizumab in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.” Am Heart J 149, no. 3 (March 2005): 402–7. https://doi.org/10.1016/j.ahj.2004.12.015.
    Full Text Link to Item
  - Patel, Manesh R., Kenneth W. Mahaffey, Paul W. Armstrong, W Douglas Weaver, Gudaye Tasissa, Judith S. Hochman, Thomas G. Todaro, et al. “Prognostic usefulness of white blood cell count and temperature in acute myocardial infarction (from the CARDINAL Trial).” Am J Cardiol 95, no. 5 (March 1, 2005): 614–18. https://doi.org/10.1016/j.amjcard.2004.11.008.
    Full Text Link to Item
  - Ezekowitz, Justin A., Finlay A. McAlister, and Paul W. Armstrong. “The interaction among sex, hemoglobin and outcomes in a specialty heart failure clinic.” Can J Cardiol 21, no. 2 (February 2005): 165–71.
    Link to Item
  - Ezekowitz, Justin A., Carl van Walraven, Finlay A. McAlister, Paul W. Armstrong, and Padma Kaul. “Impact of specialist follow-up in outpatients with congestive heart failure.” Cmaj 172, no. 2 (January 18, 2005): 189–94. https://doi.org/10.1503/cmaj.1032017.
    Full Text Link to Item
  - Armstrong, Paul W., and Yuling Fu. “Assessing risk in FRISC.” Eur Heart J 26, no. 2 (January 2005): 103–4. https://doi.org/10.1093/eurheartj/ehi072.
    Full Text Link to Item
  - Johanson, P., P. W. Armstrong, N. A. Barbagelata, B. S. Chaitman, P. Clemmensen, M. Dellborg, J. French, et al. “An academic ECG core lab perspective of the FDA initiative for digital ECG capture and data management in large-scale clinical trials.” Drug Information Journal 39, no. 4 (2005): 345–51.
  - Labinaz, Marino, Jasmine Mathias, Karen Pieper, Christopher B. Granger, A Michael Lincoff, David J. Moliterno, Frans Van de Werf, et al. “Outcomes of patients with acute coronary syndromes and prior percutaneous coronary intervention: a pooled analysis of three randomized clinical trials.” Eur Heart J 26, no. 2 (January 2005): 128–36. https://doi.org/10.1093/eurheartj/ehi061.
    Full Text Link to Item
  - Armstrong, Paul W., L Kristin Newby, Christopher B. Granger, Kerry L. Lee, R John Simes, Frans Van de Werf, Harvey D. White, Robert M. Califf, and Robert M. Virtual Coordinating Centre for Global Collaborative Cardiovascular Research (VIGOUR) Group. “Lessons learned from a clinical trial.” Circulation 110, no. 23 (December 7, 2004): 3610–14. https://doi.org/10.1161/01.CIR.0000148680.83392.50.
    Full Text Link to Item
  - Welsh, Robert C., and Paul W. Armstrong. “A marriage of enhancement: fibrinolysis and conjunctive therapy.” Thromb Haemost 92, no. 6 (December 2004): 1194–1200. https://doi.org/10.1160/TH04-02-0072.
    Full Text Link to Item
  - Dorian, P., P. Bogaty, C. E. Buller, B. J. O’Neill, and P. W. Armstrong. “Erratum: Applying the new STEMI guidelines: 2. Disturbances of cardiac rhythm after ST-segment elevation myocardial infarction (Canadian Medical Association Journal (2004) 171, 9 (1042-1044)).” Cmaj. Canadian Medical Association Journal 171, no. 11 (November 23, 2004): 1327. https://doi.org/10.1503/cmaj.1041681.
    Full Text
  - Chang, Wei-Ching, and Paul W. Armstrong. “Bridging American-Canadian health care outcome differences: is there really a gap?” Can J Cardiol 20, no. 13 (November 2004): 1341–42.
    Link to Item
  - Barbagelata, Alejandro, Robert M. Califf, Elena B. Sgarbossa, David Knight, Daniel B. Mark, Christopher B. Granger, Paul W. Armstrong, et al. “Prognostic value of predischarge electrocardiographic measurement of infarct size after thrombolysis: insights from GUSTO I Economics and Quality of Life substudy.” Am Heart J 148, no. 5 (November 2004): 795–802. https://doi.org/10.1016/j.ahj.2004.04.046.
    Full Text Link to Item
  - Velazquez, Eric J., Gary S. Francis, Paul W. Armstrong, Phillip E. Aylward, Rafael Diaz, Christopher M. O’Connor, Harvey D. White, et al. “An international perspective on heart failure and left ventricular systolic dysfunction complicating myocardial infarction: the VALIANT registry.” Eur Heart J 25, no. 21 (November 2004): 1911–19. https://doi.org/10.1016/j.ehj.2004.08.006.
    Full Text Link to Item
  - Bogaty, Peter, Christopher E. Buller, Paul Dorian, Blair J. O’Neill, Paul W. Armstrong, and Paul W. Canadian Cardiovascular Society Working Group. “Applying the new STEMI guidelines: 1. Reperfusion in acute ST-segment elevation myocardial infarction.” Cmaj 171, no. 9 (October 26, 2004): 1039–41. https://doi.org/10.1503/cmaj.1041417.
    Full Text Link to Item
  - Dorian, Paul, Peter Bogaty, Christopher E. Buller, Blair J. O’Neill, Paul W. Armstrong, and Paul W. Canadian Cardiovascular Society Working Group. “Applying the new STEMI guidelines: 2. Disturbances of cardiac rhythm after ST-segment elevation myocardial infarction.” Cmaj 171, no. 9 (October 26, 2004): 1042–44. https://doi.org/10.1503/cmaj.1041418.
    Full Text Link to Item
  - Rao, Sunil V., James G. Jollis, Robert A. Harrington, Christopher B. Granger, L Kristin Newby, Paul W. Armstrong, David J. Moliterno, et al. “Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes.” Jama 292, no. 13 (October 6, 2004): 1555–62. https://doi.org/10.1001/jama.292.13.1555.
    Full Text Link to Item
  - Kaul, Padma, Paul W. Armstrong, Wei-Ching Chang, C David Naylor, Christopher B. Granger, Kerry L. Lee, Eric D. Peterson, Robert M. Califf, Eric J. Topol, and Daniel B. Mark. “Long-term mortality of patients with acute myocardial infarction in the United States and Canada: comparison of patients enrolled in Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I.” Circulation 110, no. 13 (September 28, 2004): 1754–60. https://doi.org/10.1161/01.CIR.0000142671.06167.91.
    Full Text Link to Item
  - Armstrong, Paul W., Peter Bogaty, Christopher E. Buller, Paul Dorian, Blair J. O’Neill, and Blair J. Canadian Cardiovascular Society Working Group. “The 2004 ACC/AHA Guidelines: a perspective and adaptation for Canada by the Canadian Cardiovascular Society Working Group.” Can J Cardiol 20, no. 11 (September 2004): 1075–79.
    Link to Item
  - Ottervanger, J. P., P. Armstrong, E. S. Barnathan, E. Boersma, J. S. Cooper, E. M. Ohman, S. James, L. Wallentin, M. L. Simoons, and M. L. GUSTO IV-ACS Investigators. “Association of revascularisation with low mortality in non-ST elevation acute coronary syndrome, a report from GUSTO IV-ACS.” Eur Heart J 25, no. 17 (September 2004): 1494–1501. https://doi.org/10.1016/j.ehj.2004.07.004.
    Full Text Link to Item
  - Antman, Elliott M., Daniel T. Anbe, Paul Wayne Armstrong, Eric R. Bates, Lee A. Green, Mary Hand, Judith S. Hochman, et al. “ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction).” Circulation 110, no. 9 (August 31, 2004): e82-292.
    Link to Item
  - Sligl, Wendy, Finlay A. McAlister, Justin Ezekowitz, and Paul W. Armstrong. “Usefulness of spironolactone in a specialized heart failure clinic.” Am J Cardiol 94, no. 4 (August 15, 2004): 443–47. https://doi.org/10.1016/j.amjcard.2004.04.059.
    Full Text Link to Item
  - Antman, Elliott M., Daniel T. Anbe, Paul Wayne Armstrong, Eric R. Bates, Lee A. Green, Mary Hand, Judith S. Hochman, et al. “ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction).” J Am Coll Cardiol 44, no. 3 (August 4, 2004): 671–719. https://doi.org/10.1016/j.jacc.2004.07.002.
    Full Text Link to Item
  - Antman, Elliott M., Daniel T. Anbe, Paul Wayne Armstrong, Eric R. Bates, Lee A. Green, Mary Hand, Judith S. Hochman, et al. “ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction).” Circulation 110, no. 5 (August 3, 2004): 588–636. https://doi.org/10.1161/01.CIR.0000134791.68010.FA.
    Full Text Link to Item
  - Armstrong, Paul W., Padma Kaul, and Padma VIGOUR group. “Charting the course of clinical research: from an inspired past to a promising future.” Am Heart J 148, no. 2 (August 2004): 190–92. https://doi.org/10.1016/j.ahj.2004.03.054.
    Full Text Link to Item
  - Antman, Elliott M., Daniel T. Anbe, Paul Wayne Armstrong, Eric R. Bates, Lee A. Green, Mary Hand, Judith S. Hochman, et al. “ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction).” Can J Cardiol 20, no. 10 (August 2004): 977–1025.
    Link to Item
  - Curtis, Jeptha P., John H. Alexander, Yao Huang, Lars Wallentin, Freek W. A. Verheugt, Paul W. Armstrong, Harlan M. Krumholz, et al. “Efficacy and safety of two unfractionated heparin dosing strategies with tenecteplase in acute myocardial infarction (results from Assessment of the Safety and Efficacy of a New Thrombolytic Regimens 2 and 3).” Am J Cardiol 94, no. 3 (August 1, 2004): 279–83. https://doi.org/10.1016/j.amjcard.2004.04.019.
    Full Text Link to Item
  - Ferguson, James J., Robert M. Califf, Elliott M. Antman, Marc Cohen, Cindy L. Grines, Shaun Goodman, Dean J. Kereiakes, et al. “Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial.” Jama 292, no. 1 (July 7, 2004): 45–54. https://doi.org/10.1001/jama.292.1.45.
    Full Text Link to Item
  - Taher, Taha, Yuling Fu, Galen S. Wagner, Shaun G. Goodman, Claudio Fresco, Christopher B. Granger, Lars Wallentin, Frans van de Werf, Freek Verheugt, and Paul W. Armstrong. “Aborted myocardial infarction in patients with ST-segment elevation: insights from the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen-3 Trial Electrocardiographic Substudy.” J Am Coll Cardiol 44, no. 1 (July 7, 2004): 38–43. https://doi.org/10.1016/j.jacc.2004.03.041.
    Full Text Link to Item
  - Chang, Wei-Ching, Eric Boersma, Christopher B. Granger, Robert A. Harrington, Robert M. Califf, Maarten L. Simoons, Neal S. Kleiman, Paul W. Armstrong, and Paul W. GUSTO-IIb and PURSUIT Investigators. “Dynamic prognostication in non-ST-elevation acute coronary syndromes: insights from GUSTO-IIb and PURSUIT.” Am Heart J 148, no. 1 (July 2004): 62–71. https://doi.org/10.1016/j.ahj.2003.05.004.
    Full Text Link to Item
  - Kaul, Padma, Paul W. Armstrong, Yuling Fu, J David Knight, Nancy E. Clapp-Channing, Wanda Sutherland, Christopher B. Granger, Daniel B. Mark, and Daniel B. GUSTO-IIb investigators. “Impact of different patterns of invasive care on quality of life outcomes in patients with non-ST elevation acute coronary syndrome: results from the GUSTO-IIb Canada-United States substudy.” Can J Cardiol 20, no. 8 (June 2004): 760–66.
    Link to Item
  - Welsh, Robert C., Patrick Goldstein, Jennifer Adgey, Freek Verheugt, Shirley A. Bestilny, Lars Wallentin, Frans Van de Werf, Paul W. Armstrong, and Paul W. Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT) 3 Plus Trial Investigators. “Variations in pre-hospital fibrinolysis process of care: insights from the Assessment of the Safety and Efficacy of a New Thrombolytic 3 Plus international acute myocardial infarction pre-hospital care survey.” Eur J Emerg Med 11, no. 3 (June 2004): 134–40. https://doi.org/10.1097/01.mej.0000127653.61705.54.
    Full Text Link to Item
  - Labinaz, Marino, Padma Kaul, Robert A. Harrington, Wei-Ching Chang, Neal S. Kleiman, Maarten L. Simoons, Eric Boersma, et al. “Six-month outcomes of percutaneous coronary balloon angioplasty in acute coronary syndromes: Results from the PURSUIT trial.” Can J Cardiol 20, no. 8 (June 2004): 773–78.
    Link to Item
  - Sinnaeve, Peter R., John H. Alexander, Kris Bogaerts, Ann Belmans, Lars Wallentin, Paul Armstrong, Jennifer A. A. Adgey, et al. “Efficacy of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: one-year follow-up results of the Assessment of the Safety of a New Thrombolytic-3 (ASSENT-3) randomized trial in acute myocardial infarction.” Am Heart J 147, no. 6 (June 2004): 993–98. https://doi.org/10.1016/j.ahj.2003.12.028.
    Full Text Link to Item
  - O’Mahony, Gavin, Mark Nieuwenhuyzen, Paul Armstrong, and Paul J. Stevenson. “Rapid stereoselective access to key pumiliotoxin precursors from a common intermediate.” J Org Chem 69, no. 11 (May 28, 2004): 3968–71. https://doi.org/10.1021/jo0497205.
    Full Text Link to Item
  - Ezekowitz, Justin A. “Stretching for prediction: the case for brain natriuretic peptide.” Can J Cardiol 20, no. 7 (May 15, 2004): 684–85.
    Link to Item
  - Lenderink, Timo, Eric Boersma, Witold Ruzyllo, Petr Widimsky, E Magnus Ohman, Paul W. Armstrong, Lars Wallentin, Maarten L. Simoons, and Maarten L. GUSTO IV-ACS Investigators. “Bleeding events with abciximab in acute coronary syndromes without early revascularization: An analysis of GUSTO IV-ACS.” Am Heart J 147, no. 5 (May 2004): 865–73. https://doi.org/10.1016/j.ahj.2003.11.009.
    Full Text Link to Item
  - Majumdar, Sumit R., Finlay A. McAlister, Marilyn Cree, Wei-Ching Chang, Milton Packer, Paul W. Armstrong, and Paul W. ATLAS Study Group. “Do evidence-based treatments provide incremental benefits to patients with congestive heart failure already receiving angiotensin-converting enzyme inhibitors? A secondary analysis of one-year outcomes from the Assessment of Treatment with Lisinopril and Survival (ATLAS) study.” Clin Ther 26, no. 5 (May 2004): 694–703. https://doi.org/10.1016/s0149-2918(04)90069-0.
    Full Text Link to Item
  - Tandon, Puneeta, Finlay A. McAlister, Ross T. Tsuyuki, Marilou Hervas-Malo, Ruth Dupuit, Justin Ezekowitz, Bibiana Cujec, and Paul W. Armstrong. “The use of beta-blockers in a tertiary care heart failure clinic: dosing, tolerance, and outcomes.” Arch Intern Med 164, no. 7 (April 12, 2004): 769–74. https://doi.org/10.1001/archinte.164.7.769.
    Full Text Link to Item
  - Fu, Y., and P. W. Armstrong. “Prognostic value of ECG changes in non-ST elevation ACS patients.” Cardiology Review 21, no. 4 (April 1, 2004): 34–39.
  - Haykowsky, M. J., J. A. Ezekowitz, and P. W. Armstrong. “Therapeutic exercise for individuals with heart failure: special attention to older women with heart failure.” J Card Fail 10, no. 2 (April 2004): 165–73. https://doi.org/10.1016/j.cardfail.2003.08.014.
    Full Text Link to Item
  - Massie, Barry M., William F. Krol, Susan E. Ammon, Paul W. Armstrong, John G. Cleland, Joseph F. Collins, Michael Ezekowitz, et al. “The Warfarin and Antiplatelet Therapy in Heart Failure trial (WATCH): rationale, design, and baseline patient characteristics.” J Card Fail 10, no. 2 (April 2004): 101–12. https://doi.org/10.1016/j.cardfail.2004.02.006.
    Full Text Link to Item
  - Ellis, Stephen G., Paul Armstrong, Amadeo Betriu, Bruce Brodie, Howard Herrmann, Gilles Montalescot, Franz-Josef Neumann, John J. Smith, Eric Topol, and Eric Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events Investigators. “Facilitated percutaneous coronary intervention versus primary percutaneous coronary intervention: design and rationale of the Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events (FINESSE) trial.” Am Heart J 147, no. 4 (April 2004): E16. https://doi.org/10.1016/j.ahj.2003.07.025.
    Full Text Link to Item
  - Maas, Arthur C. P., Christina M. Wyatt, Cynthia L. Green, Galen S. Wagner, Kathleen M. Trollinger, James E. Pope, Anatoly Langer, et al. “Combining baseline clinical descriptors and real-time response to therapy: the incremental prognostic value of continuous ST-segment monitoring in acute myocardial infarction.” Am Heart J 147, no. 4 (April 2004): 698–704. https://doi.org/10.1016/j.ahj.2003.08.014.
    Full Text Link to Item
  - Patel, Manesh R., and Paul W. Armstrong. “To transfer or not to transfer: acute myocardial infarction reperfusion.” Am Heart J 147, no. 4 (April 2004): 573–74. https://doi.org/10.1016/j.ahj.2004.02.001.
    Full Text Link to Item
  - Westerhout, Cynthia M., L Duncan Saunders, Padma Kaul, Paul W. Armstrong, Merril L. Knudtson, and William A. Ghali. “Interinstitutional variation in the use of abciximab for percutaneous coronary intervention.” Can J Cardiol 20, no. 4 (March 15, 2004): 405–10.
    Link to Item
  - McAlister, Finlay A., Justin Ezekowitz, Marcello Tonelli, and Paul W. Armstrong. “Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study.” Circulation 109, no. 8 (March 2, 2004): 1004–9. https://doi.org/10.1161/01.CIR.0000116764.53225.A9.
    Full Text Link to Item
  - Gurm, Hitinder S., A Michael Lincoff, David Lee, WH Wilson Tang, Gang Jia, Joan E. Booth, Robert M. Califf, et al. “Outcome of acute ST-segment elevation myocardial infarction in diabetics treated with fibrinolytic or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: lessons from the GUSTO V trial.” J Am Coll Cardiol 43, no. 4 (February 18, 2004): 542–48. https://doi.org/10.1016/j.jacc.2003.09.038.
    Full Text Link to Item
  - Armstrong, P., S. Feutren, H. McAlonan, G. O’Mahony, and P. J. Stevenson. “Synthesis of the putative structures of homopumiliotoxins 235C and 233F.” Tetrahedron Letters 45, no. 8 (February 16, 2004): 1627–30. https://doi.org/10.1016/j.tetlet.2003.12.126.
    Full Text
  - Kaul, Padma, L Kristin Newby, Yuling Fu, Daniel B. Mark, Robert M. Califf, Eric J. Topol, Phil Aylward, Christopher B. Granger, Frans Van de Werf, and Paul W. Armstrong. “International differences in evolution of early discharge after acute myocardial infarction.” Lancet 363, no. 9408 (February 14, 2004): 511–17. https://doi.org/10.1016/S0140-6736(04)15536-0.
    Full Text Link to Item
  - Pieper, Karen S., Anastasios A. Tsiatis, Marie Davidian, Vic Hasselblad, Neal S. Kleiman, Eric Boersma, Wei-Ching Chang, et al. “Differential treatment benefit of platelet glycoprotein IIb/IIIa inhibition with percutaneous coronary intervention versus medical therapy for acute coronary syndromes: exploration of methods.” Circulation 109, no. 5 (February 10, 2004): 641–46. https://doi.org/10.1161/01.CIR.0000112570.97220.89.
    Full Text Link to Item
  - Alexander, J. H., C. K. Dyke, H. Yang, R. C. Becker, V. Hasselblad, L. A. Zillman, N. S. Kleiman, et al. “Initial experience with factor-Xa inhibition in percutaneous coronary intervention: the XaNADU-PCI Pilot.” J Thromb Haemost 2, no. 2 (February 2004): 234–41. https://doi.org/10.1111/j.1538-7933.2004.00594.x.
    Full Text Link to Item
  - Armstrong, Paul W., Christina Ezekowitz, Evangelos Michelakis, Todd Anderson, Stephen Archer, William Ghali, Robert Hayward, Louise Jensen, Gary Lopaschuk, and Robert Sheldon. “Innovative strategic Canadian research training from TomorrOw's Research Cardiovascular Health Care Professionals (TORCH).” Clin Invest Med 27, no. 1 (February 2004): 33–41.
    Link to Item
  - James, Stefan K., Agneta Siegbahn, Paul Armstrong, Elliott Barnathan, Robert Califf, Maarten L. Simoons, and Lars Wallentin. “Activation of the inflammation, coagulation, and fibrinolysis systems, without influence of abciximab infusion in patients with non-ST-elevation acute coronary syndromes treated with dalteparin: a GUSTO IV substudy.” Am Heart J 147, no. 2 (February 2004): 267–74. https://doi.org/10.1016/j.ahj.2003.09.014.
    Full Text Link to Item
  - James, Stefan K., Bertil Lindahl, Paul Armstrong, Robert Califf, ML Maarten L. Simoons, Per Venge, Lars Wallentin, and Lars GUSTO-IV ACS Investigators. “A rapid troponin I assay is not optimal for determination of troponin status and prediction of subsequent cardiac events at suspicion of unstable coronary syndromes.” Int J Cardiol 93, no. 2–3 (February 2004): 113–20. https://doi.org/10.1016/S0167-5273(03)00157-8.
    Full Text Link to Item
  - Roe, M. T., K. W. Mahaffey, R. Kilaru, J. H. Alexander, K. M. Akkerhuis, M. L. Simoons, R. A. Harrington, et al. “Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes.” Eur Heart J 25, no. 4 (February 2004): 313–21. https://doi.org/10.1016/j.ehj.2003.12.009.
    Full Text Link to Item
  - Caille, J. C., H. Miel, P. Armstrong, and M. A. McKervey. “A new synthetic approach to 2,3-dideoxy-2-fluoro-β-D-threo- pentofuranose, the fluorofuranose unit of the anti-HIV-active nucleoside, β-FddA.” Tetrahedron Letters 45, no. 4 (January 19, 2004): 863–65. https://doi.org/10.1016/j.tetlet.2003.11.020.
    Full Text
  - Taher, Taha H., Linda Stang, Philip A. Gordon, and Paul W. Armstrong. “Clopidogrel does not induce fibrinolysis in healthy subjects.” Thromb Res 114, no. 2 (2004): 97–100. https://doi.org/10.1016/j.thromres.2004.05.004.
    Full Text Link to Item
  - Kramer, Judith M., L Kristin Newby, Wei Ching Chang, R John Simes, Frans Van de Werf, Christopher B. Granger, Kerry L. Lee, et al. “International variation in the use of evidence-based medicines for acute coronary syndromes.” Eur Heart J 24, no. 23 (December 2003): 2133–41. https://doi.org/10.1016/j.ehj.2003.09.018.
    Full Text Link to Item
  - Newby, L Kristin, Manjushri V. Bhapkar, Harvey D. White, David J. Moliterno, Nancy M Allen LaPointe, David E. Kandzari, Freek W. A. Verheugt, et al. “Aspirin use post-acute coronary syndromes: intolerance, bleeding and discontinuation.” J Thromb Thrombolysis 16, no. 3 (December 2003): 119–28. https://doi.org/10.1023/B:THRO.0000024050.78728.35.
    Full Text Link to Item
  - Channer, Kevin S. “Coronary angioplasty versus fibrinolytic therapy in acute myocardial infarction.” N Engl J Med 349, no. 22 (November 27, 2003): 2167–69. https://doi.org/10.1056/NEJM200311273492217.
    Full Text Link to Item
  - Chang, Wei-Ching, Padma Kaul, Cynthia M. Westerhout, Michelle M. Graham, Yuling Fu, Tapan Chowdhury, and Paul W. Armstrong. “Impact of sex on long-term mortality from acute myocardial infarction vs unstable angina.” Arch Intern Med 163, no. 20 (November 10, 2003): 2476–84. https://doi.org/10.1001/archinte.163.20.2476.
    Full Text Link to Item
  - Peterson, Eric D., Padma Kaul, Ronald G. Kaczmarek, Bradley G. Hammill, Paul W. Armstrong, Charles R. Bridges, T Bruce Ferguson, and T Bruce Society of Thoracic Surgeons. “From controlled trials to clinical practice: monitoring transmyocardial revascularization use and outcomes.” J Am Coll Cardiol 42, no. 9 (November 5, 2003): 1611–16. https://doi.org/10.1016/j.jacc.2003.07.003.
    Full Text Link to Item
  - Armstrong, Paul W., and Robert C. Welsh. “Tailoring therapy to best suit ST-segment elevation myocardial infarction: searching for the right fit.” Cmaj 169, no. 9 (October 28, 2003): 925–27.
    Link to Item
  - Dubois, Christophe L., Ann Belmans, Christopher B. Granger, Paul W. Armstrong, Lars Wallentin, Paolo M. Fioretti, José L. López-Sendón, et al. “Outcome of urgent and elective percutaneous coronary interventions after pharmacologic reperfusion with tenecteplase combined with unfractionated heparin, enoxaparin, or abciximab.” J Am Coll Cardiol 42, no. 7 (October 1, 2003): 1178–85. https://doi.org/10.1016/s0735-1097(03)00917-3.
    Full Text Link to Item
  - Lockwood, Evan, Yuling Fu, Brian Wong, Frans Van de Werf, Christopher B. Granger, Paul W. Armstrong, Shaun G. Goodman, and Shaun G. ASSENT-2 Investigators. “Does 24-hour ST-segment resolution postfibrinolysis add prognostic value to a Q wave? An ASSENT 2 electrocardiographic substudy.” Am Heart J 146, no. 4 (October 2003): 640–45. https://doi.org/10.1016/S0002-8703(03)00438-1.
    Full Text Link to Item
  - Savonitto, S., P. W. Armstrong, A. M. Lincoff, G. Jia, C. A. Sila, J. Booth, P. Terrosu, et al. “Risk of intracranial haemorrhage with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy in acute myocardial infarction. Dichotomous response as a function of age in the GUSTO V trial.” Eur Heart J 24, no. 20 (October 2003): 1807–14. https://doi.org/10.1016/j.ehj.2003.07.004.
    Full Text Link to Item
  - Granger, Christopher B., Kenneth W. Mahaffey, W Douglas Weaver, Pierre Theroux, Judith S. Hochman, Thomas G. Filloon, Scott Rollins, et al. “Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: the COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trial.” Circulation 108, no. 10 (September 9, 2003): 1184–90. https://doi.org/10.1161/01.CIR.0000087447.12918.85.
    Full Text Link to Item
  - Mahaffey, Kenneth W., Christopher B. Granger, Jose C. Nicolau, Witold Ruzyllo, W Douglas Weaver, Pierre Theroux, Judith S. Hochman, et al. “Effect of pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardial infarction: the COMPlement inhibition in myocardial infarction treated with thromboLYtics (COMPLY) trial.” Circulation 108, no. 10 (September 9, 2003): 1176–83. https://doi.org/10.1161/01.CIR.0000087404.53661.F8.
    Full Text Link to Item
  - Armstrong, P. W. “Erratum: As this was before furosemide was widely available, I called for nasal oxygen, 2 mL of subcutaneous thiomerin, and a quarter of a grain of morphine (Lancet (April 26, 2003) 361 (1417).” Lancet 362, no. 9386 (September 6, 2003): 836.
  - Armstrong, P. W., J. Burton, S. Pakola, P. G. Molhoek, A. Betriu, M. Tendera, C. Bode, et al. “Collaborative Angiographic Patency Trial Of Recombinant Staphylokinase (CAPTORS II).” Am Heart J 146, no. 3 (September 2003): 484–88. https://doi.org/10.1016/S0002-8703(03)00312-0.
    Full Text Link to Item
  - Gupta, Milan, Wei-Ching Chang, Frans Van de Werf, Christopher B. Granger, William Midodzi, Gabriel Barbash, Kenneth Pehrson, et al. “International differences in in-hospital revascularization and outcomes following acute myocardial infarction: a multilevel analysis of patients in ASSENT-2.” Eur Heart J 24, no. 18 (September 2003): 1640–50. https://doi.org/10.1016/s0195-668x(03)00433-0.
    Full Text Link to Item
  - Kaul, Padma, and Paul W. Armstrong. “Connecting the pieces of the cardiovascular care puzzle in Canada.” Can J Cardiol 19, no. 10 (September 2003): 1114–15.
    Link to Item
  - James, Stefan, Paul Armstrong, Robert Califf, Maarten L. Simoons, Per Venge, Lars Wallentin, and Bertil Lindahl. “Troponin T levels and risk of 30-day outcomes in patients with the acute coronary syndrome: prospective verification in the GUSTO-IV trial.” Am J Med 115, no. 3 (August 15, 2003): 178–84. https://doi.org/10.1016/s0002-9343(03)00348-6.
    Full Text Link to Item
  - Armstrong, Paul W., Galen Wagner, Shaun G. Goodman, Frans Van de Werf, Christopher Granger, Lars Wallentin, Yuling Fu, and Yuling ASSENT 3 Investigators. “ST segment resolution in ASSENT 3: insights into the role of three different treatment strategies for acute myocardial infarction.” Eur Heart J 24, no. 16 (August 2003): 1515–22. https://doi.org/10.1016/s0195-668x(03)00322-1.
    Full Text Link to Item
  - James, Stefan K., Bertil Lindahl, Agneta Siegbahn, Mats Stridsberg, Per Venge, Paul Armstrong, Elliot S. Barnathan, et al. “N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy.” Circulation 108, no. 3 (July 22, 2003): 275–81. https://doi.org/10.1161/01.CIR.0000079170.10579.DC.
    Full Text Link to Item
  - Wallentin, L., P. Goldstein, P. W. Armstrong, C. B. Granger, A. A. J. Adgey, H. R. Arntz, K. Bogaerts, et al. “Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting: the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS randomized trial in acute myocardial infarction.” Circulation 108, no. 2 (July 15, 2003): 135–42. https://doi.org/10.1161/01.CIR.0000081659.72985.A8.
    Full Text Link to Item
  - Choy, Jonathan B., Paul W. Armstrong, Raymond A. Ulan, Patricia M. Campbell, Sita Gourishankar, Connie I. Prosser, and Wayne J. Tymchak. “Do cardiac troponins provide prognostic insight in hemodialysis patients?” Can J Cardiol 19, no. 8 (July 2003): 907–11.
    Link to Item
  - Sinnaeve, Peter, John Alexander, Ann Belmans, Kris Bogaerts, Anatoli Langer, Rafaël Diaz, Diego Ardissino, et al. “One-year follow-up of the ASSENT-2 trial: a double-blind, randomized comparison of single-bolus tenecteplase and front-loaded alteplase in 16,949 patients with ST-elevation acute myocardial infarction.” Am Heart J 146, no. 1 (July 2003): 27–32. https://doi.org/10.1016/S0002-8703(03)00117-0.
    Full Text Link to Item
  - Borer, Jeffrey, Paul Armstrong, and Paul Food and Drug Administration Cardiovascular and Renal Drugs Advisory Committee. “Proceedings of the 99th meeting of the Food and Drug Administration Cardiovascular and Renal Drugs Advisory Committee. May 29th and 30th, 2003.” Circulation 107, no. 23 (June 17, 2003): e9052. https://doi.org/10.1161/01.CIR.0000082691.46188.C8.
    Full Text Link to Item
  - Tjandrawidjaja, Michael C., Yuling Fu, Shaun G. Goodman, Frans Van de Werf, Christopher B. Granger, Paul W. Armstrong, and Paul W. ASSENT-2 Investigators. “The impact of gender on the treatment and outcomes of patients with early reinfarction after fibrinolysis: insights from ASSENT-2.” Eur Heart J 24, no. 11 (June 2003): 1024–34. https://doi.org/10.1016/s0195-668x(03)00082-4.
    Full Text Link to Item
  - Armstrong, Paul W., Désiré Collen, and Elliott Antman. “Fibrinolysis for acute myocardial infarction: the future is here and now.” Circulation 107, no. 20 (May 27, 2003): 2533–37. https://doi.org/10.1161/01.CIR.0000072930.64775.DC.
    Full Text Link to Item
  - Armstrong, Paul W. “Two hard lessons.” Lancet 361, no. 9367 (April 26, 2003): 1417. https://doi.org/10.1016/S0140-6736(03)13133-9.
    Full Text Link to Item
  - Rao, Sunil V., E Magnus Ohman, Christopher B. Granger, Paul W. Armstrong, W Brian Gibler, Robert H. Christenson, Vic Hasselblad, Amanda Stebbins, Steven McNulty, and L Kristin Newby. “Prognostic value of isolated troponin elevation across the spectrum of chest pain syndromes.” Am J Cardiol 91, no. 8 (April 15, 2003): 936–40. https://doi.org/10.1016/s0002-9149(03)00107-3.
    Full Text Link to Item
  - James, Stefan K., Paul Armstrong, Elliott Barnathan, Robert Califf, Bertil Lindahl, Agneta Siegbahn, Maarten L. Simoons, et al. “Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome: a GUSTO-IV substudy.” J Am Coll Cardiol 41, no. 6 (March 19, 2003): 916–24. https://doi.org/10.1016/s0735-1097(02)02969-8.
    Full Text Link to Item
  - Ezekowitz, Justin A., Paul W. Armstrong, and Finlay A. McAlister. “Implantable cardioverter defibrillators in primary and secondary prevention: a systematic review of randomized, controlled trials.” Ann Intern Med 138, no. 6 (March 18, 2003): 445–52. https://doi.org/10.7326/0003-4819-138-6-200303180-00007.
    Full Text Link to Item
  - Armstrong, Paul W. “Primary angioplasty or thrombolysis for acute myocardial infarction?” Lancet 361, no. 9361 (March 15, 2003): 966–67. https://doi.org/10.1016/S0140-6736(03)12748-1.
    Full Text Link to Item
  - Auer, Johann, Robert Berent, Thomas Weber, and Bernd Eber. “Primary angioplasty or thrombolysis for acute myocardial infarction?” Lancet 361, no. 9361 (March 15, 2003): 965–66. https://doi.org/10.1016/S0140-6736(03)12746-8.
    Full Text Link to Item
  - Khadour, Fadi H., Yuling Fu, Wei-Ching Chang, Xin Ma, Dan Mark, Christopher B. Granger, Eric J. Topol, Robert M. Califf, Paul W. Armstrong, and Paul W. GUSTO IIb investigators. “Impact of on-site cardiac interventional facilities on management and outcome of patients with acute coronary syndromes.” Can J Cardiol 19, no. 3 (March 15, 2003): 257–63.
    Link to Item
  - Armstrong, Paul W. “Do guidelines influence practice?” Heart 89, no. 3 (March 2003): 349–52. https://doi.org/10.1136/heart.89.3.349.
    Full Text Link to Item
  - Al-Khatib, Sana M., Amanda L. Stebbins, Robert M. Califf, Kerry L. Lee, Christopher B. Granger, Harvey D. White, Paul W. Armstrong, Eric J. Topol, E Magnus Ohman, and E Magnus GUSTO-III trial. “Sustained ventricular arrhythmias and mortality among patients with acute myocardial infarction: results from the GUSTO-III trial.” Am Heart J 145, no. 3 (March 2003): 515–21. https://doi.org/10.1067/mhj.2003.170.
    Full Text Link to Item
  - Hersi, A., Y. Fu, B. Wong, K. W. Mahaffey, R. A. Harrington, R. M. Califf, F. Van de Werf, P. W. Armstrong, and P. W. PARAGON-B Investigators. “Does the discharge ECG provide additional prognostic insight(s) in non-ST elevation ACS patients from that acquired on admission?” Eur Heart J 24, no. 6 (March 2003): 522–31. https://doi.org/10.1016/s0195-668x(02)00525-0.
    Full Text Link to Item
  - Kaul, Padma, L Kristin Newby, Yuling Fu, Vic Hasselblad, Kenneth W. Mahaffey, Robert H. Christenson, Robert A. Harrington, et al. “Troponin T and quantitative ST-segment depression offer complementary prognostic information in the risk stratification of acute coronary syndrome patients.” J Am Coll Cardiol 41, no. 3 (February 5, 2003): 371–80. https://doi.org/10.1016/s0735-1097(02)02824-3.
    Full Text Link to Item
  - Brown, Ruth, Paul Armstrong, and Paul Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy. “Cost effectiveness in Canada of eptifibatide treatment for acute coronary syndrome patients using PURSUIT subgroup analysis.” Can J Cardiol 19, no. 2 (February 2003): 161–66.
    Link to Item
  - Batchelor, Wayne B., Daniel B. Mark, J David Knight, Christopher B. Granger, Paul W. Armstrong, Robert M. Califf, and Eric D. Peterson. “Development and validation of a simple model to predict severe coronary artery disease after myocardial infarction: potential impact on cardiac catheterization use in the United States and Canada.” Am Heart J 145, no. 2 (February 2003): 349–55. https://doi.org/10.1067/mhj.2003.111.
    Full Text Link to Item
  - Ottervanger, J. P., P. Armstrong, E. S. Barnathan, E. Boersma, J. S. Cooper, E. M. Ohman, S. James, et al. “Long-term results after the glycoprotein IIb/IIIa inhibitor abciximab in unstable angina: one-year survival in the GUSTO IV-ACS (Global Use of Strategies To Open Occluded Coronary Arteries IV--Acute Coronary Syndrome) Trial.” Circulation 107, no. 3 (January 28, 2003): 437–42. https://doi.org/10.1161/01.cir.0000046487.06811.5e.
    Full Text Link to Item
  - Goodman, Shaun G., David Fitchett, Paul W. Armstrong, Mary Tan, Anatoly Langer, and Anatoly Integrilin and Enoxaparin Randomized Assessment of Acute Coronary Syndrome Treatment (INTERACT) Trial Investigators. “Randomized evaluation of the safety and efficacy of enoxaparin versus unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitor eptifibatide.” Circulation 107, no. 2 (January 21, 2003): 238–44. https://doi.org/10.1161/01.cir.0000050144.67910.13.
    Full Text Link to Item
  - Ezekowitz, Justin A., Finlay A. McAlister, and Paul W. Armstrong. “Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with new-onset heart failure.” Circulation 107, no. 2 (January 21, 2003): 223–25. https://doi.org/10.1161/01.cir.0000052622.51963.fc.
    Full Text Link to Item
  - Fleming, Thomas, Jeff Borer, Paul W. Armstrong, Marc Pfeffer, and Marc Food and Drug Administration. Cardiovascular and Renal Drugs Advisory Committee. “Food and Drug Administration: Cardiovascular and Renal Drugs Advisory Committee, 98th meeting, January 6th-7th, 2003.” Circulation 107, no. 2 (January 21, 2003): e9002–3. https://doi.org/10.1161/01.cir.0000057552.70961.f3.
    Full Text Link to Item
  - Goodman, S. G., D. Fitchett, P. W. Armstrong, and S. Khosla. “Enoxaparin is safer and more effective than heparin in acute coronary syndrome.” Evidence Based Cardiovascular Medicine 7, no. 3 (January 1, 2003): 129–30. https://doi.org/10.1016/S1361-2611(03)00069-1.
    Full Text
  - Hersi, A., Y. Fu, B. Wong, P. Armstrong, and J. Barrabés. “A discharge ECG adds prognostic value to an admission ECG in determining patients' subsequent risk of death or myocardial infarction.” Evidence Based Cardiovascular Medicine 7, no. 3 (January 1, 2003): 156–57. https://doi.org/10.1016/S1361-2611(03)00070-8.
    Full Text
  - Newby, L. K., V. Hasselblad, P. W. Armstrong, F. Van de Werf, D. B. Mark, H. D. White, E. J. Topol, and R. M. Califf. “Time-based risk assessment after myocardial infarction. Implications for timing of discharge and applications to medical decision-making.” Eur Heart J 24, no. 2 (January 2003): 182–89. https://doi.org/10.1016/s0195-668x(02)00301-9.
    Full Text Link to Item
  - Welsh, Robert C., Joseph Ornato, and Paul W. Armstrong. “Prehospital management of acute ST-elevation myocardial infarction: a time for reappraisal in North America.” Am Heart J 145, no. 1 (January 2003): 1–8. https://doi.org/10.1067/mhj.2003.47.
    Full Text Link to Item
  - O’Shea, J Conor, Robert G. Wilcox, Allan M. Skene, Amanda L. Stebbins, Christopher B. Granger, Paul W. Armstrong, Christoph Bode, et al. “Comparison of outcomes of patients with myocardial infarction when living alone versus those not living alone.” Am J Cardiol 90, no. 12 (December 15, 2002): 1374–77. https://doi.org/10.1016/s0002-9149(02)02876-x.
    Full Text Link to Item
  - Goldstone, Michael. “Managing interdependence: emergency medicine's competitive advantage; fellowships in cardiovascular emergencies.” Ann Emerg Med 40, no. 6 (December 2002): 658–59. https://doi.org/10.1067/mem.2002.129716.
    Full Text Link to Item
  - Wong, Brian Y. L., Judy Gnarpe, Koon K. Teo, E Magnus Ohman, Connie Prosser, W Brian Gibler, Anatoly Langer, Wei-Ching Chang, and Paul W. Armstrong. “Does chronic Chlamydia pneumoniae infection increase the risk of myocardial injury? Insights from patients with non-ST-elevation acute coronary syndromes.” Am Heart J 144, no. 6 (December 2002): 987–94. https://doi.org/10.1067/mhj.2002.126734.
    Full Text Link to Item
  - Ezekowitz, Justin A., and Paul W. Armstrong. “The waiting game: facing the consequences.” Cmaj 167, no. 11 (November 26, 2002): 1247–48.
    Link to Item
  - Armstrong, Paul, Neil R. Cashman, Deborah J. Cook, David H. Feeny, William A. Ghali, Frank R. de Gruijl, Judith G. Hall, et al. “A letter from CMAJ's editorial board to the CMA.” Cmaj 167, no. 11 (November 26, 2002): 1230.
    Link to Item
  - Lincoff, A Michael, Robert M. Califf, Frans Van de Werf, James T. Willerson, Harvey D. White, Paul W. Armstrong, Victor Guetta, et al. “Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy vs conventional fibrinolytic therapy for acute myocardial infarction: GUSTO V randomized trial.” Jama 288, no. 17 (November 6, 2002): 2130–35. https://doi.org/10.1001/jama.288.17.2130.
    Full Text Link to Item
  - Armstrong, Paul W. “The ebb and flow of the NHS waiting list: how do recruitment and admission affect event-based measures of the length of 'time-to-admission'?” Stat Med 21, no. 20 (October 30, 2002): 2991–3009. https://doi.org/10.1002/sim.1254.
    Full Text Link to Item
  - James, S., P. Armstrong, R. Califf, S. Husted, F. Kontny, M. Niemminen, M. Pfisterer, M. L. Simoons, and L. Wallentin. “Safety and efficacy of abciximab combined with dalteparin in treatment of acute coronary syndromes.” Eur Heart J 23, no. 19 (October 2002): 1538–45. https://doi.org/10.1053/euhj.2002.3257.
    Full Text Link to Item
  - Dagenais, Gilles R., Paul W. Armstrong, Pierre Théroux, C David Naylor, and C David CCS Ad Hoc Committee for Revising the CCS Grading of Stable Angina. “Revisiting the Canadian Cardiovascular Society grading of stable angina pectoris after a quarter of a century of use.” Can J Cardiol 18, no. 9 (September 2002): 941–44.
    Link to Item
  - Leung, Raymond C. M., and Paul W. Armstrong. “Reperfusion in waiting: what queue should we join?” Am Heart J 144, no. 3 (September 2002): 377–79. https://doi.org/10.1067/mhj.2002.124867.
    Full Text Link to Item
  - Goodman, Shaun G., Aiala Barr, Anatoly Langer, Galen S. Wagner, David Fitchett, Paul W. Armstrong, and C David Naylor. “Development and prognosis of non-Q-wave myocardial infarction in the thrombolytic era.” Am Heart J 144, no. 2 (August 2002): 243–50. https://doi.org/10.1067/mhj.2002.124059.
    Full Text Link to Item
  - Majumdar, Sumit R., Wei-Ching Chang, and Paul W. Armstrong. “Do the investigative sites that take part in a positive clinical trial translate that evidence into practice?” Am J Med 113, no. 2 (August 1, 2002): 140–45. https://doi.org/10.1016/s0002-9343(02)01166-x.
    Full Text Link to Item
  - Al-Khatib, Sana M., Christopher B. Granger, Yao Huang, Kerry L. Lee, Robert M. Califf, Maarten L. Simoons, Paul W. Armstrong, et al. “Sustained ventricular arrhythmias among patients with acute coronary syndromes with no ST-segment elevation: incidence, predictors, and outcomes.” Circulation 106, no. 3 (July 16, 2002): 309–12. https://doi.org/10.1161/01.cir.0000022692.49934.e3.
    Full Text Link to Item
  - Anderson, R David, Harvey D. White, E Magnus Ohman, Galen S. Wagner, Mitchell W. Krucoff, Paul W. Armstrong, W Douglas Weaver, et al. “Predicting outcome after thrombolysis in acute myocardial infarction according to ST-segment resolution at 90 minutes: a substudy of the GUSTO-III trial. Global Use of Strategies To Open occluded coronary arteries.” Am Heart J 144, no. 1 (July 2002): 81–88. https://doi.org/10.1067/mhj.2002.123319.
    Full Text Link to Item
  - Chang, W. -. C., R. A. Harrington, M. L. Simoons, R. M. Califf, A. M. Lincoff, P. W. Armstrong, and P. W. PURSUIT Investigators. “Does eptifibatide confer a greater benefit to patients with unstable angina than with non-ST segment elevation myocardial infarction? Insights from the PURSUIT Trial.” Eur Heart J 23, no. 14 (July 2002): 1102–11. https://doi.org/10.1053/euhj.2001.3151.
    Full Text Link to Item
  - Cantor, Warren J., L Kristin Newby, Robert H. Christenson, Robert H. Tuttle, Vic Hasselblad, Paul W. Armstrong, David J. Moliterno, et al. “Prognostic significance of elevated troponin I after percutaneous coronary intervention.” J Am Coll Cardiol 39, no. 11 (June 5, 2002): 1738–44. https://doi.org/10.1016/s0735-1097(02)01877-6.
    Full Text Link to Item
  - Julian, Desmond. “Absolute and relative truth in clinical trials.” Lancet 359, no. 9321 (June 1, 2002): 1945–46. https://doi.org/10.1016/S0140-6736(02)08750-0.
    Full Text Link to Item
  - Newby, L Kristin, Robert M. Califf, Harvey D. White, Robert A. Harrington, Frans Van de Werf, Christopher B. Granger, R John Simes, Vic Hasselblad, and Paul W. Armstrong. “The failure of orally administered glycoprotein IIb/IIIa inhibitors to prevent recurrent cardiac events.” Am J Med 112, no. 8 (June 1, 2002): 647–58. https://doi.org/10.1016/s0002-9343(02)01106-3.
    Full Text Link to Item
  - Dyke, Christopher K., Richard C. Becker, Neal S. Kleiman, Judith S. Hochman, Edwin G. Bovill, A Michael Lincoff, Gary Gerstenblith, et al. “First experience with direct factor Xa inhibition in patients with stable coronary disease: a pharmacokinetic and pharmacodynamic evaluation.” Circulation 105, no. 20 (May 21, 2002): 2385–91. https://doi.org/10.1161/01.cir.0000016351.12759.52.
    Full Text Link to Item
  - Lindenfeld, JoAnn, Jeffrey Borer, and Paul W. Armstrong. “Losartan potassium (Cozaar).” Circulation 105, no. 16 (April 23, 2002): e9100. https://doi.org/10.1161/01.cir.0000019667.61241.2b.
    Full Text Link to Item
  - Kerigan, Anthony. “Fibrinolytic therapy for acute ST-segment elevation myocardial infarction.” Cmaj 166, no. 6 (March 19, 2002): 708.
    Link to Item
  - Armstrong, Paul W. “Coronary reperfusion: numerators searching for denominators.” Lancet 359, no. 9304 (February 2, 2002): 371–72. https://doi.org/10.1016/S0140-6736(02)07588-8.
    Full Text Link to Item
  - Gibler, W Brian, Eric J. Topol, Brian Holroyd, and Paul W. Armstrong. “Cardiology and emergency medicine: united we stand, divided we fall.” Ann Emerg Med 39, no. 2 (February 2002): 164–67. https://doi.org/10.1067/mem.2002.121469.
    Full Text Link to Item
  - Gibler, W Brian, Paul W. Armstrong, E Magnus Ohman, W Douglas Weaver, Amanda L. Stebbins, Joel M. Gore, L Kristin Newby, Robert M. Califf, Eric J. Topol, and Eric J. Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) Investigators. “Persistence of delays in presentation and treatment for patients with acute myocardial infarction: The GUSTO-I and GUSTO-III experience.” Ann Emerg Med 39, no. 2 (February 2002): 123–30. https://doi.org/10.1067/mem.2002.121402.
    Full Text Link to Item
  - Mahaffey, Kenneth W., Matthew T. Roe, Christopher K. Dyke, L Kristin Newby, Neal S. Kleiman, Patty Connolly, Lisa G. Berdan, et al. “Misreporting of myocardial infarction end points: results of adjudication by a central clinical events committee in the PARAGON-B trial. Second Platelet IIb/IIIa Antagonist for the Reduction of Acute Coronary Syndrome Events in a Global Organization Network Trial.” Am Heart J 143, no. 2 (February 2002): 242–48. https://doi.org/10.1067/mhj.2002.120145.
    Full Text Link to Item
  - Labinaz, Marino, Rakhi Kilaru, Karen Pieper, Steven P. Marso, Michael M. Kitt, Maarten L. Simoons, Robert M. Califf, Eric J. Topol, Paul W. Armstrong, and Robert A. Harrington. “Outcomes of patients with acute coronary syndromes and prior coronary artery bypass grafting: results from the platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial.” Circulation 105, no. 3 (January 22, 2002): 322–27. https://doi.org/10.1161/hc0302.102578.
    Full Text Link to Item
  - Boersma, Eric, Robert A. Harrington, David J. Moliterno, Harvey White, Pierre Théroux, Frans Van de Werf, Anneke de Torbal, et al. “Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials.” Lancet 359, no. 9302 (January 19, 2002): 189–98. https://doi.org/10.1016/S0140-6736(02)07442-1.
    Full Text Link to Item
  - Savonitto, Stefano, Christopher B. Granger, Diego Ardissino, Laura Gardner, Claudio Cavallini, Marcello Galvani, Filippo Ottani, et al. “The prognostic value of creatine kinase elevations extends across the whole spectrum of acute coronary syndromes.” J Am Coll Cardiol 39, no. 1 (January 2, 2002): 22–29. https://doi.org/10.1016/s0735-1097(01)01706-5.
    Full Text Link to Item
  - Roe, M. T., C. B. Granger, J. A. Puma, A. S. Hellkamp, J. S. Hochman, E. M. Ohman, H. D. White, et al. “Comparison of benefits and complications of hirudin versus heparin for patients with acute coronary syndromes undergoing early percutaneous coronary intervention.” Am J Cardiol 88, no. 12 (December 15, 2001): 1403-A6. https://doi.org/10.1016/s0002-9149(01)02119-1.
    Full Text Link to Item
  - Angeja, B. G., J. H. Alexander, R. Chin, X. Li, H. V. Barron, P. W. Armstrong, C. B. Granger, F. Van de Werf, and C. M. Gibson. “Safety of the weight-adjusted dosing regimen of tenecteplase in the ASSENT-Trial.” Am J Cardiol 88, no. 11 (December 1, 2001): 1240–45. https://doi.org/10.1016/s0002-9149(01)02084-7.
    Full Text Link to Item
  - Van de Werf, F., H. V. Barron, P. W. Armstrong, C. B. Granger, S. Berioli, G. Barbash, K. Pehrsson, et al. “Incidence and predictors of bleeding events after fibrinolytic therapy with fibrin-specific agents: a comparison of TNK-tPA and rt-PA.” Eur Heart J 22, no. 24 (December 2001): 2253–61. https://doi.org/10.1053/euhj.2001.2686.
    Full Text Link to Item
  - White, H., and H. Hirulog and Early Reperfusion or Occlusion (HERO)-2 Trial Investigators. “Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: the HERO-2 randomised trial.” Lancet 358, no. 9296 (December 1, 2001): 1855–63. https://doi.org/10.1016/s0140-6736(01)06887-8.
    Full Text Link to Item
  - Fu, Y., S. Goodman, W. C. Chang, F. Van De Werf, C. B. Granger, and P. W. Armstrong. “Time to treatment influences the impact of ST-segment resolution on one-year prognosis: insights from the assessment of the safety and efficacy of a new thrombolytic (ASSENT-2) trial.” Circulation 104, no. 22 (November 27, 2001): 2653–59. https://doi.org/10.1161/hc4701.099731.
    Full Text Link to Item
  - McAlister, F. A., F. M. Lawson, K. K. Teo, and P. W. Armstrong. “Randomised trials of secondary prevention programmes in coronary heart disease: systematic review.” Bmj 323, no. 7319 (October 27, 2001): 957–62. https://doi.org/10.1136/bmj.323.7319.957.
    Full Text Link to Item
  - Armstrong, P. W. “New advances in the management of acute coronary syndromes: 2. Fibrinolytic therapy for acute ST-segment elevation myocardial infarction.” Cmaj 165, no. 6 (September 18, 2001): 791–97.
    Link to Item
  - Hudson, M. P., C. B. Granger, E. J. Topol, K. S. Pieper, P. W. Armstrong, G. I. Barbash, A. D. Guerci, A. Vahanian, R. M. Califf, and E. M. Ohman. “Early reinfarction after fibrinolysis: experience from the global utilization of streptokinase and tissue plasminogen activator (alteplase) for occluded coronary arteries (GUSTO I) and global use of strategies to open occluded coronary arteries (GUSTO III) trials.” Circulation 104, no. 11 (September 11, 2001): 1229–35. https://doi.org/10.1161/hc3601.095717.
    Full Text Link to Item
  - Cleland, J. G., K. Thygesen, B. F. Uretsky, P. Armstrong, J. D. Horowitz, B. Massie, M. Packer, P. A. Poole-Wilson, L. Rydén, and L. ATLAS investigators. “Cardiovascular critical event pathways for the progression of heart failure; a report from the ATLAS study.” Eur Heart J 22, no. 17 (September 2001): 1601–12. https://doi.org/10.1053/euhj.2000.2570.
    Full Text Link to Item
  - Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 Investigators, Elizabeth. “Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction.” Lancet 358, no. 9282 (August 25, 2001): 605–13. https://doi.org/10.1016/S0140-6736(01)05775-0.
    Full Text Link to Item
  - Kaul, P., Y. Fu, W. C. Chang, R. A. Harrington, G. S. Wagner, S. G. Goodman, C. B. Granger, et al. “Prognostic value of ST segment depression in acute coronary syndromes: insights from PARAGON-A applied to GUSTO-IIb. PARAGON-A and GUSTO IIb Investigators. Platelet IIb/IIIa Antagonism for the Reduction of Acute Global Organization Network.” J Am Coll Cardiol 38, no. 1 (July 2001): 64–71. https://doi.org/10.1016/s0735-1097(01)01307-9.
    Full Text Link to Item
  - O’Shea, J. C., Y. Fu, W. C. Chang, and P. W. Armstrong. “A tale of two countries: Insights from the differences in Canadian/American patterns of care for patients with acute coronary syndromes.” Am Heart J 142, no. 1 (July 2001): 14–20. https://doi.org/10.1067/mhj.2001.116330.
    Full Text Link to Item
  - Armstrong, P. W., and D. Collen. “Fibrinolysis for acute myocardial infarction: current status and new horizons for pharmacological reperfusion, part 2.” Circulation 103, no. 24 (June 19, 2001): 2987–92. https://doi.org/10.1161/01.cir.103.24.2987.
    Full Text Link to Item
  - Newby, L. K., E. M. Ohman, R. H. Christenson, D. J. Moliterno, R. A. Harrington, H. D. White, P. W. Armstrong, et al. “Benefit of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes and troponin t-positive status: the paragon-B troponin T substudy.” Circulation 103, no. 24 (June 19, 2001): 2891–96. https://doi.org/10.1161/01.cir.103.24.2891.
    Full Text Link to Item
  - Armstrong, P. W., and D. Collen. “Fibrinolysis for acute myocardial infarction: current status and new horizons for pharmacological reperfusion, part 1.” Circulation 103, no. 23 (June 12, 2001): 2862–66. https://doi.org/10.1161/01.cir.103.23.2862.
    Full Text Link to Item
  - Bahit, M. C., E. J. Topol, R. M. Califf, P. W. Armstrong, D. A. Criger, V. Hasselbad, A. Betriu, J. Hirsh, D. Ardissino, and C. B. Granger. “Erratum: Reactivation of ischemic events in acute coronary syndromes: Results from GUSTO-IIb (Journal of American College of Cardiology (2001) 37 (1001-1007)) [1].” Journal of the American College of Cardiology 37, no. 7 (June 1, 2001): 2012.
  - Armstrong, P. W. “New advances in the management of acute coronary syndromes.” Cmaj 164, no. 9 (May 1, 2001): 1303–4.
    Link to Item
  - Aronow, H. D., E. J. Topol, M. T. Roe, P. L. Houghtaling, K. E. Wolski, A. M. Lincoff, R. A. Harrington, et al. “Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study.” Lancet 357, no. 9262 (April 7, 2001): 1063–68. https://doi.org/10.1016/S0140-6736(00)04257-4.
    Full Text Link to Item
  - McAlister, F. A., F. M. Lawson, K. K. Teo, and P. W. Armstrong. “A systematic review of randomized trials of disease management programs in heart failure.” Am J Med 110, no. 5 (April 1, 2001): 378–84. https://doi.org/10.1016/s0002-9343(00)00743-9.
    Full Text Link to Item
  - Bahit, M. C., E. J. Topol, R. M. Califf, P. W. Armstrong, D. A. Criger, V. Hasselblad, A. Betriu, J. Hirsh, D. Ardissino, and C. B. Granger. “Reactivation of ischemic events in acute coronary syndromes: results from GUSTO-IIb. Gobal Use of Strategies To Open occluded arteries in acute coronary syndromes.” J Am Coll Cardiol 37, no. 4 (March 15, 2001): 1001–7. https://doi.org/10.1016/s0735-1097(01)01143-3.
    Full Text Link to Item
  - Armstrong, P. W., C. Granger, and F. Van de Werf. “Bolus fibrinolysis: risk, benefit, and opportunities.” Circulation 103, no. 8 (February 27, 2001): 1171–73. https://doi.org/10.1161/01.cir.103.8.1171.
    Full Text Link to Item
  - Armstrong, P. W. “Erratum: Intracranial haemorrhage with bolus thrombolytic agents (The Lancet (November 25) (1849)).” Lancet 357, no. 9256 (February 24, 2001): 642.
  - Massie, B. M., P. W. Armstrong, J. G. Cleland, J. D. Horowitz, M. Packer, P. A. Poole-Wilson, and L. Rydén. “Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic heart failure: results from the ATLAS trial. The Assessment of Treatment with Lisinopril and Survival.” Arch Intern Med 161, no. 2 (January 22, 2001): 165–71. https://doi.org/10.1001/archinte.161.2.165.
    Full Text Link to Item
  - Chang, W. C., Y. Fu, E. M. Ohman, M. Gupta, A. Morris, S. N. Roth, C. B. Granger, et al. “Temporal evolution in the management of acute ST elevation myocardial infarction: The seven-year GUSTO experience from Canada and the United States.” Canadian Journal of Cardiology 16, no. 10 (December 12, 2000): 1231–39.
  - Armstrong, P. W. “Reperfusion synergism: will it be both sustained and safe?” Eur Heart J 21, no. 23 (December 2000): 1913–16. https://doi.org/10.1053/euhj.2000.2432.
    Full Text Link to Item
  - Packer, M., P. A. Poole-Wilson, and P. W. Armstrong. “Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure.” Congestive Heart Failure 6, no. 1 (December 1, 2000).
  - Sculpher, M. J., L. Poole, J. Cleland, M. Drummond, P. W. Armstrong, J. D. Horowitz, B. M. Massie, P. A. Poole-Wilson, and L. Ryden. “Low doses vs. high doses of the angiotensin converting-enzyme inhibitor lisinopril in chronic heart failure: a cost-effectiveness analysis based on the Assessment of Treatment with Lisinopril and Survival (ATLAS) study. The ATLAS Study Group.” Eur J Heart Fail 2, no. 4 (December 2000): 447–54. https://doi.org/10.1016/s1388-9842(00)00122-7.
    Full Text Link to Item
  - Rydén, L., P. W. Armstrong, J. G. Cleland, J. D. Horowitz, B. M. Massie, M. Packer, and P. A. Poole-Wilson. “Efficacy and safety of high-dose lisinopril in chronic heart failure patients at high cardiovascular risk, including those with diabetes mellitus. Results from the ATLAS trial.” Eur Heart J 21, no. 23 (December 2000): 1967–78. https://doi.org/10.1053/euhj.2000.2311.
    Full Text Link to Item
  - Collen, D., and B. Sobel. “Intracranial haemorrhage with bolus thrombolytic agents.” Lancet 356, no. 9244 (November 25, 2000): 1848. https://doi.org/10.1016/S0140-6736(00)03247-5.
    Full Text Link to Item
  - Armstrong, P. W., C. Granger, and F. Van de Werf. “Intracranial haemorrhage with bolus thrombolytic agents.” Lancet 356, no. 9244 (November 25, 2000): 1849. https://doi.org/10.1016/S0140-6736(05)73310-9.
    Full Text Link to Item
  - Théroux, P., J. T. Willerson, and P. W. Armstrong. “Progress in the treatment of acute coronary syndromes: a 50-year perspective (1950-2000).” Circulation 102, no. 20 Suppl 4 (November 14, 2000): IV2–13. https://doi.org/10.1161/01.cir.102.suppl_4.iv-2.
    Full Text Link to Item
  - Topol, E. J., E. M. Ohman, P. W. Armstrong, R. Wilcox, A. M. Skene, P. Aylward, J. Simes, et al. “Survival outcomes 1 year after reperfusion therapy with either alteplase or reteplase for acute myocardial infarction: results from the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) III Trial.” Circulation 102, no. 15 (October 10, 2000): 1761–65. https://doi.org/10.1161/01.cir.102.15.1761.
    Full Text Link to Item
  - Fu, Y., W. C. Chang, D. Mark, R. M. Califf, B. Mackenzie, C. B. Granger, E. J. Topol, M. Hlatky, and P. W. Armstrong. “Canadian-American differences in the management of acute coronary syndromes in the GUSTO IIb trial: one-year follow-up of patients without ST-segment elevation. Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) II Investigators.” Circulation 102, no. 12 (September 19, 2000): 1375–81. https://doi.org/10.1161/01.cir.102.12.1375.
    Full Text Link to Item
  - Alpert, J. S., K. Thygesen, E. Antman, and J. P. Bassand. “Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.” J Am Coll Cardiol 36, no. 3 (September 2000): 959–69. https://doi.org/10.1016/s0735-1097(00)00804-4.
    Full Text Link to Item
  - Armstrong, P. W. “Left ventricular dysfunction: causes, natural history, and hopes for reversal.” Heart 84 Suppl 1, no. Suppl 1 (September 2000): i15-7:discussioni50. https://doi.org/10.1136/heart.84.suppl_1.i15.
    Full Text Link to Item
  - “Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.” Eur Heart J 21, no. 18 (September 2000): 1502–13. https://doi.org/10.1053/euhj.2000.2305.
    Full Text Link to Item
  - Armstrong, P. W. “First steps in analysing NHS waiting times: avoiding the 'stationary and closed population' fallacy.” Stat Med 19, no. 15 (August 15, 2000): 2037–51. https://doi.org/10.1002/1097-0258(20000815)19:15<2037::aid-sim606>3.0.co;2-r.
    Full Text Link to Item
  - Harrington, R. A., P. W. Armstrong, C. Graffagnino, F. Van De Werf, D. J. Kereiakes, K. N. Sigmon, T. Card, et al. “Dose-finding, safety, and tolerability study of an oral platelet glycoprotein IIb/IIIa inhibitor, lotrafiban, in patients with coronary or cerebral atherosclerotic disease.” Circulation 102, no. 7 (August 15, 2000): 728–35. https://doi.org/10.1161/01.cir.102.7.728.
    Full Text Link to Item
  - Uretsky, B. F., K. Thygesen, P. W. Armstrong, J. G. Cleland, J. D. Horowitz, B. M. Massie, M. Packer, P. A. Poole-Wilson, and L. Ryden. “Acute coronary findings at autopsy in heart failure patients with sudden death: results from the assessment of treatment with lisinopril and survival (ATLAS) trial.” Circulation 102, no. 6 (August 8, 2000): 611–16. https://doi.org/10.1161/01.cir.102.6.611.
    Full Text Link to Item
  - Barbagelata, A., R. M. Califf, E. B. Sgarbossa, S. G. Goodman, D. Knight, D. B. Mark, C. B. Granger, et al. “Use of resources, quality of life, and clinical outcomes in patients with and without new Q waves after thrombolytic therapy for acute myocardial infarction (from the GUSTO-I trial).” Am J Cardiol 86, no. 1 (July 1, 2000): 24–29. https://doi.org/10.1016/s0002-9149(00)00823-7.
    Full Text Link to Item
  - Boersma, E., K. S. Pieper, E. W. Steyerberg, R. G. Wilcox, W. C. Chang, K. L. Lee, K. M. Akkerhuis, et al. “Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators.” Circulation 101, no. 22 (June 6, 2000): 2557–67. https://doi.org/10.1161/01.cir.101.22.2557.
    Full Text Link to Item
  - Califf, R. M., K. S. Pieper, K. L. Lee, F. Van De Werf, R. J. Simes, P. W. Armstrong, and E. J. Topol. “Prediction of 1-year survival after thrombolysis for acute myocardial infarction in the global utilization of streptokinase and TPA for occluded coronary arteries trial.” Circulation 101, no. 19 (May 16, 2000): 2231–38. https://doi.org/10.1161/01.cir.101.19.2231.
    Full Text Link to Item
  - Armstrong, P. W., J. R. Burton, D. Palisaitis, C. R. Thompson, F. Van de Werf, B. Rose, D. Collen, and K. K. Teo. “Collaborative angiographic patency trial of recombinant staphylokinase (CAPTORS).” Am Heart J 139, no. 5 (May 2000): 820–23. https://doi.org/10.1016/s0002-8703(00)90013-9.
    Full Text Link to Item
  - Sholter, D. E., and P. W. Armstrong. “Adverse effects of corticosteroids on the cardiovascular system.” Can J Cardiol 16, no. 4 (April 2000): 505–11.
    Link to Item
  - Newby, L. K., E. L. Eisenstein, R. M. Califf, T. D. Thompson, C. L. Nelson, E. D. Peterson, P. W. Armstrong, et al. “Cost effectiveness of early discharge after uncomplicated acute myocardial infarction.” N Engl J Med 342, no. 11 (March 16, 2000): 749–55. https://doi.org/10.1056/NEJM200003163421101.
    Full Text Link to Item
  - Armstrong, P. W. “Unrepresentative, invalid and misleading: are waiting times for elective admission wrongly calculated?” J Epidemiol Biostat 5, no. 2 (2000): 117–23.
    Link to Item
  - Hasdai, D., R. M. Califf, T. D. Thompson, J. S. Hochman, E. M. Ohman, M. Pfisterer, E. R. Bates, et al. “Predictors of cardiogenic shock after thrombolytic therapy for acute myocardial infarction.” J Am Coll Cardiol 35, no. 1 (January 2000): 136–43. https://doi.org/10.1016/s0735-1097(99)00508-2.
    Full Text Link to Item
  - Packer, M., P. A. Poole-Wilson, P. W. Armstrong, J. G. Cleland, J. D. Horowitz, B. M. Massie, L. Rydén, K. Thygesen, and B. F. Uretsky. “Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group.” Circulation 100, no. 23 (December 7, 1999): 2312–18. https://doi.org/10.1161/01.cir.100.23.2312.
    Full Text Link to Item
  - Ohman, E. M., P. W. Armstrong, H. D. White, C. B. Granger, R. G. Wilcox, W. D. Weaver, W. B. Gibler, et al. “Risk stratification with a point-of-care cardiac troponin T test in acute myocardial infarction. GUSTOIII Investigators. Global Use of Strategies To Open Occluded Coronary Arteries.” Am J Cardiol 84, no. 11 (December 1, 1999): 1281–86. https://doi.org/10.1016/s0002-9149(99)00558-5.
    Full Text Link to Item
  - Armstrong, P. W. “Unsticking platelets: the role of glycoprotein IIb/IIIa receptor blockade.” Cmaj 161, no. 11 (November 30, 1999): 1423–24.
    Link to Item
  - Armstrong, P. W. “Pursuing progress in acute coronary syndromes.” Circulation 100, no. 15 (October 12, 1999): 1586–89. https://doi.org/10.1161/01.cir.100.15.1586.
    Full Text Link to Item
  - Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT-2) Investigators, H., F. Van De Werf, J. Adgey, D. Ardissino, P. W. Armstrong, P. Aylward, G. Barbash, et al. “Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial.” Lancet 354, no. 9180 (August 28, 1999): 716–22. https://doi.org/10.1016/s0140-6736(99)07403-6.
    Full Text Link to Item
  - McAlister, F. A., K. K. Teo, M. Taher, T. J. Montague, D. Humen, L. Cheung, M. Kiaii, R. Yim, and P. W. Armstrong. “Insights into the contemporary epidemiology and outpatient management of congestive heart failure.” Am Heart J 138, no. 1 Pt 1 (July 1999): 87–94. https://doi.org/10.1016/s0002-8703(99)70251-6.
    Full Text Link to Item
  - Batchelor, W. B., E. D. Peterson, D. B. Mark, J. D. Knight, C. B. Granger, P. W. Armstrong, and R. M. Califf. “A comparison of U.S. and Canadian cardiac catheterization practices in detecting severe coronary artery disease after myocardial infarction: efficiency, yield and long-term implications.” J Am Coll Cardiol 34, no. 1 (July 1999): 12–19. https://doi.org/10.1016/s0735-1097(99)00174-6.
    Full Text Link to Item
  - Moe, G. W., and P. Armstrong. “Pacing-induced heart failure: a model to study the mechanism of disease progression and novel therapy in heart failure.” Cardiovasc Res 42, no. 3 (June 1999): 591–99. https://doi.org/10.1016/s0008-6363(99)00032-2.
    Full Text Link to Item
  - Choy, J. B., and P. W. Armstrong. “Anticoagulant therapy in unstable angina.” Cardiol Clin 17, no. 2 (May 1999): 327–ix. https://doi.org/10.1016/s0733-8651(05)70078-3.
    Full Text Link to Item
  - Alexander, J. H., R. A. Harrington, R. H. Tuttle, L. G. Berdan, A. M. Lincoff, J. W. Deckers, M. L. Simoons, et al. “Prior aspirin use predicts worse outcomes in patients with non-ST-elevation acute coronary syndromes. PURSUIT Investigators. Platelet IIb/IIIa in Unstable angina: Receptor Suppression Using Integrilin Therapy.” Am J Cardiol 83, no. 8 (April 15, 1999): 1147–51. https://doi.org/10.1016/s0002-9149(99)00049-1.
    Full Text Link to Item
  - Armstrong, P. W. “Improved outcome in heart failure.” International Journal of Clinical Practice. Supplement 100 (April 1, 1999): 10–11.
  - Cleland, J. G., P. Armstrong, J. D. Horowitz, B. Massie, M. Packer, P. A. Poole-Wilson, and L. Rydén. “Baseline clinical characteristics of patients recruited into the assessment of treatment with lisinopril and survival study.” Eur J Heart Fail 1, no. 1 (March 1999): 73–79. https://doi.org/10.1016/S1388-9842(98)00002-6.
    Full Text Link to Item
  - Wong, M. P., and P. W. Armstrong. “Supraventricular tachycardia terminated by external mechanical stimulation: a case of "pothole conversion".” Pacing Clin Electrophysiol 22, no. 2 (February 1999): 376–78. https://doi.org/10.1111/j.1540-8159.1999.tb00455.x.
    Full Text Link to Item
  - “Consensus recommendations for the management of chronic heart failure. On behalf of the membership of the advisory council to improve outcomes nationwide in heart failure.” Am J Cardiol 83, no. 2A (January 21, 1999): 1A-38A.
    Link to Item
  - Hasdai, D., D. R. Holmes, E. J. Topol, P. B. Berger, D. A. Criger, J. S. Hochman, E. R. Bates, et al. “Frequency and clinical outcome of cardiogenic shock during acute myocardial infarction among patients receiving reteplase or alteplase. Results from GUSTO-III. Global Use of Strategies to Open Occluded Coronary Arteries.” Eur Heart J 20, no. 2 (January 1999): 128–35. https://doi.org/10.1053/euhj.1999.1282.
    Full Text Link to Item
  - Kleiman, N. S., C. B. Granger, H. D. White, P. Armstrong, D. Ardissino, F. V. de Werf, P. Zoldeyhi, T. D. Thompson, R. M. Califf, and E. J. Topol. “Death and nonfatal reinfarction within the first 24 hours after presentation with an acute coronary syndrome: experience from GUSTO-IIb. Global Utilization of Strategies for Total Occlusion.” Am Heart J 137, no. 1 (January 1999): 12–23. https://doi.org/10.1016/s0002-8703(99)70455-2.
    Full Text Link to Item
  - Khadour, F. H., D. W. O’Brien, Y. Fu, P. W. Armstrong, and R. Schulz. “Endothelial nitric oxide synthase increases in left atria of dogs with pacing-induced heart failure.” American Journal of Physiology Heart and Circulatory Physiology 275, no. 6 44-6 (December 1, 1998).
  - Khadour, F. H., D. W. O’Brien, Y. Fu, P. W. Armstrong, and R. Schulz. “Endothelial nitric oxide synthase increases in left atria of dogs with pacing-induced heart failure.” Am J Physiol 275, no. 6 (December 1998): H1971–78. https://doi.org/10.1152/ajpheart.1998.275.6.H1971.
    Full Text Link to Item
  - Alexander, K. P., E. D. Peterson, C. B. Granger, A. C. Casas, F. Van de Werf, P. W. Armstrong, A. Guerci, E. J. Topol, and R. M. Califf. “Potential impact of evidence-based medicine in acute coronary syndromes: insights from GUSTO-IIb. Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes trial.” J Am Coll Cardiol 32, no. 7 (December 1998): 2023–30. https://doi.org/10.1016/s0735-1097(98)00466-5.
    Full Text Link to Item
  - “Combining thrombolysis with the platelet glycoprotein IIb/IIIa inhibitor lamifiban: results of the Platelet Aggregation Receptor Antagonist Dose Investigation and Reperfusion Gain in Myocardial Infarction (PARADIGM) trial.” J Am Coll Cardiol 32, no. 7 (December 1998): 2003–10. https://doi.org/10.1016/s0735-1097(98)00474-4.
    Full Text Link to Item
  - Armstrong, P. W., Y. Fu, W. C. Chang, E. J. Topol, C. B. Granger, A. Betriu, F. Van de Werf, K. L. Lee, and R. M. Califf. “Acute coronary syndromes in the GUSTO-IIb trial: prognostic insights and impact of recurrent ischemia. The GUSTO-IIb Investigators.” Circulation 98, no. 18 (November 3, 1998): 1860–68. https://doi.org/10.1161/01.cir.98.18.1860.
    Full Text Link to Item
  - Newby, L. K., R. H. Christenson, E. M. Ohman, P. W. Armstrong, T. D. Thompson, K. L. Lee, C. W. Hamm, et al. “Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndromes. The GUSTO-IIa Investigators.” Circulation 98, no. 18 (November 3, 1998): 1853–59. https://doi.org/10.1161/01.cir.98.18.1853.
    Full Text Link to Item
  - Pfisterer, M., J. L. Cox, C. B. Granger, S. J. Brener, C. D. Naylor, R. M. Califf, F. van de Werf, et al. “Atenolol use and clinical outcomes after thrombolysis for acute myocardial infarction: the GUSTO-I experience. Global Utilization of Streptokinase and TPA (alteplase) for Occluded Coronary Arteries.” J Am Coll Cardiol 32, no. 3 (September 1998): 634–40. https://doi.org/10.1016/s0735-1097(98)00279-4.
    Full Text Link to Item
  - Armstrong, P. W. “Toward improved coronary artery revascularization: is this as good as it gets?” Cmaj 159, no. 3 (August 11, 1998): 237–38.
    Link to Item
  - Uretsky, B. F., I. Pina, R. J. Quigg, J. V. Brill, E. J. MacInerney, R. Mintzer, and P. W. Armstrong. “Beyond drug therapy: nonpharmacologic care of the patient with advanced heart failure.” Am Heart J 135, no. 6 Pt 2 Su (June 1998): S264–84. https://doi.org/10.1016/s0002-8703(98)70255-8.
    Full Text Link to Item
  - Metz, B. K., H. D. White, C. B. Granger, R. J. Simes, P. W. Armstrong, J. Hirsh, V. Fuster, C. M. MacAulay, R. M. Califf, and E. J. Topol. “Randomized comparison of direct thrombin inhibition versus heparin in conjunction with fibrinolytic therapy for acute myocardial infarction: results from the GUSTO-IIb Trial. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO-IIb) Investigators.” J Am Coll Cardiol 31, no. 7 (June 1998): 1493–98. https://doi.org/10.1016/s0735-1097(98)00138-7.
    Full Text Link to Item
  - Hochrein, J., F. Sun, K. S. Pieper, K. L. Lee, K. B. Gates, P. W. Armstrong, W. D. Weaver, et al. “Higher T-wave amplitude associated with better prognosis in patients receiving thrombolytic therapy for acute myocardial infarction (a GUSTO-I substudy). Global Utilization of Streptokinase and Tissue plasminogen Activator for Occluded Coronary Arteries.” Am J Cardiol 81, no. 9 (May 1, 1998): 1078–84. https://doi.org/10.1016/s0002-9149(98)00112-x.
    Full Text Link to Item
  - Braunwald, E., A. Maseri, P. W. Armstrong, R. M. Califf, W. B. Gibler, C. W. Hamm, M. L. Simoons, and F. Van de Werf. “Rationale and clinical evidence for the use of GP IIb/IIIa inhibitors in acute coronary syndromes.” Am Heart J 135, no. 4 (April 1998): S56–66. https://doi.org/10.1016/s0002-8703(98)70298-4.
    Full Text Link to Item
  - Braunwald, E., A. Maseri, P. W. Armstrong, R. M. Califf, W. B. Gibler, C. W. Hamm, M. L. Simoons, and F. Van de Werf. “Rationale and clinical evidence for the use of GP IIb/IIIa inhibitors in acute coronary syndromes.” Eur Heart J 19 Suppl D (April 1998): D22–30.
    Link to Item
  - Armstrong, P. W., and J. T. Willerson. “Clinical cardiology: New frontiers.” Circulation 97, no. 12 (March 31, 1998): 1107.
  - Langer, A., M. W. Krucoff, P. Klootwijk, M. L. Simoons, C. B. Granger, A. Barr, R. M. Califf, and P. W. Armstrong. “Prognostic significance of ST segment shift early after resolution of ST elevation in patients with myocardial infarction treated with thrombolytic therapy: the GUSTO-I ST Segment Monitoring Substudy.” J Am Coll Cardiol 31, no. 4 (March 15, 1998): 783–89. https://doi.org/10.1016/s0735-1097(97)00544-5.
    Full Text Link to Item
  - Christenson, R. H., S. H. Duh, L. K. Newby, E. M. Ohman, R. M. Califf, C. B. Granger, S. Peck, et al. “Cardiac troponin T and cardiac troponin I: relative values in short-term risk stratification of patients with acute coronary syndromes. GUSTO-IIa Investigators.” Clin Chem 44, no. 3 (March 1998): 494–501.
    Link to Item
  - Massie, B. M., J. G. Cleland, P. W. Armstrong, J. D. Horowitz, M. Packer, P. A. Poole-Wilson, and L. Ryden. “Regional differences in the characteristics and treatment of patients participating in an international heart failure trial. The Assessment of Treatment with Lisinopril and Survival (ATLAS) Trial Investigators.” J Card Fail 4, no. 1 (March 1998): 3–8. https://doi.org/10.1016/s1071-9164(98)90502-4.
    Full Text Link to Item
  - Goodman, S. G., A. Langer, A. M. Ross, N. M. Wildermann, A. Barbagelata, E. B. Sgarbossa, G. S. Wagner, et al. “Non-Q-wave versus Q-wave myocardial infarction after thrombolytic therapy: angiographic and prognostic insights from the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries-I angiographic substudy. GUSTO-I Angiographic Investigators.” Circulation 97, no. 5 (February 10, 1998): 444–50. https://doi.org/10.1161/01.cir.97.5.444.
    Full Text Link to Item
  - Kearon, C. “Low-molecular-weight heparin versus unfractionated heparin for unstable coronary disease.” N Engl J Med 338, no. 2 (January 8, 1998): 129–30. https://doi.org/10.1056/NEJM199801083380213.
    Full Text Link to Item
  - Cairns, J., P. Theroux, P. Armstrong, P. Bogaty, C. Kells, C. R. Thompson, and W. Warnica. “Management of unstable angina: Tailoring therapeutic elements and intensity to risk profile.” Acc Current Journal Review 7, no. 4 (January 1, 1998): 43–48. https://doi.org/10.1016/S1062-1458(98)00046-4.
    Full Text
  - Massie, B. M., J. G. F. Cleland, P. W. Armstrong, J. D. Horowitz, M. Packer, P. A. Poole- Wilson, and L. Ryden. “Erratum: Regional differences in the characteristics and treatment of patients participating in an international heart failure trial (Journal of Cardiac Failure (1998) 4:3)).” Journal of Cardiac Failure 4, no. 2 (January 1, 1998): 153.
  - Krucoff, M. W., C. L. Green, A. Langer, P. Klootwijk, K. M. Trollinger, J. E. Pope, P. W. Armstrong, M. L. Simoons, E. J. Topol, and R. M. Califf. “Continuous 12-lead ST-segment recovery predicts outcome in acute myocardial infarction better than 'snapshot' angiograms of TIMI flow.” Journal of Electrocardiology 30, no. SUPPL. (January 1, 1998): 167. https://doi.org/10.1016/S0022-0736(98)80069-1.
    Full Text
  - Singh, N., D. Mironov, P. W. Armstrong, A. M. Ross, and A. Langer. “Prognostic implications of early reduced heart rate variability after infarction.” Cardiology Review 14, no. 1 (December 1, 1997): 35–39.
  - Tymchak, W. J., and P. W. Armstrong. “Spectrum of ischemic heart disease and the role of biochemical markers.” Clin Lab Med 17, no. 4 (December 1997): 701–25.
    Link to Item
  - Gill, S., S. Majumdar, N. E. Brown, and P. W. Armstrong. “Ticlopidine-associated pancytopenia: implications of an acetylsalicylic acid alternative.” Can J Cardiol 13, no. 10 (October 1997): 909–13.
    Link to Item
  - Khadour, F. H., R. H. Kao, S. Park, P. W. Armstrong, B. J. Holycross, and R. Schulz. “Age-dependent augmentation of cardiac endothelial NOS in a genetic rat model of heart failure.” Am J Physiol 273, no. 3 Pt 2 (September 1997): H1223–30. https://doi.org/10.1152/ajpheart.1997.273.3.H1223.
    Full Text Link to Item
  - Armstrong, P. W. “Heparin in acute coronary disease--requiem for a heavyweight?” N Engl J Med 337, no. 7 (August 14, 1997): 492–94. https://doi.org/10.1056/NEJM199708143370710.
    Full Text Link to Item
  - Markel, K. “Thrombolytic therapy: time to treatment.” Cmaj 157, no. 3 (August 1, 1997): 250–51.
    Link to Item
  - Armstrong, P. W. “Carvedilol reduced death and hospitalization in congestive heart failure.” Evidence Based Medicine 2, no. 4 (July 1, 1997): 115.
  - Berkowitz, S. D., C. B. Granger, K. S. Pieper, K. L. Lee, J. M. Gore, M. Simoons, P. W. Armstrong, E. J. Topol, and R. M. Califf. “Incidence and predictors of bleeding after contemporary thrombolytic therapy for myocardial infarction. The Global Utilization of Streptokinase and Tissue Plasminogen activator for Occluded coronary arteries (GUSTO) I Investigators.” Circulation 95, no. 11 (June 3, 1997): 2508–16. https://doi.org/10.1161/01.cir.95.11.2508.
    Full Text Link to Item
  - Armstrong, P. W., M. M. Caverson, L. Adams, M. Taylor, and P. M. Olley. “Evaluation of the Heart and Stroke Foundation of Canada Research Scholarship Program: research productivity and impact.” Can J Cardiol 13, no. 5 (May 1997): 507–16.
    Link to Item
  - Tsang, T. S., R. M. Califf, A. L. Stebbins, K. L. Lee, S. Cho, A. M. Ross, and P. W. Armstrong. “Incidence and impact on outcome of streptokinase allergy in the GUSTO-I trial. Global Utilization of Streptokinase and t-PA in Occluded Coronary Arteries.” Am J Cardiol 79, no. 9 (May 1, 1997): 1232–35. https://doi.org/10.1016/s0002-9149(97)00087-8.
    Full Text Link to Item
  - Topol, E. J., R. M. Califf, F. Van de Werf, M. Simoons, J. Hampton, K. L. Lee, H. White, J. Simes, and P. W. Armstrong. “Perspectives on large-scale cardiovascular clinical trials for the new millennium. The Virtual Coordinating Center for Global Collaborative Cardiovascular Research (VIGOUR) Group.” Circulation 95, no. 4 (February 18, 1997): 1072–82. https://doi.org/10.1161/01.cir.95.4.1072.
    Full Text Link to Item
  - Cox, J. L., E. Lee, A. Langer, P. W. Armstrong, and C. D. Naylor. “Time to treatment with thrombolytic therapy: determinants and effect on short-term nonfatal outcomes of acute myocardial infarction. Canadian GUSTO Investigators. Global Utilization of Streptokinase and + PA for Occluded Coronary Arteries.” Cmaj 156, no. 4 (February 15, 1997): 497–505.
    Link to Item
  - Chan, S. Y., G. B. Mancini, Y. Fu, D. W. O’Brien, and P. W. Armstrong. “Novel methodology for echocardiographic quantification of cardiac shape.” Can J Cardiol 13, no. 2 (February 1997): 153–59.
    Link to Item
  - Fu, Y., D. W. O’Brien, S. Y. Chan, S. Kaufman, G. W. Moe, and P. W. Armstrong. “Does a hypertonic saline load predict fluid retention in pacing induced heart failure?” Cardiovasc Res 33, no. 1 (January 1997): 172–80. https://doi.org/10.1016/s0008-6363(96)00200-3.
    Full Text Link to Item
  - Cairns, J., P. Théroux, P. Armstrong, P. Bogaty, C. Kells, C. Thompson, and W. Warnica. “Unstable angina--report from a Canadian expert roundtable.” Can J Cardiol 12, no. 12 (December 1996): 1279–92.
    Link to Item
  - Anderson, J. L. “Non-Q wave infarction after thrombolytic therapy.” J Am Coll Cardiol 28, no. 6 (November 15, 1996): 1638–39. https://doi.org/10.1016/s0735-1097(96)90209-0.
    Full Text Link to Item
  - Ohman, E. M., P. W. Armstrong, R. H. Christenson, C. B. Granger, H. A. Katus, C. W. Hamm, M. A. O’Hanesian, et al. “Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIA Investigators.” N Engl J Med 335, no. 18 (October 31, 1996): 1333–41. https://doi.org/10.1056/NEJM199610313351801.
    Full Text Link to Item
  - Armstrong, P. W. “Evolution of the CCU from rhythm, function and protection to reperfusion and beyond: a personal journey and perspective.” Can J Cardiol 12, no. 10 (October 1996): 909–13.
    Link to Item
  - Califf, R. M., H. D. White, F. Van de Werf, Z. Sadowski, P. W. Armstrong, A. Vahanian, M. L. Simoons, R. J. Simes, K. L. Lee, and E. J. Topol. “One-year results from the Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries (GUSTO-I) trial. GUSTO-I Investigators.” Circulation 94, no. 6 (September 15, 1996): 1233–38. https://doi.org/10.1161/01.cir.94.6.1233.
    Full Text Link to Item
  - Moe, G. W., E. A. Grima, R. J. Howard, and P. W. Armstrong. “Biatrial appendage hypertrophy but not ventricular hypertrophy: a unique feature of canine pacing-induced heart failure.” J Card Fail 2, no. 2 (June 1996): 127–32. https://doi.org/10.1016/s1071-9164(96)80031-5.
    Full Text Link to Item
  - Newby, L. K., W. R. Rutsch, R. M. Califf, M. L. Simoons, P. E. Aylward, P. W. Armstrong, L. H. Woodlief, K. L. Lee, E. J. Topol, and F. Van de Werf. “Time from symptom onset to treatment and outcomes after thrombolytic therapy. GUSTO-1 Investigators.” J Am Coll Cardiol 27, no. 7 (June 1996): 1646–55. https://doi.org/10.1016/0735-1097(96)00053-8.
    Full Text Link to Item
  - Klootwijk, P., A. Langer, S. Meij, C. Green, R. F. Veldkamp, A. M. Ross, P. W. Armstrong, and M. L. Simoons. “Non-invasive prediction of reperfusion and coronary artery patency by continuous ST segment monitoring in the GUSTO-I trial.” Eur Heart J 17, no. 5 (May 1996): 689–98. https://doi.org/10.1093/oxfordjournals.eurheartj.a014935.
    Full Text Link to Item
  - Langer, A., S. G. Goodman, E. J. Topol, A. Charlesworth, A. M. Skene, R. G. Wilcox, and P. W. Armstrong. “Late assessment of thrombolytic efficacy (LATE) study: prognosis in patients with non-Q wave myocardial infarction. (LATE Study Investigators).” J Am Coll Cardiol 27, no. 6 (May 1996): 1327–32. https://doi.org/10.1016/0735-1097(96)00012-5.
    Full Text Link to Item
  - Califf, R. M., P. W. Armstrong, J. R. Carver, R. B. D’Agostino, and W. E. Strauss. “27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 5. Stratification of patients into high, medium and low risk subgroups for purposes of risk factor management.” J Am Coll Cardiol 27, no. 5 (April 1996): 1007–19. https://doi.org/10.1016/0735-1097(96)87733-3.
    Full Text Link to Item
  - Singh, N., D. Mironov, P. W. Armstrong, A. M. Ross, and A. Langer. “Heart rate variability assessment early after acute myocardial infarction. Pathophysiological and prognostic correlates. GUSTO ECG Substudy Investigators. Global Utilization of Streptokinase and TPA for Occluded Arteries.” Circulation 93, no. 7 (April 1, 1996): 1388–95. https://doi.org/10.1161/01.cir.93.7.1388.
    Full Text Link to Item
  - Moe, G. W., E. A. Grima, N. L. Wong, R. J. Howard, and P. W. Armstrong. “Plasma and cardiac tissue atrial and brain natriuretic peptides in experimental heart failure.” J Am Coll Cardiol 27, no. 3 (March 1, 1996): 720–27. https://doi.org/10.1016/0735-1097(95)00504-8.
    Full Text Link to Item
  - Armstrong, P. W. “Towards 2000 - New pathways for the clinical management of acute ischemic syndromes: Introductory editorial to symposium.” Journal of Thrombosis and Thrombolysis 3, no. 2 (January 1, 1996): 99–100. https://doi.org/10.1007/BF00132401.
    Full Text
  - Klootwijk, P., A. Langer, S. Melj, C. Green, R. F. Veldkamp, A. M. Ross, P. W. Armstrong, and L. Simoons. “Erratum: Non-invasive prediction of reperfusion and coronary artery patency by continuous ST segment monitoring in the GUSTO-I trial (European Heart Journal (1996) 17 (689-698)).” European Heart Journal 17, no. 9 (January 1, 1996): 1451.
  - Armstrong, P. W. “The 49th parallel: how much latitude?” J Am Coll Cardiol 26, no. 5 (November 1, 1995): 1123–24. https://doi.org/10.1016/0735-1097(95)00402-5.
    Full Text Link to Item
  - Barbash, G. I., J. Reiner, H. D. White, R. G. Wilcox, P. W. Armstrong, Z. Sadowski, D. Morris, P. Aylward, L. H. Woodlief, and E. J. Topol. “Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: mechanism of the "smoker's paradox" from the GUSTO-I trial, with angiographic insights. Global Utilization of Streptokinase and Tissue-Plasminogen Activator for Occluded Coronary Arteries.” J Am Coll Cardiol 26, no. 5 (November 1, 1995): 1222–29. https://doi.org/10.1016/0735-1097(95)00299-5.
    Full Text Link to Item
  - Armstrong, P. W. “Collaborative cardiovascular clinical research in Canada: coming of age.” Can J Cardiol 11, no. 8 (September 1995): 645–47.
    Link to Item
  - Price, K. M., R. Silman, P. Armstrong, and J. G. Grudzinskas. “Abnormal amniotic fetal antigen 2 concentrations in trisomy 18 and trisomy 21.” Hum Reprod 10, no. 9 (September 1995): 2438–40. https://doi.org/10.1093/oxfordjournals.humrep.a136314.
    Full Text Link to Item
  - Pilote, L., R. M. Califf, S. Sapp, D. P. Miller, D. B. Mark, W. D. Weaver, J. M. Gore, P. W. Armstrong, E. M. Ohman, and E. J. Topol. “Regional variation across the United States in the management of acute myocardial infarction. GUSTO-1 Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.” N Engl J Med 333, no. 9 (August 31, 1995): 565–72. https://doi.org/10.1056/NEJM199508313330907.
    Full Text Link to Item
  - Van de Werf, F., R. M. Califf, P. W. Armstrong, E. R. Bates, A. M. Ross, N. S. Kleinman, and E. J. Topol. “Progress culminating from ten years of clinical trials on thrombolysis for acute myocardial infarction. GUSTO-I Steering Committee. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.” Eur Heart J 16, no. 8 (August 1995): 1024–26. https://doi.org/10.1093/oxfordjournals.eurheartj.a061042.
    Full Text Link to Item
  - Moe, G. W., R. J. Howard, E. A. Grima, and P. W. Armstrong. “How does intermittent pacing modify the response to rapid ventricular pacing in experimental heart failure?” J Card Fail 1, no. 3 (June 1995): 223–28. https://doi.org/10.1016/1071-9164(95)90028-4.
    Full Text Link to Item
  - Naylor, C. D., and P. W. Armstrong. “From thrombolytic megatrials to clinical policy-making: facing the facts.” Can J Cardiol 11, no. 6 (June 1995): 472–76.
    Link to Item
  - Langer, A., M. W. Krucoff, P. Klootwijk, R. Veldkamp, M. L. Simoons, C. Granger, R. M. Califf, and P. W. Armstrong. “Noninvasive assessment of speed and stability of infarct-related artery reperfusion: results of the GUSTO ST segment monitoring study. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.” J Am Coll Cardiol 25, no. 7 (June 1995): 1552–57. https://doi.org/10.1016/0735-1097(95)00110-p.
    Full Text Link to Item
  - Pilote, L., C. Granger, P. W. Armstrong, D. B. Mark, and M. A. Hlatky. “Differences in the treatment of myocardial infarction between the United States and Canada. A survey of physicians in the GUSTO trial.” Med Care 33, no. 6 (June 1995): 598–610. https://doi.org/10.1097/00005650-199506000-00003.
    Full Text Link to Item
  - Mark, D. B., M. A. Hlatky, R. M. Califf, C. D. Naylor, K. L. Lee, P. W. Armstrong, G. Barbash, H. White, M. L. Simoons, and C. L. Nelson. “Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction.” N Engl J Med 332, no. 21 (May 25, 1995): 1418–24. https://doi.org/10.1056/NEJM199505253322106.
    Full Text Link to Item
  - Van de Werf, F., E. J. Topol, K. L. Lee, L. H. Woodlief, C. B. Granger, P. W. Armstrong, G. I. Barbash, J. R. Hampton, A. Guerci, and R. J. Simes. “Variations in patient management and outcomes for acute myocardial infarction in the United States and other countries. Results from the GUSTO trial. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.” Jama 273, no. 20 (May 24, 1995): 1586–91. https://doi.org/10.1001/jama.273.20.1586.
    Full Text Link to Item
  - Legault, S. E., A. Langer, P. W. Armstrong, and M. R. Freeman. “Usefulness of ischemic response to mental stress in predicting silent myocardial ischemia during ambulatory monitoring.” Am J Cardiol 75, no. 15 (May 15, 1995): 1007–11. https://doi.org/10.1016/s0002-9149(99)80713-9.
    Full Text Link to Item
  - Price, K. M., R. Silman, P. Armstrong, B. Teisner, and J. G. Grudzinskas. “The typing of fetal antigen 2 in human amniotic fluid.” Clin Chim Acta 236, no. 2 (May 15, 1995): 181–94. https://doi.org/10.1016/0009-8981(95)06052-f.
    Full Text Link to Item
  - Cairns, J., P. W. Armstrong, I. Belenkie, J. Hirsh, D. E. Johnstone, M. Knudtson, M. Lemieux, D. Massel, C. D. Naylor, and L. Roy. “Maximizing the benefits of thrombolytic therapy for acute myocardial infarction.” Cmaj 152, no. 6 (March 15, 1995): 819–22.
    Link to Item
  - Husain, M., P. W. Armstrong, P. W. Connelly, and R. A. Hegele. “Lipoprotein(a) and apolipoproteins B and A-I after acute myocardial infarction.” Can J Cardiol 11, no. 3 (March 1995): 206–10.
    Link to Item
  - Langer, A., M. R. Freeman, R. G. Josse, and P. W. Armstrong. “Metaiodobenzylguanidine imaging in diabetes mellitus: assessment of cardiac sympathetic denervation and its relation to autonomic dysfunction and silent myocardial ischemia.” J Am Coll Cardiol 25, no. 3 (March 1, 1995): 610–18. https://doi.org/10.1016/0735-1097(94)00459-4.
    Full Text Link to Item
  - Legault, S. E., M. R. Freeman, A. Langer, and P. W. Armstrong. “Pathophysiology and time course of silent myocardial ischaemia during mental stress: clinical, anatomical, and physiological correlates.” Br Heart J 73, no. 3 (March 1995): 242–49. https://doi.org/10.1136/hrt.73.3.242.
    Full Text Link to Item
  - Doherty, N. “Quality of life after myocardial infarction: Canada versus the United States.” N Engl J Med 332, no. 7 (February 16, 1995): 469.
    Link to Item
  - Armstrong, P. W., and C. D. Furberg. “Clinical trial Data and Safety Monitoring Boards. The search for a constitution.” Circulation 91, no. 3 (February 1, 1995): 901–4. https://doi.org/10.1161/01.cir.91.3.901.
    Full Text Link to Item
  - Langer, A., N. Singh, M. R. Freeman, R. Tibshirani, and P. W. Armstrong. “Detection of silent ischemia adds to the prognostic value of coronary anatomy and left ventricular function in predicting outcome in unstable angina patients.” Can J Cardiol 11, no. 2 (February 1995): 117–22.
    Link to Item
  - Armstrong, P. “Inhalation injury.” Topics in Emergency Medicine 17, no. 1 (January 1, 1995): 25–34.
  - Hegele, R. A., P. W. Connelly, P. W. Armstrong, and A. Langer. “Lipoprotein(a) and silent myocardial ischemia in IDDM.” Diabetes Care 17, no. 11 (November 1994): 1365–67. https://doi.org/10.2337/diacare.17.11.1365.
    Full Text Link to Item
  - Morgan, C. D., M. Gent, P. A. Daly, R. S. Baigrie, A. Haq, R. S. Roberts, and P. W. Armstrong. “Graded exercise testing following thrombolytic therapy for acute myocardial infarction: the importance of timing and infarct location. TPAT Study Group.” Can J Cardiol 10, no. 9 (November 1994): 897–904.
    Link to Item
  - Natarajan, M. K., T. A. Salerno, B. Burke, B. Chiu, and P. W. Armstrong. “Chronic false aneurysms of the left ventricle: management revisited.” Can J Cardiol 10, no. 9 (November 1994): 927–31.
    Link to Item
  - Mark, D. B., C. D. Naylor, M. A. Hlatky, R. M. Califf, E. J. Topol, C. B. Granger, J. D. Knight, C. L. Nelson, K. L. Lee, and N. E. Clapp-Channing. “Use of medical resources and quality of life after acute myocardial infarction in Canada and the United States.” N Engl J Med 331, no. 17 (October 27, 1994): 1130–35. https://doi.org/10.1056/NEJM199410273311706.
    Full Text Link to Item
  - Larosa, G., P. W. Armstrong, and C. Forster. “Endothelium-dependent relaxations in canine coronary arteries are enhanced in early heart failure and persist in recovery.” Can J Physiol Pharmacol 72, no. 10 (October 1994): 1148–54. https://doi.org/10.1139/y94-162.
    Full Text Link to Item
  - Strauss, B. H., R. J. Chisholm, F. W. Keeley, A. I. Gotlieb, R. A. Logan, and P. W. Armstrong. “Extracellular matrix remodeling after balloon angioplasty injury in a rabbit model of restenosis.” Circ Res 75, no. 4 (October 1994): 650–58. https://doi.org/10.1161/01.res.75.4.650.
    Full Text Link to Item
  - McGlynn, E. A., C. D. Naylor, G. M. Anderson, L. L. Leape, R. E. Park, L. H. Hilborne, S. J. Bernstein, B. S. Goldman, P. W. Armstrong, and J. W. Keesey. “Comparison of the appropriateness of coronary angiography and coronary artery bypass graft surgery between Canada and New York State.” Jama 272, no. 12 (September 28, 1994): 934–40.
    Link to Item
  - O’Brien, P. J., G. W. Moe, L. M. Nowack, E. A. Grima, and P. W. Armstrong. “Sarcoplasmic reticulum Ca-release channel and ATP-synthesis activities are early myocardial markers of heart failure produced by rapid ventricular pacing in dogs.” Can J Physiol Pharmacol 72, no. 9 (September 1994): 999–1006. https://doi.org/10.1139/y94-139.
    Full Text Link to Item
  - Dorian, P., A. Langer, C. Morgan, L. Casella, L. Harris, and P. Armstrong. “Importance of ST-segment depression as a determinant of ventricular premature complex frequency after thrombolysis for acute myocardial infarction. Tissue Plasminogen Activator: Toronto (TPAT) Study Group.” Am J Cardiol 74, no. 5 (September 1, 1994): 419–23. https://doi.org/10.1016/0002-9149(94)90895-8.
    Full Text Link to Item
  - Grudzinskas, J. G., M. Palomino, P. Armstrong, and A. Lower. “Relocation of ectopic pregnancy to the uterine cavity: a dream or a reality?” Br J Obstet Gynaecol 101, no. 8 (August 1994): 651–53. https://doi.org/10.1111/j.1471-0528.1994.tb13176.x.
    Full Text Link to Item
  - Steinberg, J. S., J. S. Hochman, C. D. Morgan, P. Dorian, C. D. Naylor, P. Theroux, E. J. Topol, and P. W. Armstrong. “Effects of thrombolytic therapy administered 6 to 24 hours after myocardial infarction on the signal-averaged ECG. Results of a multicenter randomized trial. LATE Ancillary Study Investigators. Late Assessment of Thrombolytic Efficacy.” Circulation 90, no. 2 (August 1994): 746–52. https://doi.org/10.1161/01.cir.90.2.746.
    Full Text Link to Item
  - Freeman, M. R., L. de Yang, A. Langer, B. Foley, and P. W. Armstrong. “Frequency of transient reductions in left ventricular ejection fraction at rest in coronary artery disease.” Am J Cardiol 74, no. 2 (July 15, 1994): 137–43. https://doi.org/10.1016/0002-9149(94)90086-8.
    Full Text Link to Item
  - Tu, J. V., C. D. Mazer, C. Levinton, P. W. Armstrong, and C. D. Naylor. “A predictive index for length of stay in the intensive care unit following cardiac surgery.” Cmaj 151, no. 2 (July 15, 1994): 177–85.
    Link to Item
  - Cairns, J., P. Armstrong, I. Belenkie, J. Hirsh, D. Johnstone, M. Knudtson, M. Lemieux, D. Massel, D. Naylor, and L. Roy. “Canadian Consensus Conference on Coronary Thrombolysis--1994 update.” Can J Cardiol 10, no. 5 (June 1994): 517–21.
    Link to Item
  - Simmons, W. W., M. R. Freeman, E. A. Grima, T. W. Hsia, and P. W. Armstrong. “Abnormalities of cardiac sympathetic function in pacing-induced heart failure as assessed by [123I]metaiodobenzylguanidine scintigraphy.” Circulation 89, no. 6 (June 1994): 2843–51. https://doi.org/10.1161/01.cir.89.6.2843.
    Full Text Link to Item
  - Goodman, S. G., M. R. Freeman, P. W. Armstrong, and A. Langer. “Does ambulatory monitoring contribute to exercise testing and myocardial perfusion scintigraphy in the prediction of the extent of coronary artery disease in stable angina?” Am J Cardiol 73, no. 11 (April 15, 1994): 747–52. https://doi.org/10.1016/0002-9149(94)90875-3.
    Full Text Link to Item
  - Armstrong, P. W., G. W. Moe, R. J. Howard, E. A. Grima, and T. F. Cruz. “Structural remodelling in heart failure: gelatinase induction.” Can J Cardiol 10, no. 2 (March 1994): 214–20.
    Link to Item
  - Grima, E. A., G. W. Moe, R. J. Howard, and P. W. Armstrong. “Recovery of attenuated baroreflex sensitivity in conscious dogs after reversal of pacing induced heart failure.” Cardiovasc Res 28, no. 3 (March 1994): 384–90. https://doi.org/10.1093/cvr/28.3.384.
    Full Text Link to Item
  - Price, K. M., R. Silman, P. Armstrong, and J. G. Grudzinskas. “Development of a radioimmunoassay for fetal antigen 2.” Clin Chim Acta 224, no. 1 (January 14, 1994): 95–102. https://doi.org/10.1016/0009-8981(94)90125-2.
    Full Text Link to Item
  - Forster, C., G. Naik, and P. W. Armstrong. “Noradrenaline biosynthesis and metabolism during development and recovery from pacing-induced heart failure in the dog.” Can J Physiol Pharmacol 72, no. 1 (January 1994): 45–49. https://doi.org/10.1139/y94-008.
    Full Text Link to Item
  - Moe, G. W., E. A. Grima, R. J. Howard, R. Seth, and P. W. Armstrong. “Left ventricular remodelling and disparate changes in contractility and relaxation during the development of and recovery from experimental heart failure.” Cardiovasc Res 28, no. 1 (January 1994): 66–71. https://doi.org/10.1093/cvr/28.1.66.
    Full Text Link to Item
  - Simmons, W. W., G. W. Moe, E. A. Grima, R. J. Howard, and P. W. Armstrong. “Myocardial energetics and blood flow in acute rapid ventricular pacing.” Can J Physiol Pharmacol 72, no. 1 (January 1994): 6–10. https://doi.org/10.1139/y94-002.
    Full Text Link to Item
  - Naik, G. O., C. Forster, and P. W. Armstrong. “Measurement of angiotensin II: use of two injectors to minimize HPLC shadowing.” Peptides 15, no. 7 (1994): 1255–59. https://doi.org/10.1016/0196-9781(94)90150-3.
    Full Text Link to Item
  - Armstrong, P. W., and G. W. Moe. “Medical advances in the treatment of congestive heart failure.” Circulation 88, no. 6 (December 1993): 2941–52. https://doi.org/10.1161/01.cir.88.6.2941.
    Full Text Link to Item
  - Armstrong, P. W. “Progressive left ventricular dysfunction and remodeling after myocardial infarction.” Circulation 88, no. 3 (September 1993): 1355.
    Link to Item
  - Moe, G. W., E. A. Grima, N. L. Wong, R. J. Howard, and P. W. Armstrong. “Dual natriuretic peptide system in experimental heart failure.” J Am Coll Cardiol 22, no. 3 (September 1993): 891–98. https://doi.org/10.1016/0735-1097(93)90208-i.
    Full Text Link to Item
  - Haq, A., C. D. Morgan, R. F. Wilson, P. A. Daly, R. S. Baigrie, C. W. White, R. Roberts, M. Gent, and P. W. Armstrong. “Impact of tissue plasminogen activator and heparin versus heparin alone on quantitative coronary angiographic findings in myocardial infarction. The Toronto Tissue Plasminogen Activator Trial Study Group.” Am J Cardiol 72, no. 5 (August 15, 1993): 379–83. https://doi.org/10.1016/0002-9149(93)91126-3.
    Full Text Link to Item
  - Di Lorenzo, M., P. Salvini, M. Levi Della Vida, and E. Maddaloni. “Acute reduction of lipoprotein(a) by tissue-type plasminogen activator.” Circulation 87, no. 3 (March 1993): 1052–53.
    Link to Item
  - Larosa, G., P. W. Armstrong, P. Seeman, and C. Forster. “Beta adrenoceptor recovery after heart failure in the dog.” Cardiovasc Res 27, no. 3 (March 1993): 489–93. https://doi.org/10.1093/cvr/27.3.489.
    Full Text Link to Item
  - Moe, G. W., C. Montgomery, R. J. Howard, E. A. Grima, and P. W. Armstrong. “Left ventricular myocardial blood flow, metabolism, and effects of treatment with enalapril: further insights into the mechanisms of canine experimental pacing-induced heart failure.” J Lab Clin Med 121, no. 2 (February 1993): 294–301.
    Link to Item
  - Armstrong, P. W. “Plasma endothelin in chronic heart failure.” Circulation 87, no. 2 (February 1993): 656.
    Link to Item
  - Krucoff, M. W., C. L. Green, A. Langer, L. J. Klootwijk, K. M. Trollinger, S. T. Sawchak, N. M. Wilderman, R. F. Veldkamp, J. E. Pope, and M. L. Simoons. “Global utilization of streptokinase and tPA for occluded arteries (GUSTO) ECG-monitoring substudy. Study design and technical considerations.” J Electrocardiol 26 Suppl (1993): 249–55.
    Link to Item
  - Simmons, W. W., and P. W. Armstrong. “Thrombolytic therapy in acute myocardial infarction.” Current Opinion in Cardiology 8, no. 4 (January 1, 1993): 604–12. https://doi.org/10.1097/00001573-199307000-00008.
    Full Text
  - Langer, A., J. Minkowitz, P. Dorian, L. Casella, L. Harris, C. D. Morgan, and P. W. Armstrong. “Pathophysiology and prognostic significance of Holter-detected ST segment depression after myocardial infarction. The Tissue Plasminogen Activator: Toronto (TPAT) Study Group.” J Am Coll Cardiol 20, no. 6 (November 15, 1992): 1313–17. https://doi.org/10.1016/0735-1097(92)90242-f.
    Full Text Link to Item
  - Foley, J. B., R. J. Chisholm, A. A. Common, A. Langer, and P. W. Armstrong. “Aggressive clinical pattern of angina at restenosis following coronary angioplasty in unstable angina.” Am Heart J 124, no. 5 (November 1992): 1174–80. https://doi.org/10.1016/0002-8703(92)90397-e.
    Full Text Link to Item
  - Forster, C., G. Larosa, and P. W. Armstrong. “Impact of enalapril therapy on in vitro coronary artery responsiveness in pacing-induced heart failure.” Can J Physiol Pharmacol 70, no. 10 (October 1992): 1417–22. https://doi.org/10.1139/y92-199.
    Full Text Link to Item
  - Langer, A., R. J. Burns, M. R. Freeman, P. Liu, C. D. Morgan, R. Wilson, and P. W. Armstrong. “Reverse redistribution on exercise thallium scintigraphy: relationship to coronary patency and ventricular function after myocardial infarction.” Can J Cardiol 8, no. 7 (September 1992): 709–15.
    Link to Item
  - Forster, C., P. M. Campbell, and P. W. Armstrong. “Temporal alterations in peripheral vascular responsiveness during both the development and recovery from pacing-induced heart failure.” J Cardiovasc Pharmacol 20, no. 2 (August 1992): 206–15. https://doi.org/10.1097/00005344-199208000-00005.
    Full Text Link to Item
  - O’Brien, P. J., M. O’Grady, L. J. McCutcheon, H. Shen, L. Nowack, R. D. Horne, S. M. Mirsalimi, R. J. Julian, E. A. Grima, and G. W. Moe. “Myocardial myoglobin deficiency in various animal models of congestive heart failure.” J Mol Cell Cardiol 24, no. 7 (July 1992): 721–30. https://doi.org/10.1016/0022-2828(92)93386-x.
    Full Text Link to Item
  - Weber, K. T., P. Anversa, P. W. Armstrong, C. G. Brilla, J. C. Burnett, J. M. Cruickshank, R. B. Devereux, T. D. Giles, N. Korsgaard, and C. V. Leier. “Remodeling and reparation of the cardiovascular system.” J Am Coll Cardiol 20, no. 1 (July 1992): 3–16. https://doi.org/10.1016/0735-1097(92)90130-f.
    Full Text Link to Item
  - Hegele, R. A., M. R. Freeman, A. Langer, P. W. Connelly, and P. W. Armstrong. “Acute reduction of lipoprotein(a) by tissue-type plasminogen activator.” Circulation 85, no. 6 (June 1992): 2034–38. https://doi.org/10.1161/01.cir.85.6.2034.
    Full Text Link to Item
  - Legault, S. E., R. T. Joffe, and P. W. Armstrong. “Psychiatric morbidity during the early phase of coronary care for myocardial infarction: association with cardiac diagnosis and outcome.” Can J Psychiatry 37, no. 5 (June 1992): 316–25. https://doi.org/10.1177/070674379203700505.
    Full Text Link to Item
  - Kalbfleisch, J., U. Thadani, J. K. LittleJohn, G. Brown, R. Magorien, M. Kutcher, G. Taylor, W. T. Maddox, W. B. Campbell, and J. Perry. “Evaluation of a prolonged infusion of recombinant tissue-type plasminogen activator (Duteplase) in preventing reocclusion following successful thrombolysis in acute myocardial infarction.” Am J Cardiol 69, no. 14 (May 1, 1992): 1120–27. https://doi.org/10.1016/0002-9149(92)90923-m.
    Full Text Link to Item
  - Moe, G. W., R. Canepa-Anson, and P. W. Armstrong. “Atrial natriuretic factor: pharmacokinetics and cyclic GMP response in relation to biologic effects in severe heart failure.” J Cardiovasc Pharmacol 19, no. 5 (May 1992): 691–700.
    Link to Item
  - Armstrong, P. W., M. R. Freeman, and A. Langer. “Thrombolytic therapy and unstable angina.” Circulation 85, no. 5 (May 1992): 1952.
    Link to Item
  - Topol, E. J., P. Armstrong, F. Van de Werf, N. Kleiman, K. Lee, D. Morris, M. Simoons, et al. “Confronting the issues of patient safety and investigator conflict of interest in an international clinical trial of myocardial reperfusion.” Journal of the American College of Cardiology 19, no. 6 (May 1, 1992): 1123–28.
  - Moe, G. W., C. Angus, R. J. Howard, T. G. Parker, and P. W. Armstrong. “Evaluation of indices of left ventricular contractility and relaxation in evolving canine experimental heart failure.” Cardiovasc Res 26, no. 4 (April 1992): 362–66. https://doi.org/10.1093/cvr/26.4.362.
    Full Text Link to Item
  - Freeman, M. R., A. Langer, R. F. Wilson, C. D. Morgan, and P. W. Armstrong. “Thrombolysis in unstable angina. Randomized double-blind trial of t-PA and placebo.” Circulation 85, no. 1 (January 1992): 150–57. https://doi.org/10.1161/01.cir.85.1.150.
    Full Text Link to Item
  - Freeman, M. R., A. Langer, and P. W. Armstrong. “Will thrombolytic therapy prevent cardiac events in unstable angina?” Cardiology Board Review 9, no. 9 (January 1, 1992): 57-58+65.
  - Naylor, C. D., and P. W. Armstrong. “Cardiogenic shock after acute myocardial infarction.” Annals of Internal Medicine 116, no. SUPPL. 2 (January 1, 1992): 58.
  - Watson, K. R., R. J. Chisholm, J. R. Azpiri, and P. W. Armstrong. “Elevated left atrial pressure does not cause left-to-right shunting after mitral balloon valvuloplasty.” Cathet Cardiovasc Diagn 24, no. 3 (November 1991): 173–75. https://doi.org/10.1002/ccd.1810240306.
    Full Text Link to Item
  - Forster, C., D. Wanes, and P. W. Armstrong. “Novel vascular effects of isoprenaline following pacing-induced heart failure in the dog.” Eur J Pharmacol 200, no. 2–3 (August 6, 1991): 251–57. https://doi.org/10.1016/0014-2999(91)90579-f.
    Full Text Link to Item
  - Azpiri, J. R., R. J. Chisholm, K. R. Watson, and P. W. Armstrong. “Effects of hemoperfusion during percutaneous transluminal coronary angioplasty on left ventricular function.” Am J Cardiol 67, no. 16 (June 15, 1991): 1324–29. https://doi.org/10.1016/0002-9149(91)90459-x.
    Full Text Link to Item
  - Howard, R. J., G. W. Moe, and P. W. Armstrong. “Sequential echocardiographic-Doppler assessment of left ventricular remodelling and mitral regurgitation during evolving experimental heart failure.” Cardiovasc Res 25, no. 6 (June 1991): 468–74. https://doi.org/10.1093/cvr/25.6.468.
    Full Text Link to Item
  - Moe, G. W., R. Canepa-Anson, R. J. Howard, and P. W. Armstrong. “Sequential changes in atrial pressures, dimensions, and plasma atrial natriuretic factor concentrations during volume loading in hemodynamically normal human subjects.” J Lab Clin Med 117, no. 6 (June 1991): 528–34.
    Link to Item
  - Morgan, C. D., R. S. Roberts, A. Haq, R. S. Baigrie, P. A. Daly, M. Gent, and P. W. Armstrong. “Coronary patency, infarct size and left ventricular function after thrombolytic therapy for acute myocardial infarction: results from the tissue plasminogen activator: Toronto (TPAT) placebo-controlled trial. TPAT Study Group.” J Am Coll Cardiol 17, no. 7 (June 1991): 1451–57. https://doi.org/10.1016/0735-1097(91)90630-r.
    Full Text Link to Item
  - Langer, A., M. R. Freeman, R. G. Josse, G. Steiner, and P. W. Armstrong. “Detection of silent myocardial ischemia in diabetes mellitus.” Am J Cardiol 67, no. 13 (May 15, 1991): 1073–78. https://doi.org/10.1016/0002-9149(91)90868-l.
    Full Text Link to Item
  - Moe, G. W., E. A. Grima, C. Angus, N. L. Wong, D. C. Hu, R. J. Howard, and P. W. Armstrong. “Response of atrial natriuretic factor to acute and chronic increases of atrial pressures in experimental heart failure in dogs. Role of changes in heart rate, atrial dimension, and cardiac tissue concentration.” Circulation 83, no. 5 (May 1991): 1780–87. https://doi.org/10.1161/01.cir.83.5.1780.
    Full Text Link to Item
  - Fallen, E. L., P. Armstrong, J. Cairns, W. Dafoe, N. Frasure-Smith, A. Langer, D. Massel, N. Oldridge, D. Peretz, and G. J. Tremblay. “Report of the Canadian Cardiovascular Society's consensus conference on the Management of the Postmyocardial Infarction Patient.” Cmaj 144, no. 8 (April 15, 1991): 1015–25.
    Link to Item
  - Brennan, F. J., J. F. Brien, and P. W. Armstrong. “Plasma concentration time course and pharmacological effects of a standardized oral amiodarone dosing regimen in humans.” Can J Cardiol 7, no. 3 (April 1991): 117–24.
    Link to Item
  - Main, J. S., C. Forster, and P. W. Armstrong. “Inhibitory role of the coronary arterial endothelium to alpha-adrenergic stimulation in experimental heart failure.” Circ Res 68, no. 4 (April 1991): 940–46. https://doi.org/10.1161/01.res.68.4.940.
    Full Text Link to Item
  - O’Brien, P. J., H. Shen, J. Weiler, C. D. Ianuzzo, C. Wittnich, G. W. Moe, and P. W. Armstrong. “Cardiac and muscle fatigue due to relative functional overload induced by excessive stimulation, hypersensitive excitation-contraction coupling, or diminished performance capacity correlates with sarcoplasmic reticulum failure.” Can J Physiol Pharmacol 69, no. 2 (February 1991): 262–68. https://doi.org/10.1139/y91-040.
    Full Text Link to Item
  - Gotlieb, A. I., M. R. Freeman, T. A. Salerno, S. V. Lichtenstein, and P. W. Armstrong. “Ultrastructural studies of unstable angina in living man.” Mod Pathol 4, no. 1 (January 1991): 75–80.
    Link to Item
  - Freeman, M. R., A. Langer, N. Kanwar, M. Morrison, and P. W. Armstrong. “Quantitative analysis of exercise SPECT thallium in the detection of coronary disease.” American Journal of Cardiac Imaging 4, no. 4 (December 1, 1990): 231–38.
  - Langer, A., M. R. Freeman, and P. W. Armstrong. “Relation of angiographic detected intracoronary thrombus and silent myocardial ischemia in unstable angina pectoris.” Am J Cardiol 66, no. 19 (December 1, 1990): 1381–82. https://doi.org/10.1016/0002-9149(90)91175-6.
    Full Text Link to Item
  - Forster, C., and P. W. Armstrong. “Pacing-induced heart failure in the dog: evaluation of peripheral vascular alpha-adrenoceptor subtypes.” J Cardiovasc Pharmacol 16, no. 5 (November 1990): 708–18. https://doi.org/10.1097/00005344-199011000-00004.
    Full Text Link to Item
  - Marmur, J. D., M. R. Freeman, A. Langer, and P. W. Armstrong. “Prognosis in medically stabilized unstable angina: early Holter ST-segment monitoring compared with predischarge exercise thallium tomography.” Ann Intern Med 113, no. 8 (October 15, 1990): 575–79. https://doi.org/10.7326/0003-4819-113-8-575.
    Full Text Link to Item
  - Merritt, J. E., W. P. Armstrong, C. D. Benham, T. J. Hallam, R. Jacob, A. Jaxa-Chamiec, B. K. Leigh, S. A. McCarthy, K. E. Moores, and T. J. Rink. “SK&F 96365, a novel inhibitor of receptor-mediated calcium entry.” Biochem J 271, no. 2 (October 15, 1990): 515–22. https://doi.org/10.1042/bj2710515.
    Full Text Link to Item
  - Weber, K. T., R. Pick, M. A. Silver, G. W. Moe, J. S. Janicki, I. H. Zucker, and P. W. Armstrong. “Fibrillar collagen and remodeling of dilated canine left ventricle.” Circulation 82, no. 4 (October 1990): 1387–1401. https://doi.org/10.1161/01.cir.82.4.1387.
    Full Text Link to Item
  - Forster, C., J. S. Main, and P. W. Armstrong. “Endothelium modulation of the effects of nitroglycerin on blood vessels from dogs with pacing-induced heart failure.” Br J Pharmacol 101, no. 1 (September 1990): 109–14. https://doi.org/10.1111/j.1476-5381.1990.tb12098.x.
    Full Text Link to Item
  - Moe, G. W., R. Canepa-Anson, R. J. Howard, and P. W. Armstrong. “Response of atrial natriuretic factor to postural change in patients with heart failure versus subjects with normal hemodynamics.” J Am Coll Cardiol 16, no. 3 (September 1990): 599–606. https://doi.org/10.1016/0735-1097(90)90349-t.
    Full Text Link to Item
  - Moe, G. W., C. Angus, R. J. Howard, A. J. De Bold, and P. W. Armstrong. “Pathophysiological role of changing atrial size and pressure in modulation of atrial natriuretic factor during evolving experimental heart failure.” Cardiovasc Res 24, no. 7 (July 1990): 570–77. https://doi.org/10.1093/cvr/24.7.570.
    Full Text Link to Item
  - Moe, G. W., C. Forster, A. J. de Bold, and P. W. Armstrong. “Pharmacokinetics, hemodynamic, renal, and neurohormonal effects of atrial natriuretic factor in experimental heart failure.” Clin Invest Med 13, no. 3 (June 1990): 111–18.
    Link to Item
  - Howard, R. J., T. P. Stopps, G. W. Moe, and P. W. Armstrong. “A new method for hemodynamic and echocardiographic assessment of conscious dogs: comparison with thiopental-morphine anaesthesia.” Clin Invest Med 13, no. 1 (February 1990): 6–10.
    Link to Item
  - Howson, W., W. Armstrong, K. Cassidy, R. Novelli, M. Tchorzewska, A. Jaxa-Chamiec, R. Dolle, et al. “Design and synthesis of a series of glycerol-derived receptor mediated calcium entry (RMCE) blockers.” European Journal of Medicinal Chemistry 25, no. 7 (January 1, 1990): 595–602. https://doi.org/10.1016/0223-5234(90)90184-5.
    Full Text
  - Langer, A., M. R. Freeman, and P. W. Armstrong. “Prognostic importance of ST-segment shift in hospitalized unstable angina patients.” Cardiology Board Review 7, no. 10 (January 1, 1990): 65-68+73.
  - O’Brien, P. J., C. D. Ianuzzo, G. W. Moe, T. P. Stopps, and P. W. Armstrong. “Rapid ventricular pacing of dogs to heart failure: biochemical and physiological studies.” Can J Physiol Pharmacol 68, no. 1 (January 1990): 34–39. https://doi.org/10.1139/y90-004.
    Full Text Link to Item
  - Biem, H. J., A. S. Detsky, and P. W. Armstrong. “Management of asymptomatic chronic aortic regurgitation with left ventricular dysfunction: a decision analysis.” J Gen Intern Med 5, no. 5 (1990): 394–401. https://doi.org/10.1007/BF02599423.
    Full Text Link to Item
  - Brien, J. F., S. Jimmo, F. J. Brennan, P. W. Armstrong, and H. Abdollah. “Disposition of amiodarone and its proximate metabolite, desethylamiodarone, in the dog for oral administration of single-dose and short-term drug regimens.” Drug Metab Dispos 18, no. 6 (1990): 846–51.
    Link to Item
  - Floras, J. S., C. D. Naylor, and P. W. Armstrong. “Coronary revascularization after thrombolytic therapy for myocardial infarction: what caseloads could Canadian centres face?” Cmaj 141, no. 8 (October 15, 1989): 783–90.
    Link to Item
  - Armstrong, P. W., R. J. Howard, and G. W. Moe. “Clinical lessons learned from experimental heart failure.” Int J Cardiol 24, no. 2 (August 1989): 133–36. https://doi.org/10.1016/0167-5273(89)90296-9.
    Full Text Link to Item
  - Armstrong, P. W., and M. R. Freeman. “Reply.” The American Journal of Cardiology 64, no. 3 (July 15, 1989): 256. https://doi.org/10.1016/0002-9149(89)90475-X.
    Full Text
  - Freeman, M. R., A. E. Williams, R. J. Chisholm, and P. W. Armstrong. “Intracoronary thrombus and complex morphology in unstable angina. Relation to timing of angiography and in-hospital cardiac events.” Circulation 80, no. 1 (July 1989): 17–23. https://doi.org/10.1161/01.cir.80.1.17.
    Full Text Link to Item
  - Forster, C., S. Carter, and P. Armstrong. “Vascular smooth muscle responsiveness to noradrenaline and phenylephrine following experimental heart failure in dogs.” Cardiovasc Res 23, no. 6 (June 1989): 489–97. https://doi.org/10.1093/cvr/23.6.489.
    Full Text Link to Item
  - Langer, A., M. R. Freeman, and P. W. Armstrong. “ST segment shift in unstable angina: pathophysiology and association with coronary anatomy and hospital outcome.” J Am Coll Cardiol 13, no. 7 (June 1989): 1495–1502. https://doi.org/10.1016/0735-1097(89)90338-0.
    Full Text Link to Item
  - Naylor, C. D., and P. W. Armstrong. “Guidelines for the use of intravenous thrombolytic agents in acute myocardial infarction. Ontario Medical Association Consensus Group on Thrombolytic Therapy.” Cmaj 140, no. 11 (June 1, 1989): 1289–99.
    Link to Item
  - Armstrong, P. W., R. S. Baigrie, P. A. Daly, A. Haq, M. Gent, R. S. Roberts, M. R. Freeman, R. Burns, P. Liu, and C. D. Morgan. “Tissue plasminogen activator: Toronto (TPAT) placebo-controlled randomized trial in acute myocardial infarction.” J Am Coll Cardiol 13, no. 7 (June 1989): 1469–76. https://doi.org/10.1016/0735-1097(89)90334-3.
    Full Text Link to Item
  - Forster, C., S. L. Carter, and P. W. Armstrong. “Alpha 1-adrenoceptor activity in arterial smooth muscle following congestive heart failure.” Can J Physiol Pharmacol 67, no. 2 (February 1989): 110–15. https://doi.org/10.1139/y89-019.
    Full Text Link to Item
  - Freeman, M. R., A. E. Williams, R. J. Chisholm, N. L. Patt, N. D. Greyson, and P. W. Armstrong. “Role of resting thallium201 perfusion in predicting coronary anatomy, left ventricular wall motion, and hospital outcome in unstable angina pectoris.” Am Heart J 117, no. 2 (February 1989): 306–14. https://doi.org/10.1016/0002-8703(89)90773-4.
    Full Text Link to Item
  - Freeman, M. R., N. Kanwar, and P. W. Armstrong. “Comparison of rest and exercise thallium-201 kinetics in man and implications for quantitation.” Am J Physiol Imaging 4, no. 1 (1989): 4–10.
    Link to Item
  - Moe, G. W., T. P. Stopps, C. Angus, C. Forster, A. J. De Bold, and P. W. Armstrong. “Alterations in serum sodium in relation to atrial natriuretic factor and other neuroendocrine variables in experimental pacing-induced heart failure.” J Am Coll Cardiol 13, no. 1 (January 1989): 173–79. https://doi.org/10.1016/0735-1097(89)90567-6.
    Full Text Link to Item
  - Moe, G. W., and P. W. Armstrong. “Circulatory pathophysiology of cardiac failure.” Current Opinion in Cardiology 4, no. 3 (January 1, 1989): 349–54. https://doi.org/10.1097/00001573-198906000-00003.
    Full Text
  - Freeman, M. R., R. J. Chisholm, and P. W. Armstrong. “Usefulness of exercise electrocardiography and thallium scintigraphy in unstable angina pectoris in predicting the extent and severity of coronary artery disease.” Am J Cardiol 62, no. 17 (December 1, 1988): 1164–70. https://doi.org/10.1016/0002-9149(88)90253-6.
    Full Text Link to Item
  - Howard, R. J., T. P. Stopps, G. W. Moe, A. Gotlieb, and P. W. Armstrong. “Recovery from heart failure: structural and functional analysis in a canine model.” Can J Physiol Pharmacol 66, no. 12 (December 1988): 1505–12. https://doi.org/10.1139/y88-246.
    Full Text Link to Item
  - Moe, G. W., C. Forster, A. J. de Bold, and P. W. Armstrong. “Physiological effects of synthetic atrial natriuretic factor in normal conscious dogs.” Clin Invest Med 11, no. 6 (December 1988): 417–24.
    Link to Item
  - Williams, A. E., M. R. Freeman, R. J. Chisholm, N. L. Patt, and P. W. Armstrong. “Angiographic morphology in unstable angina pectoris.” Am J Cardiol 62, no. 16 (November 15, 1988): 1024–27. https://doi.org/10.1016/0002-9149(88)90541-3.
    Full Text Link to Item
  - Moe, G. W., T. P. Stopps, R. J. Howard, and P. W. Armstrong. “Early recovery from heart failure: insights into the pathogenesis of experimental chronic pacing-induced heart failure.” J Lab Clin Med 112, no. 4 (October 1988): 426–32.
    Link to Item
  - Moe, G. W., S. J. Karlinsky, D. Frankel, and P. W. Armstrong. “Intravenous nisoldipine in severe congestive heart failure.” J Cardiovasc Pharmacol 12, no. 2 (August 1988): 160–66. https://doi.org/10.1097/00005344-198808000-00006.
    Full Text Link to Item
  - Siminoski, K., C. Lukinuk, and P. W. Armstrong. “Treatment of postural hypotension with aerosol ergotamine.” Cmaj 139, no. 1 (July 1, 1988): 51–52.
    Link to Item
  - Moe, G. W., and P. W. Armstrong. “Congestive heart failure.” Cmaj 138, no. 8 (April 15, 1988): 689–94.
    Link to Item
  - Armstrong, P. W., L. M. Langevin, and D. G. Watts. “Randomized trial of prostacyclin infusion in acute myocardial infarction.” Am J Cardiol 61, no. 6 (February 15, 1988): 455–57. https://doi.org/10.1016/0002-9149(88)90303-7.
    Full Text Link to Item
  - Armstrong, P., A. Silver, A. Dawnay, J. G. Grudzinskas, and T. Chard. “Microalbuminuria in normal pregnancy: Relation to obstetric factors.” Journal of Obstetrics and Gynaecology 9, no. 2 (January 1, 1988): 100–103. https://doi.org/10.3109/01443618809151363.
    Full Text
  - Dolle, R. E., W. P. Armstrong, A. N. Shaw, and R. Novelli. “Intramolecular [4+2] cycloaddition of α,β-unsaturated hydrazones as a route to annelated pyridines.” Tetrahedron Letters 29, no. 48 (January 1, 1988): 6349–52. https://doi.org/10.1016/S0040-4039(00)82344-8.
    Full Text
  - Hirsh, J., T. Stalker, V. Fuster, R. Hall, P. Armstrong, and D. P. Lillicra. “Symposium: Antithrombotic therapy in coronary artery disease.” Annals of the Royal College of Physicians and Surgeons of Canada 21, no. 6 (January 1, 1988): 419–20.
  - Abdollah, A., J. A. Moffat, and P. W. Armstrong. “N-acetylcysteine does not modify nitroglycerin-induced tolerance in canine vascular rings.” J Cardiovasc Pharmacol 9, no. 4 (April 1987): 445–50. https://doi.org/10.1097/00005344-198704000-00009.
    Full Text Link to Item
  - Kafka, H., L. Langevin, and P. W. Armstrong. “Serum magnesium and potassium in acute myocardial infarction. Influence on ventricular arrhythmias.” Arch Intern Med 147, no. 3 (March 1987): 465–69.
    Link to Item
  - Armstrong, P. W. “Pharmacokinetic-hemodynamic studies of transdermal nitroglycerin in congestive heart failure.” J Am Coll Cardiol 9, no. 2 (February 1987): 420–25. https://doi.org/10.1016/s0735-1097(87)80398-4.
    Full Text Link to Item
  - Lefkowitz, C. A., G. W. Moe, and P. W. Armstrong. “A comparative evaluation of hemodynamic and neurohumoral effects of nitroglycerin and nifedipine in congestive heart failure.” Am J Cardiol 59, no. 3 (January 30, 1987): 59B-63B. https://doi.org/10.1016/0002-9149(87)90083-x.
    Full Text Link to Item
  - Armstrong, P., R. Grigg, S. Surendrakumar, and W. J. Warnock. “Tandem intramolecular Michael addition and 1,3-dipolar cycloaddition reactions of oximes; versatile new carbon-carbon bond forming methodology.” Journal of the Chemical Society, Chemical Communications, no. 17 (January 1, 1987): 1327–28. https://doi.org/10.1039/C39870001327.
    Full Text
  - Armstrong, P., R. Grigg, and W. J. Warnock. “Cycloaddition reactions of oximes; powerful new carbon-carbon bond forming methodology.” Journal of the Chemical Society, Chemical Communications, no. 17 (January 1, 1987): 1325–27. https://doi.org/10.1039/C39870001325.
    Full Text
  - Brien, J. F., S. Jimmo, F. J. Brennan, S. E. Ford, and P. W. Armstrong. “Distribution of amiodarone and its metabolite, desethylamiodarone, in human tissues.” Canadian Journal of Physiology and Pharmacology 65, no. 3 (January 1, 1987): 360–64. https://doi.org/10.1139/y87-062.
    Full Text
  - Lefkowitz, C. A., G. W. Moe, and P. W. Armstrong. “Calcium antagonists: new therapy for congestive heart failure?” Chest 91, no. 1 (January 1987): 1–3. https://doi.org/10.1378/chest.91.1.1b.
    Full Text Link to Item
  - Armstrong, P. W., T. P. Stopps, S. E. Ford, and A. J. de Bold. “Rapid ventricular pacing in the dog: pathophysiologic studies of heart failure.” Circulation 74, no. 5 (November 1986): 1075–84. https://doi.org/10.1161/01.cir.74.5.1075.
    Full Text Link to Item
  - Armstrong, P. “Medical treatment of pregnancy hypertension.” Br J Hosp Med 36, no. 5 (November 1986): 347–53.
    Link to Item
  - Moe, G., and P. W. Armstrong. “Influence of skin site on bioavailability of nitroglycerin ointment in congestive heart failure.” Am J Med 81, no. 5 (November 1986): 765–70. https://doi.org/10.1016/0002-9343(86)90341-4.
    Full Text Link to Item
  - Armstrong, P. W., D. G. McMillan, and J. B. Simon. “Swallow syncope.” Can Med Assoc J 132, no. 11 (June 1, 1985): 1281–84.
    Link to Item
  - Armstrong, P., R. Grigg, M. W. Jordan, and J. F. Malone. “X=y-zh systems as potential 1,3-dipoles-5. Intramolecular cycloadditions of imines of α-amino acid esters.” Tetrahedron 41, no. 17 (January 1, 1985): 3547–58. https://doi.org/10.1016/S0040-4020(01)96708-0.
    Full Text
  - Moffat, J. A., H. Abdollah, D. Rollwage, and P. W. Armstrong. “Ethacrynic acid: acute hemodynamic effects and influence on the in vivo and in vitro response to nitroglycerin in the dog.” J Cardiovasc Pharmacol 7, no. 4 (1985): 637–42.
    Link to Item
  - Reddy, S. B., J. L. Pater, J. Pym, and P. W. Armstrong. “Hemolytic anemia following insertion of Ionescu-Shiley mitral valve bioprosthesis.” Can Med Assoc J 131, no. 12 (December 15, 1984): 1469–70.
    Link to Item
  - Finnie, K. J., D. G. Watts, and P. W. Armstrong. “Biases in the measurement of arterial pressure.” Crit Care Med 12, no. 11 (November 1984): 965–68. https://doi.org/10.1097/00003246-198411000-00009.
    Full Text Link to Item
  - Simon, J. B., P. N. Manley, J. F. Brien, and P. W. Armstrong. “Amiodarone hepatotoxicity simulating alcoholic liver disease.” N Engl J Med 311, no. 3 (July 19, 1984): 167–72. https://doi.org/10.1056/NEJM198407193110308.
    Full Text Link to Item
  - Moffat, J. A., H. Abdollah, D. G. Watts, and P. W. Armstrong. “Reproducibility of the pharmacokinetic-hemodynamic response to nitroglycerin in the dog: a model for studying the effects of chronic treatment.” J Pharmacol Methods 11, no. 1 (March 1984): 41–51. https://doi.org/10.1016/0160-5402(84)90051-2.
    Full Text Link to Item
  - Abdollah, H., J. F. Brien, and P. W. Armstrong. “Pharmacokinetic-hemodynamic studies of disopyramide.” J Cardiovasc Pharmacol 6, no. 1 (1984): 28–34.
    Link to Item
  - Bennett, B. M., D. A. Twiddy, J. A. Moffat, P. W. Armstrong, and G. S. Marks. “Sex-related difference in the metabolism of isosorbide dinitrate following incubation in human blood.” Biochem Pharmacol 32, no. 24 (December 15, 1983): 3729–34. https://doi.org/10.1016/0006-2952(83)90142-9.
    Full Text Link to Item
  - Armstrong, P. W., and J. A. Moffat. “Tolerance to organic nitrates: clinical and experimental perspectives.” Am J Med 74, no. 6B (June 27, 1983): 73–84. https://doi.org/10.1016/0002-9343(83)90857-4.
    Full Text Link to Item
  - Bennett, B. M., J. A. Moffat, P. W. Armstrong, and G. S. Marks. “Investigation of the role of prostaglandins in nitroglycerin-induced relaxation of isolated rabbit blood vessels.” Can J Physiol Pharmacol 61, no. 6 (June 1983): 554–60. https://doi.org/10.1139/y83-085.
    Full Text Link to Item
  - Brien, J. F., K. Nakatsu, and P. W. Armstrong. “Determination of disopyramide and mono-N-desisopropyl-disopyramide in serum by gas-liquid chromatography with nitrogen-selective detection.” J Pharmacol Methods 9, no. 4 (June 1983): 295–308. https://doi.org/10.1016/0160-5402(83)90069-4.
    Full Text Link to Item
  - Brien, J. F., S. Jimmo, and P. W. Armstrong. “Rapid high-performance liquid chromatographic analysis of amiodarone and N-desethyl-amiodarone in serum.” Can J Physiol Pharmacol 61, no. 3 (March 1983): 245–48. https://doi.org/10.1139/y83-038.
    Full Text Link to Item
  - Armstrong, P. W., J. A. Moffat, and G. S. Marks. “Arterial-venous nitroglycerin gradient during intravenous infusion in man.” Circulation 66, no. 6 (December 1982): 1273–76. https://doi.org/10.1161/01.cir.66.6.1273.
    Full Text Link to Item
  - Moffat, J. A., P. W. Armstrong, and G. S. Marks. “Investigations into the role of sulfhydryl groups in the mechanism of action of the nitrates.” Can J Physiol Pharmacol 60, no. 10 (October 1982): 1261–66. https://doi.org/10.1139/y82-185.
    Full Text Link to Item
  - Armstrong, P. W., M. A. Chiong, and J. O. Parker. “The spectrum of unstable angina: prognostic role of serum creatine kinase determination.” Am J Cardiol 49, no. 8 (June 1982): 1849–52. https://doi.org/10.1016/0002-9149(82)90201-6.
    Full Text Link to Item
  - Abdollah, R., J. A. Moffat, and P. W. Armstrong. “Influence of ethacrynic acid on hemodynamic response to iv nitroglycerin.” Clinical Research 30, no. 2 (January 1, 1982).
  - Henderson, M. B., and P. W. Armstrong. “On-line microcomputer system for analysis of precordial maps.” J Electrocardiol 15, no. 3 (1982): 289–94. https://doi.org/10.1016/s0022-0736(82)80032-0.
    Full Text Link to Item
  - Moffat, J. A., H. Abdollah, D. G. Watts, and P. W. Armstrong. “Pharmacokinetic-hemodynamic response to consecutive infusions of nitroglycerin in the dog.” Clinical and Investigative Medicine 5, no. 2–3 (January 1, 1982).
  - Tan, J. K., P. W. Armstrong, and J. A. Moffat. “Canine vascular rings: An in vitro model to examine the effects of in vivo drug treatment.” Clinical and Investigative Medicine 5, no. 2–3 (January 1, 1982).
  - Armstrong, P. W., and D. G. Watts. “Clinical trials:randomization before consent.” Biomedicine 34, no. 2 (September 1981): 65–66.
    Link to Item
  - Armstrong, P. W. “Vasodilator therapy in acute myocardial infarction.” Practical Cardiology 7, no. 13 (January 1, 1981): 109–17.
  - Armstrong-Moffat, J. A., G. S. Marks, and P. W. Armstrong. “Effects of sustained nitroglycerin delivery on the arterial-venous gradient in the dog.” Clinical and Investigative Medicine 4, no. 2 (January 1, 1981).
  - Armstrong, P. W., J. A. Armstrong, and G. S. Marks. “Pharmacokinetic-hemodynamic studies of nitroglycerin ointment in congestive heart failure.” Am J Cardiol 46, no. 4 (October 1980): 670–76. https://doi.org/10.1016/0002-9149(80)90519-6.
    Full Text Link to Item
  - Armstrong, P. W., J. A. Armstrong, and G. S. Marks. “Pharmacokinetic-hemodynamic studies of nitroglycerin in congestive cardiac failure.” Nouv Presse Med 9, no. 34 Suppl (September 25, 1980): 2429–32.
    Link to Item
  - Armstrong, J. A., G. S. Marks, and P. W. Armstrong. “Absence of metabolite formation during nitroglycerin-induced relaxation of isolated blood vessels.” Mol Pharmacol 18, no. 1 (July 1980): 112–16.
    Link to Item
  - Armstrong, P. W., J. A. Armstrong, and G. S. Marks. “Pharmacokinetic-hemodynamic studies of intravenous nitroglycerin in congestive cardiac failure.” Circulation 62, no. 1 (July 1980): 160–66. https://doi.org/10.1161/01.cir.62.1.160.
    Full Text Link to Item
  - Leach, A. J., J. E. Brown, and P. W. Armstrong. “Cardiac depression by intravenous disopyramide in patients with left ventricular dysfunction.” Am J Med 68, no. 6 (June 1980): 839–44. https://doi.org/10.1016/0002-9343(80)90203-x.
    Full Text Link to Item
  - Armstrong, J. A., S. E. Slaughter, G. S. Marks, and P. W. Armstrong. “Rapid disappearance of nitroglycerin following incubation with human blood.” Can J Physiol Pharmacol 58, no. 5 (May 1980): 459–62. https://doi.org/10.1139/y80-077.
    Full Text Link to Item
  - Armstrong, P. W., J. A. Armstrong, and G. S. Marks. “Plasma nitroglycerin gradient during intravenous infusion in man.” Clinical Research 28, no. 3 (January 1, 1980).
  - Armstrong, P. W., J. A. Armstrong, and G. S. Marks. “Plasma nitroglycerin gradient during intravenous infusion in man.” Circulation 62, no. 4 II (January 1, 1980).
  - Armstrong, P. W., and R. S. Baigrie. “Hemodynamic monitoring in critically ill patients.” Heart Lung 9, no. 6 (1980): 1060–62.
    Link to Item
  - Armstrong, P. W. “Contributions of hemodynamic monitoring to the treatment of chronic congestive heart failure.” Can Med Assoc J 121, no. 7 (October 6, 1979): 913–18.
    Link to Item
  - Armstrong, P. W. “A new design for randomized trials.” N Engl J Med 301, no. 14 (October 4, 1979): 786.
    Link to Item
  - Armstrong, P. W., D. G. Watts, D. C. Hamilton, M. A. Chiong, and J. O. Parker. “Quantification of myocardial infarction: template model for serial creatine kinase analysis.” Circulation 60, no. 4 (October 1979): 856–65. https://doi.org/10.1161/01.cir.60.4.856.
    Full Text Link to Item
  - Armstrong, P. W., J. A. Armstrong, and G. S. Marks. “Blood levels after sublingual nitroglycerin.” Circulation 59, no. 3 (March 1979): 585–88. https://doi.org/10.1161/01.cir.59.3.585.
    Full Text Link to Item
  - Hull, R., T. J. Delmore, J. Hirsh, M. Gent, P. Armstrong, R. Lofthouse, A. MacMillan, I. Blackstone, R. Reed-Davis, and R. C. Detwiler. “Effectiveness of intermittent pulsatile elastic stockings for the prevention of calf and thigh vein thrombosis in patients undergoing elective knee surgery.” Thromb Res 16, no. 1–2 (1979): 37–45. https://doi.org/10.1016/0049-3848(79)90267-6.
    Full Text Link to Item
  - Leach, A. J., J. E. Brown, and P. W. Armstrong. “Parenteral disopyramide in patients with left ventricular dysfunction.” Clinical Research 27, no. 2 (January 1, 1979).
  - Armstrong, P. W., and P. C. Hoaken. “Behaviour and coronary artery disease: is this the missing link?” Can Med Assoc J 119, no. 6 (September 23, 1978): 552–55.
    Link to Item
  - Boroomand, K., and P. W. Armstrong. “Preservation of pre-excitation despite acute myocardial infarction complicated by complete heart block.” Can Med Assoc J 119, no. 2 (July 22, 1978): 139–42.
    Link to Item
  - Lewis, J. R., R. Kisilevsky, and P. W. Armstrong. “Prinzmetal's angina, normal coronary arteries and pericarditis.” Can Med Assoc J 119, no. 1 (July 8, 1978): 36–39.
    Link to Item
  - Armstrong, P. W. “Reply.” The American Journal of Cardiology 42, no. 6 (January 1, 1978): 1061. https://doi.org/10.1016/0002-9149(78)90708-7.
    Full Text
  - Armstrong, P. W., A. J. Leach, J. E. Brown, and J. O. Olowoyeye. “Comparative vasodilator studies in congestive cardiac failures.” Clinical Research 26, no. 6 (January 1, 1978).
  - Armstrong, P. W., J. A. Armstrong, and G. S. Marks. “Pharmacokinetic hemodynamic studies of nitroglycerin ointment in congestive cardiac failure.” Clinical Research 26, no. 6 (January 1, 1978).
  - Armstrong, P. W., J. A. Armstrong, and G. S. Marks. “Plasma levels following sublingual nitroglycerin.” Clinical Research 26, no. 3 (January 1, 1978).
  - Armstrong, P. W., M. A. Chiong, and J. O. Parker. “Effects of propranolol on the hemodynamic, coronary sinus blood flow and myocardial metabolic response to atrial pacing.” Am J Cardiol 40, no. 1 (July 1977): 83–89. https://doi.org/10.1016/0002-9149(77)90105-9.
    Full Text Link to Item
  - Armstrong, P. W., M. T. Mathew, K. Boroomand, and J. O. Parker. “Nitroglycerin ointment in acute myocardial infarction.” Am J Cardiol 38, no. 4 (October 1976): 474–78. https://doi.org/10.1016/0002-9149(76)90466-5.
    Full Text Link to Item
  - Burton, J. R., M. T. Mathew, and P. W. Armstrong. “Comparative effects of lidocaine and procainamide on acutely impaired hemodynamics.” Am J Med 61, no. 2 (August 1976): 215–20. https://doi.org/10.1016/0002-9343(76)90172-8.
    Full Text Link to Item
  - Kitchen, A. G., and P. W. Armstrong. “Letter: Swan-Ganz catheter repair.” Circulation 54, no. 1 (July 1976): 163–64. https://doi.org/10.1161/01.cir.54.1.163.
    Full Text Link to Item
  - Armstrong, P. W., K. Boroomand, A. G. Kitchen, and J. O. Parker. “Propranolol in acute myocardial infarction: Correlative effects on hemodynamics and precordial mapping.” Clinical Research 24, no. 5 (January 1, 1976).
  - Armstrong, P. W., K. Boroomand, and J. O. Parker. “Nitroprusside in acute myocardial infarction: correlative effects on hemodynamics and precordial mapping.” Circulation 54, no. 4 Sup.2 (January 1, 1976).
  - Armstrong, P. W., M. T. Mathew, and J. O. Parker. “Hemodynamic effects of nitroglycerin ointment in congestive cardiac failure.” Annals of the Royal College of Physicians and Surgeons of Canada 9, no. 1 (January 1, 1976).
  - Parker, J. O., R. J. Augustine, J. R. Burton, R. O. West, and P. W. Armstrong. “Effect of nitroglycerin ointment on the clinical and hemodynamic response to exercise.” The American Journal of Cardiology 38, no. 2 (January 1, 1976): 162–66. https://doi.org/10.1016/0002-9149(76)90143-0.
    Full Text
  - Armstrong, P. W., D. C. Walker, J. R. Burton, and J. O. Parker. “Vasodilator therapy in acute myocardial infarction. A comparison of sodium nitroprusside and nitroglycerin.” Circulation 52, no. 6 (December 1975): 1118–22. https://doi.org/10.1161/01.cir.52.6.1118.
    Full Text Link to Item
  - Armstrong, P. W., M. A. Chiong, and J. O. Parker. “Effects of propranolol on the response to atrial pacing in patients with coronary disease.” Circulation 52, no. 4 .sup2 (January 1, 1975).
  - Armstrong, P. W., M. T. Mathew, K. Boroomand, and J. O. Parker. “Hemodynamic effects of nitroglycerin ointment in acute myocardial infarction.” Circulation 52, no. 4 .sup2 (January 1, 1975).
  - Armstrong, P. W. “Letter: Discovery of paravalvular defects.” J Thorac Cardiovasc Surg 68, no. 2 (August 1974): 331–32.
    Link to Item
  - Weisfeldt, M. L., P. Armstrong, H. E. Scully, C. A. Sanders, and W. M. Daggett. “Incomplete relaxation between beats after myocardial hypoxia and ischemia.” J Clin Invest 53, no. 6 (June 1974): 1626–36. https://doi.org/10.1172/JCI107713.
    Full Text Link to Item
  - Armstrong, P. W., and J. O. Parker. “Comparative effects of isoproterenol and atrial pacing on coronary sinus blood flow and myocardial oxygen consumption.” Clinical Research 22, no. 3 (January 1, 1974).
  - Armstrong, P. W., R. E. Dinsmore, J. W. Harthorne, and C. A. Sanders. “Hemodynamic clues to the discrepancy between the angiographic and intraoperative assessment of aortic regurgitation.” J Thorac Cardiovasc Surg 66, no. 2 (August 1973): 265–70.
    Link to Item
  - Armstrong, P. W., H. K. Gold, M. J. Buckley, J. T. Willerson, and C. A. Sanders. “Hemodynamic evaluation of rate augmentation produced by atrial pacing and isoproterenol in the early postoperative phase of cardiac valve surgery.” Circulation 44, no. 4 (October 1971): 649–56. https://doi.org/10.1161/01.cir.44.4.649.
    Full Text Link to Item
  - Sanders, C. A., P. W. Armstrong, J. T. Willerson, and R. E. Dinsmore. “Etiology and differential diagnosis of acute mitral regurgitation.” Prog Cardiovasc Dis 14, no. 2 (September 1971): 129–52. https://doi.org/10.1016/0033-0620(71)90051-x.
    Full Text Link to Item
  - Armstrong, P. W., H. K. Gold, W. M. Daggett, W. G. Austen, and C. A. Sanders. “Hemodynamic evaluation of glucagon in symptomatic heart disease.” Circulation 44, no. 1 (July 1971): 67–73. https://doi.org/10.1161/01.cir.44.1.67.
    Full Text Link to Item
  - Armstrong, P. W., and J. O. Parker. “The complications of brachial arteriotomy.” J Thorac Cardiovasc Surg 61, no. 3 (March 1971): 424–29.
    Link to Item
  - Khaja, F., J. O. Parker, R. J. Ledwich, R. O. West, and P. W. Armstrong. “Assessment of ventricular function in coronary artery disease by means of atrial pacing and exercise.” Am J Cardiol 26, no. 2 (August 1970): 107–16. https://doi.org/10.1016/0002-9149(70)90767-8.
    Full Text Link to Item
  - Parker, J. O., R. B. Case, F. Khaja, J. R. Ledwich, and P. W. Armstrong. “The influence of changes in blood volume on angina pectoris. A study of the effect of phlebotomy.” Circulation 41, no. 4 (April 1970): 593–604. https://doi.org/10.1161/01.cir.41.4.593.
    Full Text Link to Item
- Book Sections
  - Welsh, R. C., and P. W. Armstrong. “Treatment Opportunities with Fibrinolytic Therapy.” In Reperfusion Therapy for Acute Myocardial Infarction, 71–90, 2016.
  - Welsh, R. C., and P. W. Armstrong. “Early prehospital management of st segment elevation myocardial infarction.” In Evidence-Based Cardiology: Third Edition, 444–55, 2010. https://doi.org/10.1002/9781444309768.ch30.
    Full Text
- Other Articles
  - Granieri, Michael A., George D. Webster, and Andrew C. Peterson. “Author Reply.” Urology, May 2016. https://doi.org/10.1016/j.urology.2015.12.088.
    Full Text Link to Item
- Conference Papers
  - Pokorney, Sean D., Sana M. Al-Khatib, Jie-Lena Sun, Phillip Schulte, Christopher M. O’Connor, John R. Teerlink, Paul W. Armstrong, et al. “Sudden cardiac death after acute heart failure hospital admission: insights from ASCEND-HF.” In Eur J Heart Fail, 20:525–32, 2018. https://doi.org/10.1002/ejhf.1078.
    Full Text Link to Item
  - Melloni, Chiara, Jan H. Cornel, Gail Hafley, Megan L. Neely, Peter Clemmensen, Dmitry Zamoryakhin, Dorairaj Prabhakaran, et al. “Impact of chronic kidney disease on long-term ischemic and bleeding outcomes in medically managed patients with acute coronary syndromes: Insights from the TRILOGY ACS Trial.” In Eur Heart J Acute Cardiovasc Care, 5:443–54, 2016. https://doi.org/10.1177/2048872615598631.
    Full Text Link to Item
  - DeVore, Adam D., Vic Hasselblad, Robert J. Mentz, Christopher M. O’Connor, Paul W. Armstrong, John J. McMurray, Justin A. Ezekowitz, et al. “Loop diuretic dose adjustments after a hospitalization for heart failure: insights from ASCEND-HF.” In Eur J Heart Fail, 17:340–46, 2015. https://doi.org/10.1002/ejhf.235.
    Full Text Link to Item
  - Cornel, Jan H., E Magnus Ohman, Benjamin Neely, Peter Clemmensen, Piyamitr Sritara, Dmitry Zamoryakhin, Paul W. Armstrong, et al. “Impact of smoking status on platelet function and clinical outcomes with prasugrel vs. clopidogrel in patients with acute coronary syndromes managed without revascularization: Insights from the TRILOGY ACS trial.” In Am Heart J, 168:76-87.e1, 2014. https://doi.org/10.1016/j.ahj.2014.04.011.
    Full Text Link to Item
  - Dianati Maleki, Neda, Arash Ehteshami Afshar, and Paul W. Armstrong. “Use of electrocardiogram indices of myocardial ischemia for risk stratification and decision making of reperfusion strategies.” In J Electrocardiol, 47:520–24, 2014. https://doi.org/10.1016/j.jelectrocard.2014.04.006.
    Full Text Link to Item
  - Smith, Laurajane. “Discussion,” 389–95. Göttingen, Germany: Universitätsverlag Göttingen, 2012.
  - Armstrong, Paul W. “A time for transformative leadership in academic health sciences.” In Clin Invest Med, 30:E127–32, 2007. https://doi.org/10.25011/cim.v30i3.1081.
    Full Text Link to Item
  - Fleming, Thomas, Steven E. Nissen, Jeffrey S. Borer, Paul W. Armstrong, and Paul W. Cardiovascular and Renal Drugs Advisory Committee: US Food and Drug Administration. “Report from the 100th Cardiovascular and Renal Drugs Advisory Committee meeting: US Food and Drug Administration: December 8-9, 2003 Gaithersburg, MD.” In Circulation, 109:e9004–5, 2004. https://doi.org/10.1161/01.CIR.0000118364.89571.16.
    Full Text Link to Item
  - Fleming, T., J. Borer, R. Lipicky, and P. W. Armstrong. “Report from the 94th Cardiovascular and Renal Drugs Advisory Committee Meeting, October 11, 2001.” In Circulation, 104:E9039, 2001. https://doi.org/10.1161/hc4301.101126.
    Full Text Link to Item
  - Naik, G. O., G. W. Moe, and P. W. Armstrong. “Specific and non-specific measurements of tissue angiotensin II cascade members.” In J Pharm Biomed Anal, 24:947–55, 2001. https://doi.org/10.1016/s0731-7085(00)00565-3.
    Full Text Link to Item
  - Kovacs, K. A. “Gene abnormalities may lead to multiple system defects for heart patients.” In Cmaj, 164:254, 2001.
    Link to Item
  - Armstrong, P. W. “New strategies for acute coronary syndromes.” In Sapporo Medical Journal, 69:76–81, 2000.
  - Armstrong, P. W. “Improved outcome in heart failure.” In Int J Clin Pract Suppl, 100:10–11, 1999.
    Link to Item
  - Langer, A., and P. W. Armstrong. “ST segment monitoring in patients with acute ischemic syndromes: Past and future.” In Journal of Thrombosis and Thrombolysis, Vol. 5, 1998. https://doi.org/10.1023/a:1008877932639.
    Full Text
  - Armstrong, P. W. “Perspectives gained from large-scale thrombolytic comparative trials.” In Eur Heart J, 17 Suppl E:9–13, 1996. https://doi.org/10.1093/eurheartj/17.suppl_e.9.
    Full Text Link to Item
  - Armstrong, P. W., and M. J. Mant. “Bleeding risks, risk factors and management of bleeding complications after treatment with anticoagulants, specific antithrombins, thrombolytics IIb-IIIa receptor blockers.” In Eur Heart J, 16 Suppl L:75–80, 1995. https://doi.org/10.1093/eurheartj/16.suppl_l.75.
    Full Text Link to Item
  - Cairns, J., P. Armstrong, I. Belenkie, J. Hirsh, D. Johnstone, M. Knudtson, M. Lemieux, D. Massel, D. Naylor, and L. Roy. “[Canadian Consensus Conference on Coronary Thrombolysis--current aspects].” In Can J Cardiol, 11:581–86, 1995.
    Link to Item
  - “Canadian Task Force for Cardiovascular Science. A Joint Initiative of the Heart and Stroke Foundation of Canada and the Canadian Cardiovascular Society.” In Can J Cardiol, 9:699–735, 1993.
    Link to Item
  - Armstrong, P. W. “New dose regimens for coronary thrombolysis.” In Can J Cardiol, 9:523–24, 1993.
    Link to Item
  - Armstrong, P. W., and C. D. Naylor. “Important patient subgroups in thrombolytic therapy.” In Can J Cardiol, 9:497–99, 1993.
    Link to Item
  - Massel, D., J. A. Cairns, P. W. Armstrong, M. Knudtson, and M. Lemieux. “Postcoronary thrombolysis management.” In Can J Cardiol, 9:541–52, 1993.
    Link to Item
  - Baird, M. G., W. P. Klinke, L. A. J. Higginson, P. W. Armstrong, B. J. Gersh, and J. A. Cairns. “Symposium: Thrombolytic therapy in acute myocardial infarction.” In Annals of the Royal College of Physicians and Surgeons of Canada, 23:285–88, 1990.
  - Armstrong, P. W., and R. S. Baigrie. “Hemodynamic monitoring in the critically ill patient: overview of symposium.” In Can Med Assoc J, 121:865–66, 1979.
    Link to Item

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.

Education, Training, & Certifications

Previous Appointments & Affiliations

Selected Publications

Academic Articles

Book Sections

Other Articles

Conference Papers